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Abstract 
In May 2002 the National Institute for Clinical Excellence (NICE) made the 
recommendation that all pregnant women with an RhD negative blood type should 
be offered routine antenatal anti-D immunoglobulin (Ig) prophylaxis (RAADP). 
Midwives were the key professional group who would be involved in administration 
of anti-D Ig and yet they had little input to formation of policy and contributed little 
to the evidence base that informs policy and practice. A midwifery perspective is 
however important and relevant, and forms the basis of this work.  
The thesis comprises three distinct, but related, pieces of research: a survey 
conducted in 2005 to determine implementation of RAADP at UK maternity units; 
secondary analysis of anti-D Ig errors involving midwives that were reported to the 
Serious Hazards of Transfusion (SHOT) scheme in 2007/8; and focus group 
interviews conducted in 2010 to explore midwives’ views on issues that impact the 
care provided for women with an RhD negative blood type. 
The aim of the RAADP survey was to establish current {2005} policy in the United 
Kingdom in relation to the NICE recommendation for RAADP (NICE, 2002). The 
survey formed the foundation on which to build the thesis by determining that by 
2005 RAADP had become an integral aspect of maternity care within the UK. 
However it also found that there were significant variations within local policies and 
among the information that was provided to pregnant women and healthcare 
professionals. The aim of the survey was to determine implementation of policy and 
not to explain findings, raising important questions which were used to inform the 
subsequent research.  
The second piece of research was secondary analysis of existing anti-D Ig error 
reports collated by SHOT. The analysis was unique in that it included only those 
errors involving midwives. The findings highlight both individual and organisational 
impact on errors, building on the findings of the RAADP survey. The research 
identified proximal errors, trigger events and fallible practices providing a 
framework within which the common pathways to error involving anti-D Ig can be 
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understood. This will allow midwives to better understand and improve the care they 
provide. This piece of research also raised further questions about midwifery practice 
and those questions informed the focus group research. 
The focus group research aimed to consolidate the findings of the previous research 
by gaining direct input from midwives. Two focus group interviews were held, with 
clinical midwives as participants. The research found that the midwives and the 
organisations within which they worked provided care in line with policy and 
procedure at the apparent expense of a woman centred approach. This appeared to be 
linked to the midwives’ understanding of their responsibility, accountability and the 
education and information that underpinned the care they provided. The other 
important finding from the focus group research was that the midwives regarded 
RAADP as a less important intervention than they did anti-D Ig given following a 
potentially sensitising event (PSE) during pregnancy or given following delivery.  
When considered as a whole body of work, this research provides unique and 
valuable insight to midwifery involvement in the care of women with an RhD 
negative blood type. The research highlights the challenge of achieving government 
objectives for individualised, woman centred care within the present framework of 
clinical governance and evidence based care. In doing so it also raises questions 
about how individual midwives and the midwifery profession have engaged with 
medical colleagues and policy makers to maintain a midwifery context to the care 
they provide. Although the research findings relate to care provided for women with 
an RhD negative blood type the findings are pertinent to other aspects midwifery 
practice, particularly those originating within the medical profession that are now a 
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Glossary of Terms 
Antigen 
A substance that, when introduced into the circulation of a person lacking that 
antigen, can stimulate production of a specific antibody. 
 
Antibody (ies) 
A plasma protein produced as the result of the introduction of a foreign antigen. 
Antibodies have the ability to combine with, and sometimes destroy, the cells 
carrying the antigen that stimulated their production. 
 
Anti-D antibody (ies)  
The antibody produced as a result of exposure to the RhD antigen. Anti-D antibodies 
can combine with and destroy red blood cells carrying the RhD antigen. 
 
Anti-D Immunoglobulin (Ig) 
A blood product containing a high concentration of anti-D antibodies. It is 
manufactured from the blood of human donors. 
 
DATIX 
Patient safety software used to record and report healthcare incidents and errors. 
 
Feto-maternal Haemorrhage (FMH) 
Transfer of fetal blood into the maternal circulation. 
 
Flow Cytometery  
A laser-based laboratory technology that is used to count specific cells:  for example 
to count the amount of fetal haemoglobin in a maternal blood sample. 
 
Haemolytic Disease of the Fetus and Newborn (HDFN)  
An alloimmune condition that develops in a fetus and/or newborn. It occurs when 
antibodies produced by the mother pass through the placenta into fetal circulation 
causing fetal red blood cells to break down. HDFN can cause anaemia, and ranges 
from very mild to severe. Fetal or neonatal death is rare but can occur. 
 
Immune anti-D 
Anti-D antibodies produced by a person in response to exposure to the RhD antigen, 
as opposed to anti-D present as a result of injection of anti-D immunoglobulin 
(passive anti-D). 
 
Immunisation, also known as Sensitisation  
A process by which an individual’s immune system produces antibodies against a 
specific antigen. Immunisation is permanent and irreversible. 
 
Index pregnancy  
In this work it refers to the pregnancy during which a woman becomes immunised or 
sensitised. 
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Glossary of Terms  
 
Kleihauer Test 
A laboratory test that measures the amount of fetal haemoglobin present in a 
maternal blood sample. 
 
Maternal sensitisation  
Production of red cell antibodies by a mother as a result of exposure to an antigen 
from her fetus during a pregnancy. 
 
Passive anti-D  
Anti-D antibodies present in a person’s blood as a result of receiving an injection of 
anti-D immunoglobulin, as opposed to anti-D antibodies produced in response to 
exposure to the RhD antigen (immune anti-D).   
 
Potentially Sensitising Event (PSE) 
An event that is thought to increase the risk of feto-maternal haemorrhage and 
subsequent maternal sensitisation: for example, vaginal bleeding and invasive uterine 
procedures. 
 
Rhesus (Rh)  
Refers to the Rhesus blood group system, consisting of around 50 blood group 
antigens including D, C, c and E. 
 
Rhesus D (RhD)  
Refers to the D antigen, one of the antigens of the Rhesus blood group system 
 
Rhesus D (RhD) negative 
Refers to absence of the RhD antigen: RhD negative blood does not contain the RhD 
antigen. 
 
Rhesus D positive  
Refers to presence of the RhD antigen: RhD positive blood contains the RhD 
antigen. 
 
Routine Antenatal Anti-D Prophylaxis (RAADP) 
Anti-D immunoglobulin offered routinely during pregnancy regardless of any 
potentially sensitising event. It should be administered during the third trimester, 
with the aim of preventing silent sensitisation. 
 
Sensitisation, also known as Immunisation 
A process by which an individual’s immune system produces antibodies against a 
specific antigen. Sensitisation is permanent and irreversible. 
 
Silent Sensitisation 
Maternal sensitisation that occurs in the absence of any apparent potentially 
sensitising event.  
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Chapter 1: Introduction 
1.1 Introduction 
In May 2002 the National Institute for Clinical Excellence (NICE) made a 
recommendation that all pregnant women with an RhD negative blood type should 
be offered routine antenatal prophylaxis with anti-D immunoglobulin (RAADP) 
(NICE, 2002). The recommendation was controversial and constituted a significant 
change from current practice. Anti-D immunoglobulin (Ig) is a blood product and its 
use in clinical practice is controlled by the blood transfusion services of the United 
Kingdom (UK). When this work was commenced the researcher was employed as a 
Transfusion Specialist Midwife with the Scottish National Blood Transfusion 
Service, a role which involved facilitating the safe and effective use of blood and 
blood products, including anti-D Ig, through education, research and clinical 
effectiveness initiatives. The then new NICE guidance inspired the researcher to 
consider the care offered to pregnant women with an RhD negative blood type. In 
particular the impression that although midwives were the key professional group 
involved in administration of anti-D Ig, they appeared to have had little or no input in 
the formation of policy and had contributed little published evidence to inform 
practice. A midwifery perspective on this subject is relevant and important and forms 
the foundation of this research. The research was completed part time, and developed 
through and alongside the researcher’s clinical work.  This created challenges but 
also opportunities that might not otherwise have been available. The resulting work 
forms this thesis, a body of work that was also clinically relevant within the 
researcher’s role as a transfusion specialist midwife. 
The work comprises three distinct pieces of research: A survey of all UK maternity 
units to establish policy surrounding provision of RAADP; secondary analysis of 
midwifery errors involving anti-D Ig as reported to the Serious Hazards of 
Transfusion (SHOT) report and focus group interviews to explore midwives’ 
perspective on the care provided for RhD negative women. These three separate 
pieces of research, when considered together, give a broad perspective on current 
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practice and the contribution that midwives make to the care provided for pregnant 
and postnatal women with an RhD negative blood type. 
The work started in 2004, with the RAADP survey completed in 2005.  A request 
was received from a member of the NICE RAADP review group to use data from the 
RAADP survey (Appendix 2) and it was subsequently referred to in the 2008 review 
(NICE, 2008, Pg7). In 2008 the research was published in the Journal of Transfusion 
Medicine (Harkness et al, 2008 (Appendix 1)). The work is presented here as a 
concise chapter with a summary of the main findings. Completion of the RAADP 
survey research was followed by a formal break in studies. After the break the 
research project was reconsidered in context of changes to practice and emerging 
literature. Data collection and analysis for the two subsequent pieces of research 
were completed in 2010 and 2011.  
The aim of this collective research is to provide a broad overview of care provided 
for RhD negative pregnant and postnatal women in the UK, from a midwifery 
perspective. The objectives being: to describe current policy and practice, to 
understand what mistakes are made and why, and to seek a midwifery perspective on 
those aspects of care. The three pieces of research, their specific aims, methods and 
justification for undertaking them are described in subsequent chapters. The key 
theme of this research is development of an understanding of how and why midwives 
practise in relation to care of pregnant and parturient women with an RhD negative 
blood group. 
The thesis consists of eight chapters. Chapter one provides an introduction to the 
research, Chapter two gives background to the physiology of RhD blood type and 
why it is significant during pregnancy, Chapter three is a review of the literature 
concerning the issues pertinent to the thesis. Chapter four outlines the aims and 
objectives of the studies and gives a broad overview of the approach used for each of 
the three different pieces of research that make up the thesis. This chapter also 
provides other significant information such as ethical considerations. Chapter five, 
six and seven present the three separate pieces of research providing background, 
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methods, data analysis, and findings specific to those particular pieces of work. In 
the final chapter, Chapter eight, the findings of the three strands of work are 
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Chapter 2: RhD Negative Blood Type and 
Pregnancy 
This chapter provides background information about care provided for pregnant and 
parturient women with a Rhesus D (RhD) negative blood group in the United 
Kingdom (UK). It describes the physiology of RhD negative blood types, the 
problems they can cause during pregnancy and the use of anti-D immunoglobulin to 
prevent this. The following chapter, Chapter three, outlines further relevant literature 
in more detail. 
2.1 RhD blood type and maternal sensitisation 
Human blood can be categorized by the ABO system; in addition it is also often 
described as either Rhesus positive or Rhesus negative. There are several Rhesus 
antigens, but D is the most prevalent and the description of blood type as Rhesus 
positive or negative commonly refers to the presence or absence of the Rhesus D 
(RhD) antigen (Turner, 2001). Around 16% of the UK population has RhD negative 
blood, although this varies between ethnic groups. For example only 5% of West 
Africans are RhD negative and the blood type is practically non-existent in Chinese 
people (Contreras, 1998).  
People who are RhD negative may produce anti-D antibodies if RhD positive red 
blood cells enter their blood stream. This can happen either by transfusion of RhD 
positive blood or, more commonly, during a pregnancy with an RhD positive fetus. 
Fetal and maternal circulations are distinct with fetal and maternal blood separated 
by the placenta. Occasionally fetal blood does pass into maternal circulation and this 
is known as feto-maternal haemorrhage (FMH). FMH may result in a maternal 
immune response and production of anti-D antibodies. Once formed the anti-D 
antibodies will always remain in the mother’s circulation and may become active 
should further contact with RhD positive blood occur, for example during a 
subsequent pregnancy with an RhD positive baby. This reaction is known as 
sensitisation, or immunisation, and is permanent and irreversible. 
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2.1.1 Haemolytic disease of the fetus and newborn 
Sensitisation with anti-D antibodies is of little physical consequence to a person 
unless they require a blood transfusion, in which case they should receive antigen 
specific blood to avoid a haemolytic transfusion reaction. However, a potentially 
very serious consequence of maternal sensitisation is haemolytic disease of the fetus 
and newborn (HDFN). Many different anti-red cell antibodies can cause HDFN, 
including anti-c and anti-K (Kell), but the work described here relates to maternal 
sensitisation with RhD antibodies. 
RhD HDFN is a condition in which a fetus or newborn infant’s red blood cells are 
destroyed by maternal anti-D antibodies. This only happens when a sensitised RhD 
negative woman becomes pregnant with an RhD positive baby: the maternal anti-D 
antibodies are able to cross the placenta and can attack RhD positive fetal red blood 
cells, destroying them. HDFN is unlikely to cause problems for the pregnancy that 
causes sensitisation, but in subsequent pregnancies an RhD positive fetus will be at 
risk, an RhD negative fetus is not at risk. Destruction of fetal red blood cells can 
begin during intrauterine life and may lead to severe anaemia, hydrops fetalis and 
possibly death in-utero. In live born infants anaemia and jaundice caused by 
hyperbilirubinaemia worsens in the first few days of life. One of the most serious 
consequences of HDFN is kernicterus, damage to brain tissue due to high levels of 
bilirubin.  Advances in antenatal and neonatal investigations and treatment mean that 
severe HDFN is now very rare.  
2.2 Preventing maternal sensitisation: anti-D 
immunoglobulin prophylaxis 
Anti-D immunoglobulin is a manufactured blood product that contains a high 
concentration of anti-D antibodies. It is prepared from plasma from sensitised 
donors. In the early 1960’s it was recognised that intramuscular administration of 
anti-D immunoglobulin (Ig) could clear RhD positive fetal red blood cells from 
maternal circulation and prevent sensitisation from occurring (Contreras, 1998). This 
finding led to the recommendation in 1969 that anti-D Ig should be offered to all 
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RhD negative women after delivery of an RhD positive baby (postnatal prophylaxis). 
The early 1970s saw widespread introduction of anti-D Ig postnatal prophylaxis 
across the UK and a subsequent dramatic fall in deaths attributed to HDFN. In 1977 
18.5 deaths per 100,000 live births were registered as due to haemolytic disease of 
the fetus or newborn; by 1989 this figure had fallen to just 1.5 per 100,000 live births 
(Hussey and Clarke, 1991). The policy was so successful that it was hailed as “a 
major obstetrical achievement” (Crowther and Middleton, 1999, Pg2).  
The original policy was updated in 1976, 1981 and in 1991 extending the 
recommendation for prophylactic anti-D Ig to women with an RhD negative blood 
type who had an abortion and included several other events after which it was 
recognised that women may be more likely to develop antibodies. These events are 
known as potentially sensitising events and include delivery of an RhD positive 
baby, invasive procedures such as amniocentesis, antepartum haemorrhage and blunt 
abdominal trauma (Lee et al, 1997). To be effective a recommended standard dose of 
anti-D Ig (according to gestation) should be given within 72 hours of an event 
occurring. In addition a test, such as the Kleihauer test, should be used to estimate 
the size of any feto-maternal haemorrhage with additional anti-D Ig given if 
indicated.  
Without anti-D Ig prophylaxis a pregnant RhD negative woman carrying an RhD 
positive baby has a 17% chance of immunisation with each pregnancy (Contreras, 
1998). In the United Kingdom, with the widespread use of anti-D Ig prophylaxis, the 
current rate of sensitisation among RhD negative pregnant women is estimated at 
between 1.2% and 1.8% (NICE, 2008). Table 1 (below) summarises current UK 
policy for prevention of maternal sensitisation with anti-D antibodies. 
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prophylactic anti-D immunoglobulin, 2006. 
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2.2.1 Routine antenatal anti-D Ig prophylaxis (RAADP) 
The anti-D Ig programme resulted in a dramatic drop in deaths related to haemolytic 
disease in the UK (Hussey and  Clarke, 1991), but, despite the decrease, there remain 
around 17 fetal and neonatal deaths per year attributed to RhD HDFN (NICE, 2002). 
Residual morbidity and mortality related to RhD HDFN is due to maternal 
sensitisation that occurs as a result of failure to administer anti-D Ig in line with 
guidance or due to silent sensitisation (Urbaniak, 1998, Van Dijk, 1997). Silent 
sensitisation is maternal sensitisation that occurs in the absence of any potentially 
sensitising event such as vaginal bleeding or abdominal trauma and it most often 
happens during the third trimester of pregnancy. 
Routine antenatal anti-D prophylaxis (RAADP) is offering anti-D Ig to all RhD 
negative pregnant women during the third trimester of pregnancy, whether or not 
they experience a potentially sensitising event. It aims to prevent silent sensitisation 
by maintaining a prophylactic level of anti-D Ig in maternal circulation during the 
third trimester. In the UK, RAADP was first recommended in 1998 following a joint 
meeting of the Royal College of Physicians of Edinburgh and the Royal College of 
Obstetricians and Gynaecologists (RCOG). The outcome of the meeting was a 
consensus statement on prophylactic anti-D Ig recommending that all RhD negative 
pregnant women should be given anti-D Ig prophylactically (RCOG, 1998). In 2002 
the National Institute for Clinical Excellence (NICE) conducted a Technology 
Appraisal (TA) on RAADP. This examined clinical and cost effectiveness and led to 
the recommendation that all RhD negative pregnant women in the UK should be 
offered RAADP (NICE, 2002). The Health Technology Board for Scotland (HTBS) 
and the Department of Health, Social Services and Public Safety (DHSSPS) in 
Northern Ireland both endorsed the recommendation.  
Both the RCOG and the NICE guidance recommend that all pregnant women should 
be offered an injection of 500 IU anti-D Ig at 28 weeks gestation and again at 34 
weeks gestation. An alternative product is also available providing a single dose of 
1500 IU anti-D Ig given at 28 weeks gestation. There is some evidence that 
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compliance with guidance may be improved by using a single dose regimen 
(McKenzie et al, 2006 and  2011) and some authors have considered that the clinical 
implications of offering a single injection are beneficial in terms of resources and 
organisation (Chilcott et al, 2004). Both regimens have been shown to be effective, 
and the NICE TA review in 2008 revised the guidance stating that either regimen 
could be offered (NICE, 2008). 
The NHS in England and Wales has a statutory obligation to provide funding and 
resource for all medicines and treatments that NICE recommends. However it is 
acknowledged that cost remains a significant factor in an NHS Trust’s decision about 
whether to offer a specific treatment, and about which product to offer. The financial 
cost of offering RAADP is very substantial, with the gross cost of providing RAADP 
to all RhD negative pregnant women in England and Wales estimated at around 
£6.07million per year (Chilcott et al, 2004).  
UK maternity units were slow to start offering  RAADP, with Chilcott et al (2004) 
reporting that by 2001 only 12% of maternity units in England and Wales offered 
RAADP.  In 2004, when this work commenced, there was little information about 
how many maternity units offered RAADP although the researcher knew through 
personal experience and communication that many still did not. The survey 
conducted as part of this research (Chapter five) found that in 2005 75% of UK 
maternity units offered RAADP (Harkness et al, 2008). In Scotland all maternity 
units now offer RAADP, but the current state of implementation in England and 
Wales is not clear. In 2008 the Public Ombudsman for Wales upheld a complaint 
from a pregnant woman whose local health board did not offer RAADP (Public 
Services Ombudsman for Wales, 2009). 
2.3 Anti-D immunoglobulin: potential risks 
There are clear benefits from administration of anti-D Ig however it is also associated 
with some risk. Anti-D Ig is manufactured from human plasma and as a human blood 
product it carries a risk of transmission of viral infection.  
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Transmission of hepatitis C via contaminated anti-D Ig is known to have occurred in 
Ireland between 1977 and 1979 (Lawlor and Columb, 1999), and during 1978 and 
1979 a single source outbreak of hepatitis C occurred in 2533 German women who 
had received virus contaminated anti-D Ig (Meisel et al 1995). Dumasia (1989) also 
reported contamination of anti-D Ig with human immunodeficiency virus (HIV) in 
India in 1988 however there are no reports of any transmission to pregnant women. 
The cases of hepatitis C contamination in Ireland and Germany occurred prior to the 
introduction of hepatitis C screening of blood donors. In the UK anti-D Ig is 
manufactured from pools of plasma from a large number of donations. All plasma 
donations are now tested for hepatitis B, hepatitis C and HIV. When the plasma is 
pooled all testing is repeated using validated methods, in addition all plasma pools 
are tested as part of a batch release procedure for blood products. To further reduce 
the risk of viral transmission anti-D Ig is subject to solvent/detergent treatment, a 
process known to be effective against enveloped viruses such as HIV, hepatitis B and 
hepatitis C, although of limited value against non-enveloped viruses such as hepatitis 
A and parvovirus B19 (Bio Products Laboratory (BPL), 2012). Since the widespread 
introduction of anti-D Ig prophylaxis in the early 1970’s there have been no recorded 
incidents of viral transmission in the UK, or in North America where anti-D Ig is 
manufactured using a similar method (Urbaniak, 1998). Bio Products laboratory 
(BPL), one of the major manufacturers of anti-D Ig in the UK estimate that the risk 
of transmission of known viruses through anti-D Ig is around 1 in 10,000 million 
doses (BPL, 2012) 
Anti-D Ig can only be screened for the presence of known viruses for which 
screening tests are available.   The risk of transmission of new variant Creutzfeldt 
Jakob Disease (nvCJD) is impossible to quantify and there are currently no screening 
tests available. In May 1998 the Committee of Safety of Medicines recommended 
that all plasma products be manufactured from non-UK plasma. Plasma for the 
manufacture of anti-D Ig is now collected from donors within the European Union or 
the United States of America.  
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Improved screening tests and production technique mean that the risk of viral 
transmission in anti-D Ig is very small, nevertheless “a potential risk remains of 
known and unknown viruses for which screening tests are not available” (Urbaniak, 
1998, Pg14). 
Another potential risk associated with the use of anti-D Ig during pregnancy is the 
risk of transfer of anti-D Ig to the fetus, which would be expected to cause anaemia. 
Clinical trials show no such adverse effect and Urbaniak (1998) concludes that 
although anti-D Ig may cross the placenta the amount is insufficient to cause 
observable anaemia in the fetus or neonate. This is also reflected by the work of 
Maayan-Metzger et al (2001) whose research compared 101 study babies with 37 
control babies. They found no difference in haemoglobin levels between the study 
babies, whose RhD negative mothers had received one or two doses of anti-D Ig, and 
the control group of babies born to RhD positive mothers who had not received anti-
D Ig. 
Another documented side effect of anti-D Ig is hypersensitivity however the effects, 
including rash and nausea, are almost always mild. Severe allergic reaction is 
extremely rare (BPL, 2012, Urbaniak, 1998).  
2.4 Midwives’ role in anti-D Ig prophylaxis 
In the UK midwives are the key care providers for the majority of pregnancies. 
Regarded as experts in normal pregnancy they work closely with obstetricians and 
general practitioners to provide maternity care during pregnancy, around the time of 
birth and in the postnatal period. In an uncomplicated pregnancy a woman might 
receive all of her maternity care from a midwife without ever seeing a member of 
medical staff. Women with complications during pregnancy will most often receive 
multi-disciplinary care, led by a consultant obstetrician and with significant input 
from midwives. 
RAADP and postnatal anti-D Ig prophylaxis are regarded as part of routine care and 
in most maternity units in the UK midwives will identify a need for anti-D Ig, 
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discuss this with the woman concerned, offer anti-D Ig and may prescribe and 
administer it if the woman agrees. Potentially sensitising events (PSE) during 
pregnancy such as vaginal bleeding, amniocentesis and blunt abdominal trauma are 
all regarded as complications and as such would require medical input. In these cases 
the midwife would often be the first point of contact for the woman and be the 
person who advises her whether or not to attend for assessment. An obstetrician will 
then make the decision about whether anti-D Ig is appropriate and complete a 
prescription. In most cases the midwife will then go on to administer the anti-D Ig. 
The process that a midwife should follow prior to administration of anti-D Ig, 
including necessary checks, is detailed in Figure 1 below.  
Figure 1: Procedure for administration of anti-D Ig 
 
NB: The midwife must also engage the woman in a process of informed decision making. 
This process may span a number of occasions and might encompass provision of written 
information and discussion. This should result in the woman accepting or declining anti-D Ig 
prior to administration of the product. 
 
 
2.4.1 A midwifery perspective on RAADP 
Midwives are considered experts in normal childbirth with the philosophy of 
midwifery care underpinned by the ideal that pregnancy and childbirth are 
fundamentally normal processes. The midwifery paradigm acknowledges the 
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significance of women’s individual differences and offers care that is based on the 
specific needs and choices of a particular woman. This approach recognises the 
importance of empowering women through involving them in decisions about their 
care, and that the subsequent impact on their self worth and confidence has far 
reaching consequences for them and their families (Leap, 2009). In contrast the 
biomedical approach views childbirth as an inherently risky process that may only be 
described as normal in retrospect. It relies on evidence based on a population 
perspective to decide what the ‘best option’ for women is. As a result the medical 
paradigm tends towards treatment as a pre-emptive measure, whereas the midwifery 
approach will wait until there is evidence that intervention is required (Rooks, 1999).  
The Royal College of Obstetricians and Gynaecologists (RCOG, 1999) 
recommendation for a policy of offering anti-D Ig routinely during pregnancy 
(RAADP) was controversial. Midwives voiced strong concerns about the 
introduction of this routine intervention that would see all pregnant women with an 
RhD negative blood type offered a blood product (RCM, 1999).  Although anti-D Ig 
is generally regarded as a very safe product, it is not without risk. Those risks are 
particularly difficult to quantify as they are based on unknown factors (Section 2.3, 
Pg 9) and, equally, the benefits of RAADP are difficult to ascertain at an individual 
level as the likelihood of benefit is impacted by factors that are most often unknown 
at that time. These include the blood type of the unborn baby, whether or not the 
woman will go on to have another pregnancy, and if she does what the blood type of 
any future baby or babies will be. The decision making process around RAADP is 
very important, but is also difficult for midwives to facilitate effectively: requiring 
knowledge and understanding of the issues; confidence in their ability to engage in 
discussion of this nature and additional time for that discussion. The 
recommendation to establish clinical policy to offer a blood product to all pregnant 
women with an RhD negative blood type makes it imperative that those women 
know and understand the risks and benefits of what they are being offered. It has 
been suggested that when intervention is routine policy midwives’ primary 
allegiance becomes to their employer rather than to the woman and that they may 
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gather informed consent rather than offer informed choice (Thompson, 2013). 
Presenting RAADP as a choice for women within the scope of it being 
‘recommended’ was recognised by the midwifery profession as vital but also as 
significantly challenging (RCM, 1999). 
Concerns about the recommendation for RAADP can also be understood in the 
context of medical and midwifery approaches to care. The midwifery paradigm is 
one of woman centred care that takes into account individual differences and 
‘routine’ intervention is inherently inappropriate. The evidence for recommending 
RAADP (RCOG, 1999, NICE, 2002) was based on a population gain, rather than on 
any potential benefit for a particular woman. As such a policy of offering RAADP 
represents ‘routine’ pre-emptive intervention without evidence of benefit for a 
particular individual, fundamentally conflicting with the midwifery approach to care. 
Walsh and Newburn (2002) express concern that the routinisation of clinical 
practices is an example of how maternity services centre around the professional 
rather than the woman, and the concerns that were raised by midwives focused on 
potential for failure to provide woman centred care if anti-D Ig was offered to all 
RhD negative women in a routine manner (RCM, 1999). 
As a midwife working for the Scottish National Blood Transfusion Service 
(SNBTS), the researcher was vitally aware of the contrast between the medical, 
scientific and midwifery approaches to care for pregnant women with an RhD 
negative blood type. The researcher’s experience was that policy and evidence in this 
area reflected a biomedical approach to information gathering that appeared to 
separate the woman’s physiology from her experiences and her social and emotional 
context. In general the scientists and haematologists who establish policy, and 
ultimately practice, in this field appeared to consider that the only evidence of value 
was that which demonstrated physiological impact through what they regarded as 
scientifically robust quantitative experimental research. This contrasted with the 
midwifery approach that would consider the woman as important at an individual 
level and encompass a number of aspects other than physiology that might impact 
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outcomes, with the option of gathering evidence from sources other than 
experimental research.  
The RCOG (1999) and subsequent NICE (2002) recommendation for a policy of 
RAADP in the UK required midwives to assume responsibility for offering and 
subsequently administering anti-D Ig to all pregnant women with an RhD negative 
blood type. This greatly increased their involvement in this area of practice, yet as a 
profession they made very limited contribution to policy and published evidence in 
this field. It is of note that midwives were not included in the 1998 consensus 
conference that led to the recommendation for RAADP (RCOG, 1999). Their 
subsequent concern, after the event (RCM, 1999), reflects the observation of Walsh 
and Newburn (2002, Pg476) that midwives often find themselves ‘reacting to, not 
proactively engaging with, the latest initiatives.’  
The following chapter, Chapter three, considers available evidence about the care of 
RhD negative pregnant and postpartum women in greater depth. The contrast 
between medical and midwifery approaches, the midwifery perspective on anti-D Ig 
policy and the concerns raised about a policy for routine antenatal anti-D Ig are 
discussed in greater detail in Section 3.5.1, Pg 51. 
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Chapter 3: Professional and Organisational 
Issues: a review of the literature 
The overall aim of this research was to describe practice and policy surrounding the 
care of women with an RhD negative blood type from a midwifery perspective. The 
objectives being to describe midwifery practice in relation to women with an RhD 
negative blood type and to develop an understanding of the contribution that 
midwives make to this aspect of maternity care.  
Within this overall aim there were three distinct aims: 
• To determine current UK policy in relation to the NICE (2002) 
recommendation for routine antenatal anti-D Ig (RAADP). With the objective 
of describing aspects of policy, and its implementation, that impact clinical 
midwifery practice. 
• To describe anti-D Ig errors made by midwives. With the objective of gaining 
a wider understanding of the types of mistakes made and the factors that 
influence them. 
• To explore midwives’ perspectives on the care provided for women with an 
RhD negative blood type. With the objective of eliciting their views 
concerning questions identified from the previous research and in existing 
evidence. 
The literature review was initially focussed on practice and policy concerning 
women with an RhD negative blood type exploring: development of policy; the 
physiological and scientific basis for policy and guidance; and studies relating to 
actual clinical practice. As the literature review progressed the search was widened in 
order to address the further aims and objectives of the research and the emerging 
themes within the evidence.  
One topic that became central to the literature review was quality. The Oxford 
English Dictionary (2014) defines quality as ‘the degree of excellence of something’, 
and within the NHS quality is central to existing policy.  
Policy and Practice Concerning Women with an RhD Negative Blood Type:              
A midwifery perspective 
Chapter Three: Professional and organisational issues: a review of the literature 17 
The medical and midwifery perspectives (discussed in Sections 2.4.1 and 3.5.1) have 
different approaches to defining and measuring quality.  The biomedical approach 
tends towards defining quality in healthcare as based solely on clinical outcomes, 
employing checks and balances to determine and maintain their ideal of quality. The 
midwifery approach, however, would encompass the ‘whole’ experience, including 
the woman’s perception of whether her care was good or bad. Within this work it 
was deemed important to explore quality from a midwifery perspective, including 
not only objective clinical outcomes but also those other factors that might determine 
quality care within a midwifery paradigm. 
When the care of women with an RhD negative blood type is considered within a 
biomedical framework of quality it focuses on delivering safe and effective clinical 
care, principally in order to prevent maternal sensitisation with anti-D antibodies. 
This is measured through checks based on adherence to clinical recommendations 
and guidelines, and audited by incident reporting and clinical outcomes. The 
midwifery approach, however, considers that provision of woman centred care, 
including making an informed decision about whether anti-D Ig is right for a 
particular woman, is equally important to quality. This wider view of quality care in 
relation to women with an RhD negative blood type was deemed fundamental to the 
framework on which this research was based and as such ‘quality’ features as central 
to the literature presented here.  
An important aspect of quality is provision of safe and effective care. The literature 
review includes examination of factors that impact on this including incident 
reporting and investigation. The research presented in Chapter six: Anti-D Ig, 
analysis of midwifery errors reported to SHOT has as its aim ‘to describe anti-D Ig 
errors made by midwives’. As there is little information directly relating to anti-D Ig 
in this area, much of the evidence considered here relates instead to medication 
errors.  
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Another fundamental aspect of quality care for RhD negative women and a key 
feature of midwifery practice is informed decision making. This was another subject 
area that was explored within the literature review. 
The aim of the third piece of research, Chapter 7: Focus group research to gain a 
midwifery perspective, was to explore midwives’ perspectives on the care provided 
to RhD negative women. This, and the overarching aim of determining a midwifery 
perspective on care, required exploration of what a midwifery perspective is and how 
this may differ from a medical or scientific approach. This was done through review 
of literature pertaining to the ‘midwifery model’ and around medicalisation of 
childbirth.  
The literature review is wide ranging and aims to address the issues pertinent to the 
overarching, and the more specific, aims and objectives of the research. 
3.1 Search Strategy 
The literature review was undertaken using the Knowledge Network resource 
(www.knowledge.scot.nhs.uk) to search the following databases: Ovid, including 
Medline and MIDIRS; CINHAL and the Cochrane Library. The overarching search 
terms were: anti-D immunoglobulin; Rhesus; Routine antenatal anti-D and 
Haemolytic disease of the newborn. Various synonyms and abbreviations such as: 
RhD; Rhesus D; Rhesus negative; RAADP; Rhesus disease; anti-D Ig and HDN 
were also used, as were combinations of terms. The search was limited to English 
language and there was no date limit. Similarly the country of origin of articles was 
not limited, however articles were considered individually for relevance to the aims 
of this research in the context of practice within the UK. This resulted in some 
international, English language, articles being excluded. Articles deemed no longer 
relevant due to age were also excluded using the same process. The inclusion criteria 
for the literature were studies, articles and evidence that focussed on, or were 
relevant to, the physiology, treatment and/or clinical care of pregnant and parturient 
women with an RhD negative blood type in the UK. 
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As the research progressed further searches were made such as quality in health care, 
including: clinical governance; adverse events; incident reporting and informed 
decision making, and midwifery, including: midwifery model; medicalisation of 
childbirth; midwifery profession. 
Reference lists within identified articles were scrutinised in order to identify any 
further relevant literature not uncovered by the initial search. In addition books, 
articles, abstracts and policy documents recommended by colleagues, advisors and 
supervisors and encountered through work with the Scottish National Blood 
transfusion Service (SNBTS) were also considered for inclusion.  
The literature was first searched in 2004, and the search was repeated regularly 
throughout the work to ensure that any new evidence would be considered.  
A significant number of the articles referred to in the literature review were 
published during the 20th century. The consensus statement that first recommended 
routine antenatal anti-D (RAADP) in the UK resulted from a joint meeting of the 
Royal College of Physicians of Edinburgh and the Royal College of Obstetricians 
and Gynaecologists (RCOG).  This was held in 1998 at a time when there was 
heightened interest in care provided for pregnant women with an RhD negative blood 
type. Although it almost exclusively pre-dates 1998, it was important and relevant to 
discuss the evidence considered at the joint meeting as that evidence led to the 
recommendation for RAADP (RCOG, 1999, NICE, 2002). The heightened 
awareness surrounding the joint meeting and consensus statement (RCOG, 1999) 
resulted in a number of articles concerning RAADP, anti-D Ig and care provided for 
women with an RhD negative blood type. These were also published around this 
time, and were also important and relevant to the thesis.  
3.2 Quality in the NHS 
In 1997 the newly elected Labour government introduced a 10 year programme with 
the aim of renewing and improving the NHS: ‘The New NHS Modern-Dependable’ 
(DOH, 1997). Quality was regarded as being at the heart of this approach with the 
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subsequent white paper ‘A first Class Service: Quality in the New NHS’ (DOH, 
1998) outlining wide ranging quality focused ambitions for the ‘new NHS’.   
The term ‘quality’ is difficult to define. In 2008, Lord Darzi published a next stage 
review ‘High quality care for all’, a huge consultation involving over 60,000 staff, 
clinicians, patients and members of the public. The report offered a definition of 
quality as “[care which is] clinically effective, personal and safe” (Darzi, 2008, 
Pg8/9), and this definition is now widely used. In addition there are six 
internationally recognised dimensions of a quality framework: person-centred; safe; 
efficient; effective; equitable and timely (Scottish Government, 2010a). 
In Scotland healthcare policy has broadly mirrored that in the rest of the UK, and the 
publication in 2010 of ‘The Healthcare Quality Strategy for NHS Scotland’ 
reinforces the importance of quality within healthcare policy in Scotland, and echoes 
Lord Darzi’s assertion that the NHS should have quality at its heart. The report 
describes three quality ambitions that provide the focus for prioritising and 
integrating activity across Scotland, these are: safe, effective and person-centred. 
The report ‘An Organisation with Memory’ (Department of Health, 2000) 
acknowledged that although the majority of care given within the NHS is of a very 
high standard, serious failures do occur. This has important implications for 
individual patients and staff members, and potentially undermines public confidence 
in the organisation. It also carries a large financial burden.  Patient safety is seen as 
key to delivering quality in the NHS, and for most countries, worldwide, patient 
safety is the most significant issue in healthcare quality and risk management 
(National Audit Office, 2005). The National Audit Office offers a definition of a 
patient safety incident as:  
“Any unintended or unexpected event that lead to death, disability, injury, disease or 
suffering for one or more patients” 
 
(National Audit Office, 2005, Pg1) 
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Estimates suggest that in the UK adverse events that harm patients occur in around 
10% of hospital admissions, a rate similar to other high resourced countries, costing 
the NHS an estimated £2billion a year (National Audit Office, 2005 and Department 
of Health, 2000). In the United States, population based research suggests that 
between 44,000 and 98,000 patients die each year from preventable errors, making 
medical error the eighth most common cause of death (Sexton, Thomas and 
Helmreich, 2000). The National Audit Office states that the most common reported 
adverse incident are patient injury due to falls, followed by medication error, 
although others report that medication errors are the largest source of error in the 
health care system. Nemeth and Wessell (2010) found a frequency of prescribing 
error of between 0.3 per cent and 39 per cent, depending on the definition and the 
method employed in their detection. They estimate that around fifty per cent of the 
medication errors were preventable. Their research found that although significant 
opportunities exist to identify preventable medication errors and intervene before 
potential harm, effective interventions to prevent them are limited. This echoes 
National Audit Office estimates that around fifty per cent of adverse incidents could 
have been avoided if lessons from previous incidents had been learned (Department 
of Health, 2000). 
The report ‘An Organisation with Memory’ (Department of Health, 2000) placed 
great emphasis on patient safety and led to the establishment of the National Patient 
Safety Agency (NPSA) in 2003. The aim of the NPSA is to improve safety and 
quality of care though reporting, analysing and learning from patient safety incidents 
and near misses. In Scotland Quality Improvement Scotland (QIS) oversaw quality 
and risk management issues before the launch of the Scottish Patient Safety 
Programme (SPSP) in 2008. Hailed as the first national patient safety programme in 
the world it aims to reduce adverse events in hospitals by 30% and mortality rates by 
15%, by 2012 (NHS Scotland’ Chief Executive’s Annual Report 2009/10). The SPSP 
is part of the NHS Scotland organisation Healthcare Improvement Scotland (HIS) 
which describes one of its key priorities as supporting clinical governance: a system 
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of checks and balances that ensures clinical services are of the highest possible 
quality (SPSP, 2011).  
In 1998 it became a statutory duty of all health organisations to seek quality 
improvement through clinical governance, a framework by which policy makers 
have attempted to improve quality within the NHS.  Scally and Donaldson define 
clinical governance as: 
“a system through which NHS organisations are accountable for continuously 
improving the quality of their services and safeguarding high standards of care by 
creating an environment in which excellence in clinical care will flourish” 
 
Scally and Donaldson (1998, Pg 62) 
Accountability, of both individuals and of organisations, is integral to the delivery of 
quality care, with clinical governance in turn regarded as integral to the planned 
modernisation of the NHS (DOH, 1997). Clinical governance applies NHS wide and 
seeks to address variations in standards of care within the organisation. The 
framework of clinical governance is described as having seven pillars: Clinical 
effectiveness; risk management; patient experience and involvement; 
communication; resource effectiveness; strategic effectiveness; learning 
effectiveness. 
Risk management was initially focused on reducing litigation and compensation 
payments. Recognition of the need to reduce harm developed over time and now the 
term risk management includes strategies to reduce harm and improve the quality of 
care (Vincent, 1995). At the heart of most systems of clinical risk management are 
methods for early identification of adverse events, using either staff reports or 
systematic screening of records. Identification of adverse events allows recognition 
of common patterns and prevention of future incidents. 
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3.3 Quality of care: pregnant and postpartum women 
with an RhD negative blood type 
Quality of care for pregnant women with and RhD negative blood type is important 
in order to prevent unnecessary sensitisation with anti-D antibodies and subsequent 
Haemolytic Disease of the Fetus and Newborn (HDFN). Application of clinical 
guidance to ensure women are offered appropriate anti-D Ig prophylaxis is one 
aspect of this, however enabling women to recognise when to seek help and make 
decisions about the most appropriate care for them is also an important aspect of 
quality of care for this group. 
When the Royal College of Obstetricians and Gynaecologists (RCOG) recommended 
that all pregnant women with an RhD negative blood type be offered RAADP, some 
midwives argued that such mass intervention should be delayed until failures in 
current care for those women were addressed (RCM, 1999). The midwives 
contended that a significant reduction in rates of sensitisation might be better 
achieved through improving practice in relation to existing {1991} guidance for the 
use of anti-D Ig (RCM, 1999).  
There is a great deal of evidence that some aspects of care provided for pregnant 
women with an RhD negative blood type, in relation to prevention of maternal 
sensitisation, is poor. Non-compliance with guidelines for anti-D Ig administration 
has been suggested as a significant contributing factor for continuing maternal 
sensitisation by a large number of authors including Vause, Wray and  Bailie (2000) 
Howard et al (1997) Van Dijk (1997), Letsky and  De Silva (1994), Ghosh and 
Murphy (1994).  
3.3.1 Anti-D Ig prophylaxis: potentially sensitising events and 
postnatal prophylaxis 
Several studies have explored compliance with the 1991 recommendations for the 
administration of anti-D immunoglobulin (Vause, Wray and Bailie, 2000, 
McSweeney et al, 1998, Howard et al, 1997, Morrison, 1997, Ghosh and Murphy, 
1994.) All of these studies were retrospective audit of case notes and all have similar 
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findings. The findings suggest that on the whole, postnatal management of RhD 
negative pregnant women is effective and complies with current guidelines. 
However, all of the studies also describe poor adherence to guidelines and sub-
optimal management of antenatal potentially sensitising events.  
Retrospective audit of case notes presents several difficulties in examining 
information, in terms of both accessing actual case notes and in the accuracy of 
record keeping and documentation within the case notes. Maternity services are 
particularly susceptible to this problem. Often care is shared between hospital and 
community staff, such as General Practitioners and Community Midwives, with staff 
documenting antenatal care in separate notes. Hand held patient records might lead to 
further duplication, or misplacing, of documentation. The validity of studies that rely 
on retrospective audit of case notes is dependent on accurate documentation of 
maternal blood testing, administration of anti-D Ig and reporting and documentation 
of potentially sensitising events, actions over which the authors have no control.  
A study that illustrates the limitations of this research methodology is that of 
McSweeney et al (1998). McSweeney et al (1998) completed a retrospective study of 
all new cases of RhD sensitisation occurring in Yorkshire between 1988 and 1991. 
Data was analysed for 129 women with 312 pregnancies. Ninety eight potentially 
sensitising events were identified, only 58 (59%) were included in the analysis as full 
information was not available in the other cases. Information was not available for 
events that had taken place out with the NHS, such as termination of pregnancy in 
private clinics, or for events occurring prior to hospital booking at around 12 weeks 
gestation.  
McSweeney et al (1998) report that 79 (81%) of the 98 sensitising events identified 
were miscarriage and termination of pregnancy. As previous pregnancies are 
routinely and clearly documented in maternity notes, miscarriage and termination of 
pregnancy are events that are least likely to be omitted from notes. This study 
highlights the problem of undocumented potentially sensitising events that will not 
be picked up during retrospective case note analysis. Reporting and documentation 
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of a potentially sensitising event is dependent on the woman recognising and 
reporting an incident when it happens. If she is unaware of the significance of an 
event, it may go unreported and therefore undocumented. If a pregnant woman does 
report a sensitising event there is no guarantee that it will be documented. In 
particular if a woman seeks informal advice by telephone from a midwife or general 
practitioner after an event such as a small bleed or abdominal trauma (such as a light 
fall or knock to her abdomen), this may not be documented at the time. If the 
practitioner recommends no further action, or if the woman chooses to ignore advice 
to attend formally, there may be no record of the event in her notes.  
Interestingly McSweeney et al (1998) found that only 5.4% of women experienced 
antepartum haemorrhage and 0.7% antenatal abdominal trauma. In contrast the 
research of Howard et al (1997) found that around 32% of pregnant women 
experienced some form of bleeding during pregnancy and that 5% sought advice for 
abdominal pain or trauma. Wide variation of reported incidence of potentially 
sensitising events suggests inconsistency in documentation of events, rather than 
variations in incidence.  
McSweeney et al (1998) found that guidelines for the management of RhD negative 
pregnant women were followed in only 17 (22%) out of the 98 identified antenatal 
events. The most common failures were omission of anti-D Ig, incorrect dose of anti-
D Ig given and failure to perform a Kleihauer test. The authors conclude that 
educational programmes for midwives and nursing staff could be used to achieve 
better compliance with guidelines for care. Without acknowledging any limitations 
of their research, they also go on to state that a significant number of the cases of 
immunisation could be prevented with prophylactic antenatal administration of anti-
D Ig, and illustrate this point by stating that 67 (52%) of the women who became 
sensitised had no identifiable sensitising event. 
Three larger studies have examined compliance with guidelines for the 
administration of anti-D Ig in the United Kingdom (Vause, Wray and Bailie, 2000, 
Howard et al, 1997, and Ghosh and Murphy, 1994). The largest of the three, Vause, 
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Wray and Bailie (2000), involved a retrospective study of all RhD negative women 
who booked for care in NHS maternity units in Northern Ireland in 1996. Data were 
obtained on 3380 women, 106 were excluded from final analysis due to missing case 
notes or incomplete data. Data were available for analysis on 3274 women.  
The audit was commissioned by the Department of Health in Northern Ireland  and 
the Royal College of Obstetricians and Gynaecologists (RCOG) clinical audit unit 
co-ordinated the data collection and analysis. The researchers based their data 
collection on four ‘auditable standards’ developed from existing guidelines.  
The four auditable standards were that: 
1. All women should have their RhD group determined within four weeks of 
their first antenatal contact with a health care professional. 
2. All women who are RhD negative should have antibody titre checked at least 
once after 28 weeks’ gestation, and prior to their admission for delivery. 
 
With the exception of women who have already developed anti-D antibodies all 
women who are RhD negative: 
3. Must be offered an appropriate dose of anti-D Ig following a potentially 
sensitising event (PSE) in pregnancy (250 IU if less than 20weeks gestation, 
500 IU and a test to assess the size of feto-maternal bleed if 20 weeks 
gestation and over). 
4. Should be offered an appropriate dose of anti-D Ig, based on the result of a 
Kleihauer (or equivalent) test if their baby is found to be Rhesus positive. 
Vause, Wray & Bailie (2000) 
The data collection method was validated by a large multi-centred pilot study (Vause 
and Maresh, 1999) and was later refined for use. The study findings are illustrated in 
Table 2 (below), and show generally poor compliance with guidelines during 
pregnancy. 
Policy and Practice Concerning Women with an RhD Negative Blood Type:              
A midwifery perspective 
Chapter Three: Professional and organisational issues: a review of the literature 27 
Table 2: Compliance with guidelines, summary of findings of Vause, Wray and Bailie (2000) 
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Vause, Wray and Bailie (2000) found that some types of potentially sensitising 
events were more likely to be managed appropriately than others. In particular of the 
52 women reporting trauma during pregnancy, only 5 (8%) received anti-D Ig. 
A major limitation of this study is that it was retrospective. As already mentioned, 
analysis of case notes presents difficulties in accessing information, both in terms of 
accessing actual cases notes and in inaccuracy of record keeping and documentation. 
The fact that this study was multi-centred will have compounded these problems.   
Wray (2000) acknowledges these problems and outlines the methods used minimise 
problems related to data collection taking place in several centres and being 
conducted by several different researchers. The study adopted an action-orientated 
approach to facilitate local ownership and commitment. Interactive workshops and 
training sessions were held and all participants were in regular contact with the 
researchers and were supported locally by clinicians and managers. These measures 
will have helped minimise individual researcher bias in interpreting the medical 
notes. The problem of inaccurate documentation is a more pressing one and attempts 
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were made to overcome this through comparing the information in medical notes 
with the information held by the local blood transfusion service. This will have 
highlighted discrepancies in relation to laboratory tests and anti-D Ig administration, 
and although it does not counter the problem of inaccurate documentation of 
potentially sensitising events, the purpose of the research is to measure compliance 
with guidance rather than identification of all potentially sensitising events.  
This research offers a large-scale study conducted by experienced researchers using 
sound research techniques. The limitations of using a retrospective case note analysis 
remain, however, and although the study highlights non-compliance with potentially 
sensitising events identified by the authors, the method does not allow for 
discrepancies in reporting of events or for lack of documentation. This is a problem 
for all three of the major studies in this field and the findings of Vause, Wray and 
Bailie (2000) are largely comparable with the research of Howard et al (1997) and 
Ghosh and Murphy (1994). 
Howard et al (1997) examined case notes of 922 RhD negative women who 
delivered in seven maternity units in Merseyside during 1994. They identified 396 
potentially sensitising events for which women should have received anti-D Ig, with 
anti-D Ig given within 72 hours in 235 of the 396 (59%) events and in a further five 
cases it was given later than this. The dose of anti-D Ig administered was recorded in 
166 (69%) of the 240 cases where anti-D Ig was administered.  
Howard et al (1997) also found that the Kleihauer test was used diagnostically for 22 
women who presented with abdominal pain, with 14 women whose test result was 
negative not receiving any anti-D Ig. The authors also report that for 10 women who 
reported vaginal bleeding after 20 weeks gestation and four with abdominal trauma a 
negative Kleihauer test resulted in anti-D Ig being omitted. They do not state the total 
number of women who presented with potentially sensitising events after 20 weeks 
gestation.   
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Five hundred and twenty of the 922 study women gave birth to RhD positive babies, 
and anti-D Ig was given within 72 hours of delivery to 497 of them (95%). Anti-D Ig 
was administered to a further 226 mothers who delivered in hospitals where policy 
was that all RhD negative women should receive postnatal anti-D Ig, irrespective of 
their baby’s blood type. It was also given unnecessarily to 55 women who were 
already known to be sensitised. Of the 14 women in whom the Kleihauer test 
indicated further anti-D Ig was required, only 9 received this.  
A major limitation of this research is that Howard et al (1997) did not compare 
findings from medical notes with laboratory requesting and test results. There is also 
no information on whether hospital notes alone were examined, or whether General 
Practitioner notes were also accessed, which may have led to omission of details of 
potentially sensitising events reported during pregnancy. This work also highlights 
the differences in policies between hospitals in the UK, with some opting to 
administer postnatal anti-D Ig to all RhD negative women regardless of their baby’s 
blood type. The authors also have an outcome of ‘Kleihauer test taken after 12 weeks 
gestation’ rather than National policy of over 20 weeks gestation. It is not clear if this 
reflected policy in the hospitals included in the study.  
Ghosh and Murphy (1994) conducted the third major UK study concerning 
compliance with guidelines on the administration of anti-D Ig. In a retrospective case 
note analysis of 1120 pregnancies of RhD negative women in two Scottish regions, 
671 of the 1120 women delivered RhD positive babies and 663 (99%) of these 
received anti-D Ig within 72 hours. Two hundred and eighty potentially sensitising 
events during pregnancy were identified and anti-D Ig was given in 195 (70%). The 
authors also looked at the cases where women had reported a vaginal bleed after 20 
weeks gestation, and found that in only 9 out of 98 (9%) cases was a Kleihauer test 
performed. Detailed information on the methodology of this research was not 
available. However the authors do stipulate that data were collected from hospital, 
general practitioner and laboratory records by a single member of the study team. 
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In summary, the findings of studies looking at compliance with guidance for anti-D 
Ig prophylaxis are relatively consistent. Compliance appears to be good following 
delivery of an RhD positive baby, with anti-D Ig being omitted for only a small 
number of women. Potentially sensitising events during pregnancy were less well 
managed which may reflect the less routine nature of this type of event, coupled with 
the added complication of differing management depending upon the gestation of 
pregnancy. All of the studies demonstrated some confusion surrounding the use of 
the Kleihauer test and there would appear to be poor understanding of its purpose, 
when it should be used and how to interpret and act upon its result.  
The studies described above all share the limitation of being retrospective analysis of 
cases notes. Poor documentation, might lead to some potentially sensitising events 
being under reported, but equally failure to document administration of anti-D Ig or 
Kleihauer testing could also contribute to over estimation of the same failures in 
care. 
3.3.2 RAADP  
Although there is a great deal of information about compliance with the earlier 
guidance, there remains little information about compliance with RAADP in the UK. 
When considering practice in relation to RAADP, it is important to examine not only 
whether a woman received the injection, but also the gestation at which it was given. 
The aim of RAADP is to maintain a prophylactic level of anti-D Ig in maternal 
circulation throughout the third trimester of pregnancy until delivery. Given too late, 
it will not protect at the start of the third trimester and given too early it will not 
maintain a prophylactic level until delivery, particularly if the pregnancy continues 
beyond 42 weeks gestation.  
One study that has looked at this is McKenzie et al (2006) who considered 
compliance with RAADP at the John Radcliffe Hospital, Oxford, between 1992 and 
2003 by conducting case note review. RAADP had been offered at the hospital since 
1986 and the authors compared the case records of 365 women who delivered 
between 1992 and 1996, with 215 case records of women delivering between 1997 
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and 2003. In this case RAADP was offered as a two-dose regimen, with injections at 
28 and 34weeks. The findings are summarized in Table 3 below. 
Table 3: Compliance with RAADP, summary of findings of McKenzie et al (2006) 
  



















































The authors state that although there was no significant increase in the proportion of 
women receiving RAADP over time, the timing of the injections did improve. They 
concede however that documentation had improved over the years and that the 
findings may reflect improvements in documenting administration of anti-D Ig rather 
than actual administration. McKenzie et al (2006) also note that 3/350 (0.8%) of 
women refused RAADP in the period of 1992-1996, rising to 7/197 (3.5%) by 1997-
2003.They reflect that this may have been due to heightened awareness of potential 
for infection due to blood products during the study period.  
Another study that considered compliance with RAADP is that of Chaffe et al 
(2007). This study used a retrospective audit of the medical notes of 207 RhD 
negative women at two maternity units in England during 2004.  The maternity units 
had both offered a two dose regimen, with anti-D Ig offered at 28 and 34 weeks. The 
main findings were: 
• 150/207 (72%) of women had documented evidence in their notes that they 
had received written or verbal information about RAADP.   
• 185/207 (89%) of women had informed consent documented in their notes 
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• 22/207 (11%) declined RAADP before the first dose 
• 28/207 (13%) declined a second dose of RAADP after having a first 
• Of the women who consented to receive RAADP, 98% received anti-D Ig 
within 1 week of 28 and 34 weeks. 
This study has the limitations associated with retrospective case note analysis that 
have already been discussed in detail. That said, it is the only study to take into 
account maternal informed choice in relation to rates of compliance. This is 
important when looking at potential failures in provision of clinical care associated 
with RAADP, rather than overall impact on rate of sensitisation rate. This study 
found high compliance: 98% of women who wished RAADP receiving it in 
compliance with guidelines. 
These two studies suggest that compliance with RAADP is good. This reflects 
evidence surrounding anti-D Ig administration following potentially sensitising 
events and postnatally, where compliance is generally good when care is routine and 
has become embedded in clinical practice. 
3.3.3 Why do failures of care happen? 
Importantly none of this literature tells us anything about why the failures in care 
occurred or how they might be prevented. The published evidence gives little 
consideration to how failures could be addressed or about what the potential impact 
of improved compliance might be on the rate of maternal sensitisation and 
subsequent HDFN. 
One issue that has been discussed in relation to compliance with guidance for 
administration of prophylactic anti-D Ig is the knowledge and understanding of the 
health care professionals, midwives and medical staff, involved. Several authors have 
suggested that the poor rate of compliance with current guidelines is linked to poor 
understanding of the issues involved by those who provide care (Vause, Wray and 
Bailie, 2000, Howard et al, 1997, Van Dijk, 1997, Ghosh and Murphy, 1994). There 
has been no published evaluation of health professionals’ knowledge in relation to 
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management of RhD negative women, however Wray (2000), Wickham (1999a), 
Saha (1998) and Van Dijk (1997) all suggest that the knowledge of midwives and 
other clinicians may be lacking. 
It is unclear why there should be such a gap in the knowledge base in relation to the 
management of RhD negative women and it could be that failure to follow guidelines 
appropriately may reflect a more general problem of incorporating evidence into 
practice. Wray (2000) suggests that the debate over anti-D Ig administration raises a 
number of questions about the development of evidence in maternity care and its 
translation into practice.  
In the UK there is no single approach to providing education about anti-D Ig for 
midwives. The subject should be covered by curriculum at undergraduate level, but it 
is not clear how qualified midwives then receive updates and on-going education on 
this aspect of clinical care or how changes to policy are implemented and supported. 
Available evidence suggests that areas of practice where there is a standard response 
to a planned or routine event achieve the highest level of compliance with the 
guidelines. In the postnatal period, for example, almost all women (95-100%) receive 
care in line with guidelines (Vause, Wray and Bailie, 2000, McSweeney et al, 1998, 
Howard et al, 1997, Ghosh and Murphy, 1994). Around time of delivery effective 
management of RhD negative women appears to have been successfully integrated 
into practice. The only events during pregnancy to achieve similar rates of 
compliance are procedures such as amniocentesis and external cephalic version, after 
which 92-100% of women receive appropriate management (Howard et al 1997, 
Ghosh and Murphy, 1994). These events are planned and the need for anti-D Ig is not 
reliant on any further testing and it would appear that administration of anti-D Ig at 
this time has become established practice. 
When a potentially sensitising event occurs spontaneously during pregnancy women 
are less likely to be offered management in accordance with guidance. Available 
evidence suggests that events such as falls, abdominal trauma and abdominal pain are 
unlikely to be correctly managed. Howard et al (1997) found that only five of 24 
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(21%) of women who had a fall or abdominal trauma and eight of 22 (36%) of those 
with abdominal pain were managed appropriately. Vause, Wray and Bailie (2000) 
also report that abdominal trauma during pregnancy was often not managed as a 
potentially sensitising event.  
When managing potentially sensitising events during pregnancy appropriate use of a 
test for size of feto-maternal haemorrhage (FMH) and subsequent administration of a 
correct dose of anti-D immunoglobulin is another area where compliance with 
guidelines is extremely poor (Vause, Wray and Bailie, 2000, Howard et al, 1997, 
Ghosh and Murphy, 1994,).  The test most commonly used in the UK is the 
Kleihauer test, a maternal serum test that will detect fetal red blood cells in excess of 
4ml. This indicates a large FMH that requires a larger dose of anti-D Ig than is 
standard. The Kleihauer test, or equivalent, should not be used to determine whether 
or not anti-D Ig should be offered, it is intended only to ensure that an appropriate 
additional dose is given if required. Guidelines state that a test for FMH should be 
used after any potentially sensitising event occurring after 20 weeks gestation. There 
would appear to be general misunderstanding about the use of the Kleihauer test. 
Howard et al (1997) found that only 45% of the women in their study had a 
Kleihauer test performed after a potentially sensitising event at 20 weeks gestation or 
more. Vause Wray and Bailie (2000) also found that testing to assess the size of 
FMH was often omitted, making it impossible to ascertain whether an appropriate 
dose of anti-D Ig had been given. Both Howard et al (1997) and Ghosh and Murphy 
(1994) reported that a Kleihauer test was used diagnostically for 20-30% of women: 
that is clinicians believed that a negative result indicated that anti-D Ig not required, 
leading to a number of women who had reported a potentially sensitising event not 
receiving any anti-D Ig. 
It would appear that when management of an RhD negative woman is routine 
practice clinician’s adherence to guidelines is good, however when a potentially 
sensitising event occurs spontaneously during pregnancy, or if a Kleihauer test is 
indicated, there would appear to be some confusion among health care professionals 
about how to manage care most appropriately. This is of particular concern as a 
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Kleihauer testing is associated with increased risk of larger FMH, and so increased 
risk of sensitisation. Those cases where care is most likely to fail might also be the 
cases most likely to lead to sensitisation. 
Another area where there would appear to be some question over practice, is the site 
in which the injection is given. Both the 1991 and the 1998 guidelines state that an 
anti-D Ig injection should be given in the deltoid muscle. Injection into the gluteal 
area may result in sub-cutaneous rather than intra-muscular injection, reducing 
effective absorption of the anti-D Ig (RCOG, 1999, Urbaniak, 1998). There is some 
anecdotal evidence that midwives favour the gluteal site and rarely inject into the 
deltoid muscle (Benbow and Wray, 1999). 
3.3.4 Medication errors 
There is little literature available to aid understanding of the factors that impact 
errors involving anti-D Ig, however there is a body of information about medication 
errors. There are a number of similarities between the process and circumstances of 
administration of medication in general and that of offering and administering anti-D 
Ig, and so it is useful to consider the evidence concerning medication errors in this 
context. 
Medication errors are recognised as a significant cause of preventable harm to 
patients both in the UK (National Audit Office, 2005) and the United States (Sexton, 
Thomas and Helmreich, 2000). Anderson and Webster (2001, Pg35) cite Foley 
(1999) in stating that ‘it is estimated that adverse drug events are surpassed only by 
heart disease, cancer and strokes as a cause of death in the USA’. Several authors 
have also suggested that drug administration is one of the highest risk areas of 
nursing practice (Schelbred and Nord, 2007, Anderson and Webster, 2001, Gladstone 
1995). However, the actual incidence of medication error is not well understood, 
with reported incidence varying significantly (from 0.3% to 39%) due to different 
methods of collecting data and of the differing definitions of error that are used 
(Nemeth and Wessell, 2010, Williams, 2007, Birch and Culshaw 2003).  
Brady, Malone and Flemming (2009, Pg 680) define a medication error as: 
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‘any preventable event that may cause or lead to inappropriate medication use or 
patient harm while the medication is in the control of the health care professional, 
patient or consumer’ 
It has been suggested that there is significant under-reporting of medication errors, 
with estimates varying from a rate of 50% to just 2% of errors being reported, 
depending on the professions involved (Duncan, 2004, Milch et al, 2006). During a 
review of literature concerning medication errors Brady, Malone and Flemming 
(2009) found a number of factors that impacted reporting of incidents. These factors 
included fear of disciplinary action, not being able to report anonymously, 
constraints on time and thinking it was unnecessary to report errors when there was 
no negative outcome. Other authors have also reported that lack of anonymity when 
reporting errors and a tendency towards a punitive ‘blame culture’ may lead to 
significant under-reporting of errors (Schelbred and Nord, 2007, Williams, 2007, 
Anderson and Webster, 2001, Gladstone, 1995). With several authors suggesting that 
omission of medication is the category of error that is most likely to be unreported 
(Williams, 2007, Birch and Culshaw, 2003, and Anderson and Webster, 2001).  
Failure to report incidents not only means that it can be difficult to understand the 
true incidence of error, it also means that clinicians and managers are unable to fully 
investigate the cause of errors, limiting ability to learn from incidents and subsequent 
ability to put in place measures that might reduce likelihood of recurrence. 
The work by Brady, Malone and Flemming (2009) was a systematic review of 
literature concerning individual and system factors that contribute to medication 
errors in nursing practice. They selected twenty six qualitative and quantitative 
studies to illuminate the complexity of factors that influence medication errors. The 
literature review found that the factors that contribute to medication errors are 
complex and multi-faceted, but could be divided into two subgroups: those caused by 
system errors and those caused by individual health care professionals.  
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A number of authors describe the individual, person focussed approach to addressing 
medication errors as ineffective (Brady, Malone and Fleming, 2009, Williams, 2007, 
Anderson and Webster, 2001). In common with administration of anti-D Ig, the 
process for drug administration is most often multi-professional and multi-factorial. 
The complexity of the process is regarded as a significant reason why focussing 
simply on the person who made the mistake is unlikely to lead to effective 
understanding of the error. Williams (2007, Pg344) states that ‘the multiple steps in 
the medication chain, from when a drug is prescribed to when a patient receives the 
drug, leads to significant scope for error’. Instead authors advocate a multi-
disciplinary approach that adopts an attitude of ‘no blame’ (Williams, 2007, 
Anderson and Webster, 2001) to encourage reporting of errors, followed by an 
approach to understanding errors that encompasses a systems approach (Williams 
2007, Anderson and Webster, 2001). Brady, Malone and Flemming (2009) also note 
that system errors that contribute to medication errors transcend all professional 
disciplines and advance beyond professional or departmental boundaries. They too 
advocate a system-orientated approach to instigate procedures and put in place 
checks and balances to reduce or prevent medication errors. This reflects the work of 
Anderson and Webster (2001) who consider that a successful incident reporting 
system is central to implementation of an effective systems approach to drug error 
reduction. They go on to describe re-design of the clinical environment as key to 
both facilitating nursing duties and removing potential for error. However they 
reiterate that this is only possible once it is well understood how the system is going 
wrong: information gained through effective incident reporting. 
Brady, Malone and Flemming (2009) found that nurses’ knowledge was another 
significant factor in medication error. They note that the administration process 
requires nurses to ‘engage with professional judgement and critical thinking to 
observe patients, communicate with all stakeholders, interpret relevant data and 
apply knowledge and experiences to specific patient situations (Pg 692). In one of 
the studies that they reviewed, nurses’ lack of knowledge and experience was the 
cause of 79% of errors (Taxis and Barber 2003). These findings reflect those of other 
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literature which raise the issues of nurses and midwives knowledge and judgement as 
contributing as an important factor in the process of administration of drugs and the 
prevention and recurrence of errors (Karavasiliadou and Athanasakis, 2014, Birch 
and Culshaw, 2001). It is of note that some of the specific issues highlighted in 
relation to lack of knowledge during medication errors may not be directly relevant 
when considering the evidence in relation to administration of anti-D Ig: for example 
confusion over drug names and errors in calculation of dose. However other errors 
including inadequate safety knowledge, inappropriate selection of product and 
decision making in relation to drug administration are all factors that are relevant 
when considering administration of anti-D Ig.  This is of particular note as a number 
of authors have suggested that knowledge and understanding of health care 
professionals may be a contributing factor in failures of care concerning women with 
an RhD negative blood type (Vause, Wray and Bailie, 2000, Howard et al, 1997, Van 
Dijk, 1997, Ghosh and Murphy, 1994). 
The literature on medication error is important and relevant when considering error 
in relation to anti-D Ig, particularly as there is little evidence available to inform 
about factors that impact on anti-D Ig errors.  
3.4  Informed decision making  
 As described above, clinicians’ lack of knowledge and understanding of the issues 
involved may contribute to failures in care for RhD negative pregnant and postnatal 
women. Clinicians, midwives in particular, also have a substantial role in providing 
information and education to pregnant women. If knowledge of issues affecting 
pregnant RhD negative women is lacking in the health care professionals who 
provide information, this has serious implications for informed decision making and 
RhD negative pregnant women’s ability to assume responsibility for their own 
health. 
Van Dijk (1997) suggests that lack of compliance with current guidelines highlights 
lack of knowledge and understanding of issues surrounding anti-D Ig administration, 
not only among health care professionals, but also among RhD negative women. If 
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anti-D Ig is to be offered and administered within 72 hours of a potentially 
sensitising event then RhD negative women must be able to recognise such an 
occurrence and actively seek professional advice. There is some evidence that 
women’s lack of knowledge and understanding of the issues involved may prevent 
them from seeking appropriate advice when PSE’s occur.  
Although it is widely acknowledged that many women do not understand the 
implications of routine antenatal screening tests for conditions such as Down’s 
syndrome (Lee, 1998), there is little information about women’s understanding of the 
implications of being RhD negative (Benbow and Wray, 1999). Several authors have 
speculated that women’s understanding of the issues involved is poor and question 
whether women are fully aware of the implications of being RhD negative and 
pregnant (Wickham, 2001, Wray, 2000). 
Vause, Wray and Bailie (2000) reported that evidence of poor compliance with 
guidelines for the management of RhD negative women shown in their study, may 
have occurred in part due to women not reporting bleeding, falls or trauma. In 45 
(16%) of 282 identified potentially sensitising events in pregnancy, women did not 
seek advice from maternity care staff within 72 hours of a potentially sensitising 
event (Wray, 2000). The study was not designed to explore pregnant women’s 
understanding of the impact of being RhD negative, or whether they felt informed 
about the issues. However Wray (2000) considering these findings, states that 
“The relationship between information giving, women’s understanding of RhD 
negative status and the management of potentially sensitising events in pregnancy 
could be explored further”. 
Wray (2000, Pg28) 
 
Ghosh and Murphy (1994) also suggest that a major reason for non-compliance with 
clinical guidelines is that women, and/or healthcare professionals, have not 
recognised the implications of antepartum haemorrhage and Van Dijk (1997) 
suggests that preventing maternal sensitisation requires education of both 
professionals and RhD negative women. 
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Informed decision making is an important aspect of quality care. The Royal College 
of Midwives (RCM) noted the significance of informed choice in relation to anti-D 
Ig when the recommendation for RAADP was first made (RCM, 1999), and this is 
reiterated by the National Institute of Clinical Excellence (NICE) who make several 
statements and recommendations that reinforce the importance of informed choice in 
relation to RAADP within the guidance (NICE, 2002). The Royal College of 
Obstetricians and Gynaecologists (RCOG) Green Top Guideline (RCOG, 2011) also 
highlights the importance of information giving and informed decision making in 
relation to anti-D immunoglobulin.  
The chances of an individual woman benefiting from RAADP are small, and only 
those women who have a partner with an RhD positive blood group and who go on 
to have a subsequent pregnancy will have any potential benefit. Anti-D Ig, a human 
blood product, is not without risk and those risks are complex and difficult to 
quantify. These factors combine to make it important that women make a decision 
about RAADP based on their own circumstances and their personal attitude towards 
potential risks and benefits.  Facilitation of informed decision making, however, 
requires knowledge of all the issues involved, highly developed interpersonal skills 
and the time to spend in discussion with women on a one to one basis. 
With the large number of decisions to be made and the rising number and sources of 
evidence for increasingly complex interventions, there are some authors who 
question whether patients actually want to make choices about their care 
(Rowbotham, 2005). Within the medical profession, there is a growing debate about 
the appropriateness and achievability of informed decision-making in the clinical 
setting (Davies, 2005). Being able to make informed decisions about care is a 
cornerstone of midwifery care, and Cooper (2001) believes that good midwifery care 
empowers women and involves respecting them, giving them information and 
offering them choice. By engaging a woman in the decision making process and by 
taking into account her personal values and individual circumstances better decisions 
will be made: for example an RhD negative pregnant woman who knows that the 
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father of her baby is also RhD negative will have no benefit from anti-D Ig as their 
baby must also be RhD negative.  
Maternity care differs from other aspects of medical care: the population is unique in 
that they are, on the whole, healthy individuals making decisions without the added 
pressure of serious illness. Pregnancy and birth can be regarded as social events as 
well as physiological processes and, unlike most illnesses, are something that most 
women expect to experience at least once during their lifetime. As such decisions are 
made in a social context and may involve discussions with friends, family and 
acquaintances who have been, or expect to be, faced with similar choices. The 
context within which maternity care is delivered has changed greatly in recent years. 
Government policies that advocate choice and control for women (Maternity services 
action group, 2011, DoH, 1993), growth of organisations such as the National 
Childbirth Trust and much easier access to information through media and the 
internet have transformed women’s expectations. Davis (2003, Pg 575) describes 
childbearing women as having moved from being “passive recipients of health care 
to the choosy consumers of health services”. Hewson (2004) believes that this means 
that women are now more likely to question or even reject professional advice.  
There is evidence that women’s satisfaction with their maternity care is directly 
related to the quality of information they receive and that communication and 
information are regarded as top priorities (Benbow and Churchill, 2000). There is 
also evidence that women want information and choices in their care and there are 
well established links between perceived control and improved emotional outcomes 
(Kirkham, 2004) although much of this work is from large qualitative studies that 
focus primarily on women’s choices concerning place and mode of delivery and the 
care they receive during labour.  
Despite evidence that informed choice is both desirable and beneficial, within 
maternity care in the UK shared decision-making has been a relatively recent 
development. The medicalisation of childbirth was accompanied by development of  
a paternalistic relationship between healthcare professionals and patients: clinicians 
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regarded as having superior knowledge and making important decisions about 
healthcare on behalf of their patients. The shift towards shared decision making 
within maternity care in the UK was formalised with publication in 1993 of the 
‘Changing Childbirth Report’ (Department of Health, 1993). Changing Childbirth 
was a wide-ranging paper which addressed key principles that underlie effective 
‘women-centred’ care. One of those key principles was choice. The report advocated 
working in partnership with women and acknowledged the importance of engaging 
them in the decision making process, holding as its fundamental principle a woman’s 
right to be in control of her care in pregnancy (Page, Phillips and Drife, 1997). 
In 2003, 10 years after the publication of Changing Childbirth, its author Baroness 
Cumberlege wrote that she believed that it’s key principles, including choice, had 
been widely accepted and incorporated into maternity care in throughout the UK and 
that a woman-centred approach was the core belief in terms of a patient-centred NHS 
(Cumberlege, 2003). Others, however, disagree and Kirkham (2004) goes as far as to 
assert that while  
“Informed choice is important in policy statements… it remains at the level of 
rhetoric and informed compliance”. 
Kirkham (2004, Pg266) 
 
There is published research evidence that informed decision making remains unusual 
in different aspects of maternity care: Wiggins and Newburn (2004) conducted 
qualitative research to explore barriers to the facilitation of informed decision-
making and found that the women in their study felt that they had little control over 
decisions that impacted their care during labour and delivery; Lee (1998) found that 
many women do not understand the implications of routine antenatal screening tests 
for conditions such as Down’s Syndrome; and Pilley Edwards (2004) identified 
limitations within decision making about home births and inadequate choices. There 
remains, however, little information about women’s understanding of the 
implications of being RhD negative (Benbow and Wray, 1999). Some authors have 
discussed this issue, with Wickham (1999a) questioning the quality and accessibility 
Policy and Practice Concerning Women with an RhD Negative Blood Type:              
A midwifery perspective 
Chapter Three: Professional and organisational issues: a review of the literature 43 
of information available about anti-D Ig for pregnant women with an RhD negative 
blood type, Wickham (2001) and Wray (2000) also speculate that women’s 
understanding of the issues involved is poor, and question whether women are fully 
aware of the implications of being RhD negative and pregnant.  
The evidence described earlier (Pg 28-29) suggests that women do not understand 
the significance of being RhD negative and that this may impact negatively on the 
care they receive. Much of that evidence was published before the NICE guidance 
for routine antenatal anti-D Ig prophylaxis and there remain important unanswered 
questions about the decisions women make about anti-D Ig: Do women make a 
choice about this routine intervention? Do midwives assume that they will want this 
product? Are they aware that it is a blood product? (Wickham, 1999a) Several 
authors have speculated that RhD negative women are not encouraged to make 
decisions about their care although there is little research evidence to support this 
(Wray, 2000, Wickham, 1999a, Stewart, 1999, Saha, 1998). Stewart (1999) admits 
that a typical conversation about postnatal anti-D Ig would be along the lines of 
“You are rhesus negative. If you have a Rhesus positive baby you will need anti-D” 
and Wray (2000) suggests that midwives must ask themselves some questions about 
the care they provide for RhD negative women including  
“Are women fully aware of the implications of being RhD negative and what this 
means?” and “Do they know about the management of their care?” 
(Wray, 2000, Pg 27) 
 
Much of the evidence concerning women’s understanding of issues surrounding 
being RhD negative and pregnant is anecdotal.  
There is some evidence that the subject is not discussed with women who receive 
anti-D Ig. Obstetrician Saha (1998), in a letter to the British Medical Journal, 
describes an adhoc survey of women attending her antenatal clinic. Of twelve women 
who had received anti-D Ig, none were aware that it was a blood product. This letter 
prompted Wickham (2001) to conduct her own adhoc survey of 8 obstetricians. None 
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of the obstetricians approached reported making any effort to ensure that women 
received information about potential risks of anti-D Ig. Seven of them felt that 
“women should not be made to worry about such issues” (Wickham, 2001, Pg35). 
Wickham (2001), also conducted research exploring the subject of anti-D Ig in 
midwifery and reports being contacted by 19 RhD negative pregnant women who 
obtained her email address through British and American consumer organisations 
(Wickham, 2001). Of the women who contacted her, she reports that none felt that 
they had received adequate information from their caregivers, and several stated that 
they did not realise that they had a choice about their management.  
Wickham (2007) highlights the fact that around 40% of RhD negative pregnant 
women will be carrying an RhD negative baby, and so not at risk of sensitisation. 
She questions whether midwives should be engaging with women to further discuss 
all the available options, such as paternal blood typing in order to help establish fetal 
blood type. Other factors such as whether the woman plans to go on to have another 
baby may also influence her decision whether or not to have anti-D Ig. 
3.4.1 Factors that affect provision of informed decision 
making 
There are many factors that influence the provision of informed choice including 
organisational factors, culture, individual opinions and attitudes, and provision of 
written information. 
a) Organisational and Cultural Factors 
Many authors and commentators consider that organisational factors, on both a local 
and national level, influence both the availability of choices and the way in which 
options are presented. There are two main organisational factors that will influence 
the facilitation of informed choice in maternity care: the availability of treatment 
choices and the culture within which medical staff and midwives offer choice. 
Within the UK evidence based practice has become an accepted standard and is 
widely supported by government policy. Initiatives such as National Institute of 
Clinical Excellence (NICE), in England and Wales, and Healthcare Improvement 
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Scotland (previously Quality Improvement Scotland), as well as specialist colleges 
and working parties such as the Royal College of Obstetricians and Gynaecologists 
(RCOG) and Royal College of Midwives (RCM) offer recommendations for practice 
based on review of scientific and clinical evidence, often also considering social and 
economic factors, to present guidelines for best practice.  While the underlying 
principle of evidence-based care is considered fundamental to the process of 
informed decision-making, Karwalish, Fox and Pearlman (2002) note that the move 
towards providing evidence-based practice has changed the whole notion of 
informed consent. Evidence-based recommendations, such as RAADP, typically 
reflect decisions based on a population perspective, rather than on individual 
patients. This provides a juxtaposition where informed decision-making involves 
presenting a range of options tailored to an individual patient, but evidence-based 
guidance tends towards the opposite: that for each clinical situation there is a single 
‘optimum’ solution.  
If clinicians are to offer truly informed choice regarding an intervention they must 
have the knowledge, communication skills and confidence in their own practice to 
present women with options. Kirkham (2004) suggests that this level of patient 
partnership would in fact require a massive cultural change within maternity 
services: changes in power relationships and in the organisation and delivery of 
maternity care. Facilitation of informed decision making is heavily influenced by the 
context within which healthcare is currently delivered. Kirkham and Stapleton (2004) 
describe conducting a major piece of qualitative research involving women and 
healthcare professionals at three maternity units in England and Wales. The research 
involved observation of 886 antenatal consultations and 383 interviews. The majority 
of health professionals were midwives. The research describes an organisational 
structure in which senior medical staff who defined norms of practice and what 
choices were available. Kirkham and Stapleton (2004) observe that the women in the 
study largely conformed to what was expected of them and remained passive 
recipients of maternity care rather than partners.   
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Davis (2003) describes some technological interventions as having become routine 
practice and often not presented as choices at all. Piley-Edwards (2004) conducted 
qualitative research of 30 women’s experience of planning home births and described 
a situation where midwives were in an impossible position of ensuring that women 
accepted care in line with medical policies, but were also compelled by an obligation 
to offer choice. This led to a culture of ‘telling not listening’ where  
“Informed choice means informing women so that they will choose the choice being 
advised and differences in opinion indicate a lack of understanding on the part of the 
women” 
(Piley-Edwards, 2004, Pg 12/13). 
 
Davis (2003) argues that society’s propensity toward victim blaming also serves to 
press women toward medical and technological interventions so that the ‘choices’ we 
suggest she has are not really choices at all. This reinforces the notions of ‘right’ and 
‘wrong’ choices as opposed to informed choices. This may not be limited to pregnant 
women, in Kirkham and Stapleton’s (2004) research, fear of litigation on part of 
clinicians was also seen as a major influencing factor determining the way in which 
choices were presented to, or withheld from, service users.  
Other organisational factors such as: lack of continuity of carer, as midwives have to 
establish an effective relationship with women at each appointment; situations where 
women and midwives come from different social and/or cultural perspectives; work 
pressures such as time available for discussion; and local variations in options 
available, have all been seen as distancing health professionals from childbearing 
women and impeding women’s ability to make informed decisions (Kirkham and 
Stapleton, 2004 and Charles, Whelan and Gafni, 1999). 
b) Individual midwives’ influence  
While cultural and organisational factors influence the choices available and the 
context within which they are offered and considered, the influence of individual 
practitioners on provision of informed decision-making is also evident. It is 
acknowledged that pregnant women have individual biographies, come from 
Policy and Practice Concerning Women with an RhD Negative Blood Type:              
A midwifery perspective 
Chapter Three: Professional and organisational issues: a review of the literature 47 
different contexts, have different abilities and concerns and constraints –all of which 
affect the decisions they will make. It should be acknowledged that clinicians too are 
individuals and are influenced by the same factors, inevitably influencing the choices 
they offer and the context in which they present them. 
Boyd et al (1999) asked ten midwives who had offered antenatal HIV testing to a 
total of 2727 pregnant women to complete a questionnaire aimed at eliciting their 
knowledge of and attitudes towards HIV. They found that the midwives’ level of 
knowledge was not associated with uptake of testing, but that the midwife who had 
the most positive attitude towards HIV also had the highest uptake of testing and 
caused the women she offered the test to the least amount of anxiety. 
Levy (2004) undertook a grounded theory study of the processes involved when 
midwives facilitate and women make informed choices during pregnancy. Twelve 
midwife booking appointments were observed, with the midwives and the women 
subsequently interviewed separately. The authors then observed further interactions 
between the midwife/women pairs, for example home visits and appointments later 
in pregnancy. Data were analysed using a grounded theory approach, identifying two 
theoretical frameworks describing the processes of facilitating and making informed 
choices during pregnancy from the midwives’ and women’s perspectives. Levy 
found that midwives regarded facilitating informed choice as an essential part of 
their job and that they, as individuals, had a major influence on the choices offered to 
women and the way in which those choices were presented. The research highlighted 
a balance that midwives felt they had to strike between giving a woman enough 
information and frightening her. This was compounded by a desire to meet the needs 
of the women while acknowledging their own strong feelings about certain issues. 
Levy (2004) concluded that facilitating informed choice is a  
“Highly complex activity, demanding of the midwife great sensitivity and personal 
awareness, as well as highly developed personal skills and knowledge”. 
Levy (2004, Pg 70) 
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Kirkham and Stapleton (2004) also highlight midwives’ individual influence on 
decision-making. They report that midwives were observed withholding certain 
leaflets because they contradicted their personal philosophy, customary clinical 
practice or because they conveyed a ‘negative’ image. During the same research 
clinicians were frequently observed framing information in such a way as to ‘steer’ 
women towards making decisions that reflected the point of view advanced by the 
health professionals.  
c) Provision of written information 
For pregnant women the antenatal period is a time when there are a large number of 
decisions must be made. For midwives it is a time during which they must impart a 
large amount of information, establishing appropriate and efficient means of 
communication in order to do so effectively. As pressures on time available for 
antenatal appointments and the number and complexity of issues for which decisions 
need to be made increase, clinicians are ever more dependent on written patient 
information. 
A Cochrane review of decision aids for people facing health treatment or screening 
decisions provides a systematic review of randomised trials of patient decision aids 
in improving decision making and outcomes (O’Connor et al, 2007). The original 
review was completed in 1999 with the most recent update in 2004. There were 17 
studies focusing on 11 different screening or treatment decisions included. The 
review found that decision aids do a better job than usual care in improving patients 
knowledge about options, reducing their decisional conflict and stimulating them to 
take a more active role in decision making without increasing their anxiety 
(O’Connor et al, 1999). It also showed that decision aids had a variable effect on the 
decisions that were made and virtually no effect on satisfaction with care. 
There have been some studies that consider the role of decision aids within a 
maternity care setting. Soltani and Dickinson (2005) conducted an evaluation of the 
role of information plays in informed choice and decision making in routine clinical 
practice. They surveyed all women who gave birth at their maternity unit during a 
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three month period (n=700) with a 47% response rate.  The women stated that their 
preferred methods of receiving information were one to one discussion and leaflets, 
with both methods preferred by over 70% of women (the questionnaire gave multiple 
choice answers and an option to tick more than one answer). Ninety two per cent of 
the women who responded stated that they read most or all of the information given 
to them, with 54% of women stating that they understood all information provided, 
and a further 43.5% stating that they understood most of it. One of the most 
important limitations of this study is the potential bias for self-selection to complete 
the forms by those who were more likely to understand both the questionnaire and 
the information they were being asked about.  It may be that the proportion of 
women not understanding written information is in fact higher than suggested by this 
study. 
Much of the research evidence surrounding written information provided to pregnant 
women concerns the ‘informed choice’ series of leaflets produced by the Midwives 
Information and Resource Service (MIDIRS). Launched in 1996, the leaflets aim to 
provide an objective appraisal of scientific evidence and examine key decisions 
facing expectant mothers, designed to assist them in making informed choices. The 
leaflets are produced in consultation with consumers groups, are peer reviewed and 
are supported by both the Royal College of Midwives (RCM) and the National 
Childbirth Trust (NCT). The series includes 21 topics and covers all topics specified 
in the Clinical Negligence Scheme for Trusts maternity standards and they are 
reviewed on a biennial basis.  
Oliver et al (1996) report a case study based on observations from their pilot study of 
the MIDIRS informed choice leaflets on routine ultrasound scanning. At two of the 
hospitals where the leaflets were to be piloted ultrasonographers reported serious 
concerns that the information within the leaflet would cause severe anxiety for 
women and may lead to a reduction of uptake for ultrasound scanning and disruption 
to the hospital organisation. This led to the withdrawal of one of the hospitals from 
the pilot study. In fact the leaflets were received favourably by the women and their 
midwives at the hospitals that participated and ultrasonographers reported very little 
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feedback or concern as a result of their use. This study appears to reiterate the 
resistance of some healthcare professionals to providing detailed written information 
for fear of causing anxiety. In discussing their findings Oliver et al (1996) consider 
that  the call for more choice has not been accompanied by corresponding investment 
in training professionals, or in organising the health care process to make time and 
provide facilities for promoting more active participation by healthcare users. 
However this paper is now is now over 10 years old and it may be that attitudes have 
changed. 
The only published evidence about the written information provided for RhD 
negative pregnant women comes from Wickham (2007) who describes conducting a 
‘brief study’ of information leaflets Wickham (2007) questioned the quality and 
impartiality of the leaflets noting that: the majority were produced by pharmaceutical 
companies; they focussed on why anti-D Ig was important; they contained no 
mention of side effects; there was no suggestion that anti-D Ig was a choice and that 
they used simplistic language. 
3.5 A policy perspective: pregnant and postpartum 
women with an RhD negative blood type 
Maternity units in the UK were slow to implement the 1998 recommendation for 
routine antenatal anti-D Ig prophylaxis (RAADP). Although this could be explained 
in part by the significant financial implications associated with the policy, the 
recommendation had also raised other concerns. The main concerns were voiced by 
the Royal College of Midwives (RCM) who called for further review of the policy 
before it was implemented. The RCM had four major concerns about RAADP: the 
quality of the evidence used to support the policy; failure to address poor compliance 
with current {1991} guidelines; that women should receive the information 
necessary to make an informed choice;  and the financial and resource implications 
of the policy (RCM 1999). 
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3.5.1 Anti-D Ig policy: midwifery perspective  
Midwives have a key role in the identification of women for whom anti-D Ig is 
appropriate, facilitation of informed decision making about anti-D Ig and 
administration of the injection, particularly with RAADP which is often given during 
a routine antenatal appointment. However, midwives had extremely limited input to 
the expert reviews that led to the recommendation for a policy of RAADP in the UK. 
The key participants were scientists, haematologists and obstetricians.  
When the RCOG consensus statement recommending RAADP for all RhD negative 
pregnant women in the UK was published, the midwifery profession questioned not 
only the scientific evidence for RAADP, but also whether an intervention such as 
RAADP, which is not completely without risk for mothers and babies, was the only 
and best approach to the problem. A routine policy offering one option for everyone 
was regarded by some midwives as at odds with a midwifery perspective that places 
emphasis on working in partnership with women to facilitate individual choices to 
suit individual circumstances. The 1998 RAADP recommendation led to significant 
professional debate, with the Royal College of Midwives (RCM) publishing an 
‘Anti-D Update’ outlining concerns about the proposed policy and issuing guidance 
to its members that they should continue to comply with the current {1991} guidance 
(RCM 1999). The United Kingdom Central Council (UKCC: the UK nursing and 
midwifery regulatory body at the time) also questioned the policy, with a spokesman 
stating  
“We support its {anti-D Ig} previous use but are concerned that the product has not 
been tested properly for routine use. It is an unknown quantity.” 
(Coombes, 1999, Pg7). 
 
One UKCC member went as far as to state that “as a midwife in practice, I would 
advise women against the use of anti-D {RAADP}” and went on to express fear that 
midwives’ jobs might be under threat if they refused to implement the new guidance 
(Coombes, 1999, Pg7). 
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The midwifery perspective on care provided for pregnant women with an RhD 
negative blood type differs significantly from that of the scientists and medical staff 
who have, so far, been instrumental in developing policy. Considering the issues 
from a midwifery perspective is important for two main reasons:  
1. The midwives’ roles and responsibilities in relation to the care of pregnant 
women with an RhD negative blood type, and the administration of anti-D Ig 
in particular, differ significantly from those of obstetric staff.  
2. The midwifery profession has a unique underlying philosophy that influences 
policy and practice. 
It is useful to consider the midwifery perspective within the context of maternity care 
in the UK and provide some background to midwifery culture and approach in the 
UK. 
In the UK care for pregnant women is most commonly provided by midwives and 
obstetricians. Midwifery and medicine are distinct but complimentary and 
overlapping professions. Obstetricians are experts in pathology with primary 
responsibility for the care of pregnant women who have underlying illness or 
complications of pregnancy, midwives are regarded as experts in normal pregnancy 
with primary responsibility for the care of pregnant women with uncomplicated 
pregnancies. The two professions developed differently and traditionally have 
distinct approaches to the care of pregnant women, based on particular perspectives 
and with differing philosophies and focus (Rooks, 1999). The midwifery profession 
developed within a social context where women provided each other with support in 
times of need (Rooks, 1999; Silverton, 1993). In 1902 the Midwives Act established 
state regulation of midwives and the midwifery profession developed subsequently.  
Silverton (1993) describes a ‘medicalisation’ of childbirth as having occurred in the 
UK since the 1960’s, with a move towards hospital birth being the norm. Robinson 
(1989) suggests that this resulted in a loss of decision-making for midwives. It is true 
that today most women now give birth in hospital and the context within which 
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midwives practice has changed, however as the context of maternity care in the UK 
developed midwives also adapted. Yuill (2012) describes the move of midwifery 
education to higher education institutions in the late eighties and nineties as resulting 
in academic credibility and acknowledgement of midwifery as a profession. It also 
led to the midwifery profession having increased input to and influence on childbirth 
research, with establishment of midwifery Professors further enhancing this. 
Midwifery 2020, a key maternity care policy document describes a current model of 
care where most midwives now work within a hospital environment, maintaining 
their skills as the lead professional for healthy women with straightforward 
pregnancies, while developing new skills in caring for women with complex medical 
and obstetric complications (Department of Health, 2010) 
The literature often describes a midwifery ‘model’. Van Teijlingen (2005) suggests 
that the term model is better replaced with ‘approach’ or ‘ideology’ and that it is 
often used to describe ways of practising as well as an overall philosophy or 
approach to care. Unsurprisingly the midwifery approach has its roots in feminism, 
in empowering women. Wickham (2001) describes aspects of the midwifery and 
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Table 4: Aspects of the medical and midwifery models from Wickham (2001) 
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Source: Wickham (2001, Pg5) 
At its heart the midwifery approach to care regards pregnancy as “a critical, 
vulnerable, but normal part of women’s lives” (Rooks, 1999, Pg 370) with the 
normalcy of pregnancy at the core of the approach. Whereas the obstetric approach 
often calls for treatment as a preventative measure, the midwifery approach 
recommends waiting until there is evidence that the intervention is needed. This can 
lead to situations where the medical and midwifery approaches to care conflict, and 
(Rooks, 1999) describes obstetricians as often using interventions to prevent or treat 
complications before there is evidence that they exist. 
The aspects of the medical and midwifery approaches described above, and in Table 
four in particular, are extremes and in reality very few midwives or obstetricians will 
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practice at those extremes. Midwives and obstetricians are individuals who work in 
diverse locations, organisations and cultures, even within the UK, and subsequently 
have diverse approaches to care. Although there are clear differences, and even some 
areas of conflict, between obstetrics and midwifery, there is also much common 
ground. In the UK today there is a wide spectrum of views and practice within both 
medical and midwifery practice and obstetricians and midwives most often work 
together. Rooks (1999) considers that the two models have merged somewhat with 
most midwives acknowledging the importance of medical treatment and most 
obstetricians recognising the importance of social and emotional aspects of 
childbirth. Current maternity care policy in the UK supports working in partnership 
with women to facilitate informed decision making and woman-centered care based 
on individual needs (Yuill, 2012, Maternity Services Action Group, 2011, 
Cumberlege, 2003). However, the extent to which midwives are willing and able to 
practice in such a way is disputed by some authors (Kirkham, 2004). 
The use of anti-D immunoglobulin to prevent maternal sensitisation and subsequent 
HDFN is a good example of the ways in which the medical and midwifery 
professions work together to provide care for pregnant women. However it is also 
one where their different perspectives may cause conflicting opinions on best 
practice. Although the use of anti-D Ig following potentially sensitising events and 
delivery of an RhD positive baby has been an established aspect of medical and 
midwifery practice for many years, the 1998 RCOG recommendation for RAADP 
was challenged by midwives. The routine administration of anti-D Ig without 
recognised event or risk factor, typifies the juxtaposition between the medical and 
midwifery approaches to care. Medical and scientific support for RAADP might be 
regarded as an example of using a pre-emptive intervention to prevent a complication 
before there is evidence that it exists. While the midwifery profession called for 
examination of alternative approaches that might improve outcomes without giving 
all women anti-D Ig, the midwives viewing the evidence supporting 
recommendations as based on a potential population benefit rather than the benefit 
for the individual woman. Van Tiejlingen (2005) describes one of the characteristics 
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of the midwifery approach as being that each woman is considered an individual 
judged on her relevant strengths and weaknesses, rather than on a statistical chance 
of certain obstetrical and medical risks. This view is summed up by Savage (1986) 
who states that  
”as the risks of childbirth become smaller statistical methods of predicting {poor 
outcomes}… have a limited use… if you look at each woman as an individual and 
plan her care with her, you will get the best result” 
 
Savage (1986, in Van Tiejlingen, 2005, section12.4). 
 
Midwives also highlighted the importance of informed decision making in relation to 
anti-D Ig. Although this had been commented on in the RCOG recommendation 
(RCOG, 1999), midwives recognised the complexities involved and the implications 
for their practice in terms of facilitation informed decision making and in 
administrating the anti-D Ig itself. 
In many aspects of maternity care, midwifery and obstetric practice and policy 
overlap. In the case of RAADP the medical and scientific professions worked 
together to make recommendations but in excluding midwives from that process they 
failed to recognise the significant input that midwives have in this aspect of care.  
3.5.2 Anti-D Ig policy: scientific perspective 
Sensitisation of RhD negative pregnant women occurs due to one of two reasons: 
failure to administer sufficient anti-D Ig in line with guidance; or as a result of silent 
sensitisation, sensitisation without any apparent outward event. Silent sensitisation is 
presumed to be caused by transplacental fetomaternal haemorrhage (FMH) and 
Urbaniak (1998) details a number of studies that demonstrate ‘occult’ FMH 
occurring in the absence of a precipitating event. Urbaniak (1998) describes the work 
of Bowman et al (1986), a study that involved 33 RhD positive volunteers who were 
subject to serial Kleihauer testing during pregnancy (Kleihauer test can be used to 
measure the presence of fetal red blood cells in maternal circulation, FMH). Bowman 
et al (1986) demonstrated that the rate of FMH increased as gestation increased, with 
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3% of women having FMH in the first trimester, 12.1% in second trimester, 45.5% in 
third trimester and in 63.5% an FMH was seen post-delivery.  
It would appear that not all FMH lead to sensitisation since, although Bowman et al 
(1986) demonstrated the presence of FMH in up to 63.5% of pregnant women, the 
number of RhD negative pregnant women who become sensitised without any anti-D 
Ig prophylaxis is around 17% (Contreras, 1998). In Bowman’s research, of the 15 
women who were shown to have FMH in the third trimester, seven had an FMH of 
0.02ml or less, seven 0.05ml to 0.3ml and one had an FMH of 5.15ml (Bowman et 
al, 1986). The volume of FMH required to cause sensitisation varies between 
individuals, with Urbaniak (1998) stating that as little as 0.1ml may cause 
sensitisation in a ‘good responder’. 
Routine antenatal anti-D prophylaxis (RAADP), the administration of anti-D Ig 
routinely to all pregnant RhD negative women, aims to protect against silent 
sensitisation. It does this by maintaining a prophylactic level of anti-D Ig in maternal 
circulation throughout the third trimester of pregnancy. Although RAADP might be 
expected to reduce the rate of sensitisation in RhD negative women, it will not 
prevent all sensitisations. Bowman and Pollock (1987) estimate that a residual 
sensitisation rate of between 0.24% and 0.31% should be expected even with the use 
of RAADP. This is because of inevitable failures to administer either antenatal or 
postnatal anti-D Ig in line with policy, and also because a small number of women 
will experience an occult FMH prior to administration of RAADP at 28 weeks 
gestation. 
Much of the debate concerning RAADP centres on the scientific evidence of its 
efficacy. There have been no systematic studies to consider the reduction of mortality 
observed with RAADP (Urbaniak, 1998), despite Crowther and Middleton (2009, 
Pg5) stating that “the clinical benefit sought is the avoidance of haemolytic disease in 
subsequent babies”. Instead, the evidence supporting introduction of RAADP centres 
on studies that use the rate of sensitisation of RhD negative women as an outcome 
measure. This is important for a two main reasons:  
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a) The Real Clinical Impact 
Sensitisation in itself is not harmful, and the pregnancy during which a woman 
becomes sensitised is very unlikely to be affected by the red cell antibodies. The real 
impact of sensitisation comes if a woman has a subsequent pregnancy with an RhD 
positive baby and if that pregnancy is affected by haemolytic disease of the fetus and 
newborn (HDFN). Measuring sensitisation alone, particularly during the index 
pregnancy, does not tell us about the clinical impact of RAADP. A more pertinent 
outcome measure would be the number of women who go on to develop anti-D 
antibody during a subsequent pregnancy, and how many of those pregnancies are 
affected by HDFN. 
b) Measuring Sensitisation 
One of the most important issues when using sensitisation as an outcome measure is 
the timing of the test used to detect antibodies. Individual immune response varies 
greatly and it is known that while some women will have detectable antibodies 
during the sensitising (index) pregnancy, others may not have them until months 
after delivery and others still will not test positive for anti-D antibodies until they 
have a subsequent pregnancy with an RhD positive baby. Women who do not have 
detectable anti-D following the index pregnancy, but have a secondary immune 
response during a subsequent pregnancy are described as ‘sensibilised’. Studies that 
only test for sensitisation during pregnancy, or soon after delivery, may 
underestimate the true rate of sensitisation. The work of Bowman and Pollock (1978) 
suggests that even if women are screened at six to nine months following delivery, 
around 20% of cases of sensitisation will be missed. Chilcott et al (2004) 
acknowledge that studies that test for antibodies at only one point in time are likely 
to under estimate rate of sensitisation. 
For the same reason testing during pregnancy is ambiguous since it is impossible to 
tell whether sensitisation is as a result of this pregnancy or due to a previous (perhaps 
unreported or unrecognised) pregnancy, or blood transfusion. In such a situation it is 
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quite possible that a woman who has been previously sensibilised would test 
antibody negative early in her pregnancy but as the fetus grows and her immune 
response develops, anti-D antibody will be detected during later tests. This is not due 
to a failure of prophylaxis during the current pregnancy as the sensitisation resulted 
from the previous index pregnancy.  
Depending on sensitisation as an outcome measure raises another important issue. 
Laboratory testing is unable to distinguish anti-D Ig given during pregnancy, known 
as passive anti-D, from immune anti-D antibodies. Information about the date, time 
and dose of any anti-D Ig that has been administered is required in order to calculate 
whether anti-D antibody identified during testing is most likely passive or immune. 
The most recent SHOT annual report (Bolton-Mags and Cohen, 2012) describes 
seven reported cases where the laboratory assumed a positive antibody screen was 
due to passive anti-D (anti-D Ig), but babies went on to develop HDFN and the 
mothers were subsequently found to have immune anti-D antibodies. None of the 
studies concerning RAADP acknowledge the potential for false positive or false 
negative antibody screening test results, but it would seem that this could have 
significantly impacted on the reporting of sensitisation among the women in the 
study groups who received anti-D Ig during their pregnancies.  
This raises an important question about the clinical relevance of the outcomes 
measured in all of the studies described below. Crowther and Middleton (1999) 
acknowledge that one of the most important areas still to investigate is the effect of 
antenatal anti-D Ig on subsequent pregnancies. 
3.5.2.1 Formal review of the scientific evidence for RAADP 
The first formal recommendation for a policy of RAADP in the UK came following 
a meeting of the Royal College of Physicians and the Royal College of Obstetricians 
and Gynaecologists (RCOG) at a consensus conference in 1997.  
Nine clinical trials were presented as evidence at the consensus conference, with only 
the randomised clinical trial of Huchet et al (1987) considered of sufficient standard 
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to merit their ‘Grade A’ recommendation in terms of evidence-based research 
(Urbaniak, 1998). Huchet et al (1987) conducted a multi-centre randomised control 
study comparing the effect of antenatal prophylactic anti-D Ig administration on rate 
of sensitisation. One thousand eight hundred and eighty four RhD negative women 
from Paris and surrounding area were included in the study. Women were 
randomised with the study group receiving 500IU anti-D Ig, at 28 and then 34 weeks 
gestation, in addition to the standard postnatal dose. The control group received only 
the postnatal anti-D Ig, no placebo was used. The outcomes measured were rate of 
sensitisation during pregnancy and at 2-12 months following birth. The study showed 
a reduction in the rate of sensitisation during, or immediately after pregnancy from 
1.02% (6/590) to 0.17% (1/599). One additional woman in the control group was 
found to be sensitised on testing at between 2 to 12 months following pregnancy. 
There was no significant difference in rates of neonatal jaundice between the groups. 
No data were available to assess rates of sensitisation or of HDFN, during any 
subsequent pregnancy, a major limitation of this study. As already discussed limiting 
testing to the current pregnancy and postnatal period will almost certainly 
underestimate the number of women who have become sensitised. The small 
numbers involved in this work, mean that only a few more women would need to test 
as antibody positive in a subsequent pregnancy to alter the significance of the 
findings.  
Although the 1997 consensus conference report acknowledged that Hutchet et al 
(1987) was the only clinical study of adequate scientific merit, they pronounced that 
“the total body of evidence is compelling” (Urbaniak, 1998, Pg11). The outcome of 
the consensus conference was a recommendation, in 1998, for RAADP to be offered 
to all RhD negative pregnant women in the UK. Following this, Crowther and 
Middleton (2009) conducted a systematic review of the Cochrane Pregnancy and 
Childbirth Group’s Trials Register, with the objective of ‘assessing the effects of 
antenatal anti-D immunoglobulin on the incidence of Rhesus D alloimmunisation 
when given to Rh-negative women without anti-D antibodies’. They found only two 
trials that met their inclusion criteria and described them as of ‘average to poor 
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quality’. Huchet et al (1987, described above) was one and the other was a UK study 
by Lee and Rawlinson (1995). Lee and Rawlinson recruited 2541 RhD negative 
primigravid pregnant women: 1273, the study group, received 250IU anti-D Ig at 28 
and 34 weeks gestation and 1268, a control group did not. Data were incomplete for 
469 women (205 in control group and 264 in treatment group) and a further 52 
women in the treatment group did not receive both doses of anti-D Ig and so were 
excluded. Of the 2020 women remaining, 1108 gave birth to RhD positive babies and 
had test results for anti-D antibodies at the time of delivery and at six months 
postpartum available. Crowther and Middleton (2009) report that when the data from 
these two studies are pooled findings 
“Suggest a trend to reduced incidence of sensitisation during pregnancy (RR 0.42, 
95% CI 0.15 to 1.17; 3902 women) after birth of a RhD positive infant (RR 0.42, 
95% CI 0.15 to 1.17; 2297 women) and within 12 months following birth of an RhD 
positive infant (RR 0.41 95% CI 0.16 to 1.04; 2048 women)” 
 
Crowther and Middleton (2009, Pg5) 
 
Both of these studies use rates of sensitisation during or just after pregnancy as their 
outcome measure. Neither considered sensitisation in subsequent pregnancy or rate 
of HDFN and as a result may underestimate true impact on clinical outcomes.  
Another point of note is that Lee and Rawlinson (1995) excluded those women who 
did not receive both doses of anti-D Ig. Failure to administer some RAADP would be 
expected in any maternity unit and should be included in study findings order to 
reflect the true clinical impact of any programme of RAADP. The revised 
consolidated standards of reporting trials (CONSORT) statement notes the 
importance of including all participants in analysis, on an intention to treat basis. The 
group states that failure to do so may lead to erroneous conclusions (Altman et al 
(2001). It is likely that exclusion of those women who do not receive RAADP, 
because of system failures or their own refusal, will lead to over estimation of the 
true impact of a policy of RAADP.  
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Crowther and Middleton conclude that the quantity and quality of the available 
evidence for such an important question is disappointingly low, but state that the 
reduction in sensitisation rate is consistent with that seen in non-randomised trials. 
They state that because  
“Anti-D Ig does not appear to be harmful, antenatal prophylaxis is likely to decrease 
the number of sensitisations, without adverse effects and should be considered”  
 
Crowther and Middleton (2009, Pg5).  
 
They also note that further trials are warranted to determine the optimal timing, 
number of treatments and effective dose, and reiterate that one of the most important 
areas to investigate is the effect of RAADP on subsequent pregnancies. 
Around this time the Royal College of Midwives (RCM) stated its intention to lobby 
the Department of Health to ensure that the National Institute of Clinical Excellence 
(NICE) reviewed the evidence before any changes were made to anti-D Ig policy. In 
2001 the National Institute for Clinical Excellence (NICE) did commission a 
systematic review of available evidence for the clinical and cost effectiveness of a 
community based programme of routine antenatal anti-D prophylaxis citing  
“The lack of clarity concerning the available evidence for RAADP, and consequent 
ambiguity of guidance supporting its introduction” 
 
Lloyd Jones et al (2004, Pg892). 
 
Lloyd Jones et al (2004) conducted the review on behalf of NICE and found 599 
potential articles of which ten studies, reported in 11 articles, met the inclusion 
criteria. These were all included in the review despite “considerable variation in 
design, quality, patient selection criteria, dosage, administration schedule and choice 
of outcome measures” (Lloyd Jones et al, Pg 893/894). The authors describe a host 
of factors that might influence the findings including the use of non-contemporary or 
geographically distant controls: creating potential bias due to differing obstetric 
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practice and laboratory testing techniques and equipment. There was wide variation 
in the timing of testing for sensitisation, ranging from during pregnancy to two to 12 
months post-delivery, with only five studies checking for sensitisation in a 
subsequent pregnancy and only three of those providing data for the control group as 
well as the intervention group. Many of the studies only reported results for those 
women who actually received the treatment and Lloyd Jones et al (2004) consider 
that by excluding those women who did not receive prophylaxis due to refusal or 
logistical failures, some of the studies overestimated the impact of a policy of 
offering RAADP.  
The 11 studies reviewed by Lloyd Jones et al (2004) reported on 30,169 pregnancies 
of RhD negative women who gave birth to RhD positive babies, of whom 146 
(0.48%) women became sensitised. There were 12,342 women in the control group, 
of whom 168 (1.36%) became sensitised. Lloyd Jones et al (2004) state that the two 
largest studies were of poor design: one using historical controls and the other 
comparing geographically distant areas. These factors may well have created bias 
through differences in obstetric practice and laboratory testing techniques over time 
and distance.  
The NICE review was intended to determine the impact that a policy of RAADP 
might have in the UK and Lloyd Jones et al (2004) focused their review on two UK 
studies: Mayne et al (1997) and MacKenzie et al (1999). Mayne et al (1997) 
conducted a retrospective survey of routine antenatal anti-D Ig prophylaxis using 
historical controls. The study was conducted in Southern Derbyshire where an 
RAADP policy, 500 IU given at 28 and 34 weeks, had been implemented in 1990. 
The outcome measure was detection of anti-D antibody (sensitisation) during a 
subsequent pregnancy. The study found that 16/1426 RhD negative women who 
were pregnant between 1988-1990 became sensitised, compared with and 4/1425 
women who were pregnant between 1993-1995 (the earliest that any effects of the 
RAADP programme might be detected). This is a decrease in sensitisation rate from 
1.12% to 0.28%. The paper gives little detail about the study methodology other than 
that the pregnant RhD negative women were identified using the laboratory register 
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and no case note analysis was conducted. It is not clear from the paper whether the 
baseline number is the total number of RhD negative pregnant women who had first 
pregnancies or whether that figure represents the number having subsequent 
pregnancies. 
There is a potential bias within this study through the use of historical controls. As 
already discussed obstetric practice changes with time and the authors of this study 
acknowledge that requests for anti-D Ig following other potentially sensitising 
events, such as vaginal bleeding, increased during this study. They believe this was 
due to heightened awareness among community midwives and doctors and regard 
this as a benefit of the RAADP programme and a reflection of the true impact such a 
programme might have in a clinical context. However it is not clear how long such 
heightened awareness might be sustained and what impact the progression of the 
policy into routine and mundane practice might have on the effect witnessed. It is 
therefore difficult to determine whether this is a true benefit of RAADP, and an 
important factor to consider within the findings, or whether it does instead add to the 
potential bias of using historical controls. 
The other study considered by Lloyd Jones et al (2004) was that of MacKenzie et al 
(1999). This was a prospective study which was designed to determine the impact of 
RAADP offered to all nulliparous RhD negative pregnant women, using the outcome 
measure of sensitisation in a subsequent pregnancy. The study group were identified 
in Oxfordshire where RAADP, 500 IU at 28 and 34 weeks, had been offered to all 
women with no living children from April 1986. The control group came from 
Northamptonshire where there was no such policy. The researchers used fortnightly 
laboratory serology meetings to prospectively identify all sensitised pregnancies 
where a woman was RhD negative and primigravid with an expected delivery date 
between 1987 and 1996. They then examined clinical notes to obtain details of both 
the current, sensitised, pregnancy and the previous pregnancy.  
One potentially limiting feature of this study is that the researchers did not use actual 
pregnancies to determine the rate of sensitisation, instead the baseline ‘at risk’ 
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number of pregnancies was estimated using national statistics. Data on annual 
maternities per health district and randomly selected local records were used to 
determine the numbers of births to nulliparous women and to women in subsequent 
pregnancies. National statistics on the mean interval between births per woman were 
also taken into consideration. The authors used these figures to calculate a 
sensitisation rate for 1980-1986 and 1990-1996 in Oxfordshire and 
Northamptonshire. The findings are shown in table 5 below. 












































It is unclear exactly how the use of an estimated number rather than an actual number 
of pregnancies to calculate a reduction in the rate of sensitisation might impact on the 
calculated sensitisation rate. However if statistics were collected in the two different 
regions in different ways, or if there were population changes over the time frame of 
the study that were not recognised and taken into account then an inaccurate baseline 
number of pregnancies could change the percentages involved quite significantly 
particularly when such small numbers of sensitised women are involved. 
Comparing geographically remote groups also produces potential for bias. Obstetric 
practice may well have differed between the counties, and in fact the authors 
highlight that policy at the time did differ with Oxfordshire giving all RhD negative 
women anti-D Ig prophylaxis at delivery but Northamptonshire only giving it to 
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those women who delivered an RhD positive baby. It is highly likely that there were 
other difference in practice –both medical and midwifery- between the areas. 
Effective administration of anti-D Ig following potentially sensitising events during 
pregnancy requires a woman to recognise an event, seek appropriate timely help and 
attend a hospital or clinic. Different populations, logistics and organisation in the two 
different areas would impact on compliance with guidelines for administration of 
anti-D Ig. 
Interestingly the number of sensitised pregnancies in the control group, 
Northamptonshire, also fell during the study period. The authors acknowledge that it 
is possible that RAADP might have been given in Northamptonshire without their 
knowledge, although they think this unlikely. Pregnant women and medical and 
midwifery staff are geographically fluid, likely to move between areas and to have 
conversations with peers and colleagues across the county boundaries. It would not 
be surprising if there was raised awareness in Northamptonshire of the use of 
RAADP in the neighbouring county and this may have influenced its use and of that 
of anti-D Ig following sensitising events, leading to a subsequent rise in 
administration of anti-D Ig and or increased compliance with guidelines, as has been 
demonstrated in other studies (Mayne et al, 1997). 
Lloyd Jones et al (2004) describe these two studies as the best indication of the likely 
efficacy of a programme of RAADP in England and Wales, stating that their pooled 
findings suggest that RAADP could reduce the incidence of sensitisation from 0.9% 
to 0.3%. The strength of these studies lies in their analysis based on intention treat, 
they do not exclude the women who did not receive RAADP because of logistical 
failures of the system. Lloyd Jones (2004) also acknowledges the demonstrated 
reduction in sensitisations may not just be due to the anti-D Ig alone, citing Mayne et 
al (1997) observation that the policy may increase awareness of the need for anti-D 
Ig following potentially sensitising events during pregnancy. The results of these two 
studies indicate that the number of RhD negative women carrying an RhD positive 
child needed to treat (NNT) to avoid one case of sensitisation is 166, and as only 
60% will be carrying an RhD positive child the actual NNT is 278. However the true 
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purpose of RAADP is to avoid HDFN and Pilgrim, Lloyd-Jones and Rees (2009) go 
on to calculate the overall NNT to avoid fetal or neonatal loss in a subsequent 
pregnancy as 5790. The NICE review concludes that widespread introduction of 
RAADP across the UK has the potential to reduce the rate of maternal sensitisation 
from the current estimate of between 1.2% and 1.8%, to around 0.35% (NICE, 2008).  
The evidence described above was used to determine current policy for RAADP 
(NICE, 2002, RCOG, 1998) in the UK. Pilgrim, Lloyd-Jones and Rees, (2009) 
conducted a further review in 2007 in order to identify evidence for advances in the 
use of RAADP since the 2002 NICE appraisal. They found only one additional study 
and noted that it had similar limitations to those previously described.  
In 2012 Turner et al conducted a further meta-analysis on the studies that had been 
examined by the NICE review. The Turner et al (2012) work differed in that it 
adjusted the meta-analysis for differences in study design and quality. They argue 
that this approach allowed new pooled results for the effectiveness of RAADP, based 
on synthesis of all evidence and taking into account any biases present in the design 
of all the trials (Turner et al, 2012). They conclude that their  
“Bias-adjusted synthesis of all available evidence provides strong evidence for the 
effectiveness of RAADP in preventing sensitisation, in support of the current UK 
policy of recommending RAADP to all non-sensitised pregnant RhD negative 
women” 
Turner et al, 2012, Pg 14). 
 
There is also some emerging evidence about the efficacy of RAADP, with Davies et 
al (2011) conducting research to look at the protection that RAADP offers towards 
the very end of a pregnancy, the time when a significant silent FMH might be most 
likely to occur. They tested blood samples from 407 women who received two dose 
regimen RAADP and 157 women who received a single dose regimen RAADP. The 
research found that 160/407 (39%) and 123/157 (78%) of the women had no 
detectable anti-D Ig at time of delivery. There was an association between duration 
of pregnancy and detectable anti-D Ig at delivery: with women whose pregnancy 
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continued for more than 12 weeks following the last dose of RAADP less likely to 
have detectable anti-D Ig at delivery The authors did not follow the women up to 
determine the rate of maternal sensitisation or any subsequent HDFN, however they 
consider that for a significant proportion of RhD negative pregnant women, RAADP 
will offer limited protection towards the end of pregnancy.  
The most important factor common among all of the research described is the use of 
maternal sensitisation as an outcome measure. There are no studies that tell us about 
the most important potential outcome of RAADP: its impact on HDFN. The 
limitations of using sensitisation as an outcome measure have been described, and  
are recognised by the authors of all three reports and reviews described here 
(Urbaniak, 1998, Lloyd Jones et al, 2004, Crowther and Middleton, 2009). The 
alternative of using HDFN as an outcome would require an extremely large multi-
centre, possibly international, study in order to achieve numbers that might 
demonstrate effectiveness. Any such study would be further complicated by the need 
to span two or more pregnancies for each subject. As RAADP has now been 
implemented across the UK it seems unlikely that such a project will be undertaken. 
As well as using sensitisation as the outcome measure, all of the studies presented as 
evidence of the efficacy of RAADP have important limitations: inappropriate control 
groups; factors out with the researchers control such as raised awareness of the 
condition and subsequent intervention; failure to test for anti-D antibodies in a 
subsequent pregnancy. Many of these are issues that are difficult to overcome when 
dealing with large numbers of study subjects all being cared for in a ‘real’ clinical 
setting by a number of different clinicians. However they are important limitations 
that may have significant impact on the study findings.  
The reviewers all comment that the studies they reviewed all show a similar 
reduction in the rate of maternal sensitisation following the use of RAADP, citing 
this as evidence of its efficacy despite the limitations of the studies. In 
recommending RAADP as policy in the UK, all of the reviewers note the limitations 
of individual research studies, but describe a total body of evidence that points to a 
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reduction in sensitisation. They state that this, coupled with the perceived lack of 
potential harm associated with anti-D Ig mean that RAADP should be recommended. 
3.6 Pregnant and parturient women with an RhD 
negative blood type: summary of key evidence 
The overall aim of this research is to describe practice and policy surrounding the 
care of women with an RhD negative blood type, from a midwifery perspective. The 
specific aims of the three pieces of research that form this work are: 
• To determine current UK policy in relation to the NICE (2002) 
recommendation for RAADP 
• To describe anti-D Ig errors made by midwives  
• To explore midwives’ perspectives on the care provided to RhD negative 
women 
As such, the literature was reviewed with the aim of providing understanding of the 
development of National policy and guidance, factors that impact the quality of care 
provided within those guidelines and to understand the midwifery context that 
impacts this area of clinical practice.  
In particular the literature review highlights the links between the midwifery 
profession and development of policy and guidance surrounding care for RhD 
negative women. It is of note that following the 1998 recommendation for RAADP 
(RCOG, 1998) midwifery commentators voiced concerns that clinicians should 
explore gaps in practice and service delivery before implementing any changes to 
current anti-D Ig policy (RCM, 1999, Benbow and Wray1999).  The decision to 
recommend implementation was based on scientific evidence for the efficacy of 
RAADP from a small number of studies that all have significant limitations in their 
methodology. Of particular note is the fact that although evidence suggests that 
introduction of RAADP will produce a small reduction in the rate of maternal 
sensitisation, it does not determine the potential impact on important outcomes such 
as reduction in the number of fetuses and babies affected by HDFN. Evidence 
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published prior to the recommendation for RAADP points to substantial failures in 
care for women with an RhD negative blood type. It is not clear from the evidence 
what contribution failure to address poor compliance with guidance around 
potentially sensitising events in pregnancy will make to continuing sensitisation and 
subsequent HDFN, nor is it clear what could be changed to improve practice and 
reduce preventable sensitisation. The NICE guidance recommending RAADP 
(NICE, 2002) led to widespread implementation of the policy and the impetus for 
reviewing and improving other aspects of practice appears to have been largely lost. 
The literature review considered a number of aspects of provision of quality care for 
women with an RhD negative blood type. In particular midwives have highlighted 
the significance of informed choice surrounding anti-D Ig and RAADP more 
specifically. The evidence reviewed here highlights the complexity of the issues 
involved, in particular that an individual woman’s circumstances can have a 
significant bearing on whether or not anti-D Ig is of any benefit to her. There is some 
evidence to suggest that midwives and medical staff may lack knowledge and 
understanding of the issues involved and as a result lack confidence in their own 
ability to offer informed choice in relation to anti-D Ig. The literature also suggests a 
culture within the NHS where midwives might find it challenging to offer women a 
choice about an intervention that is ‘recommended policy’. Despite calls from the 
stakeholder organisations (RCOG, RCM, NICE) little information or additional 
resource has been made available to support midwives and medical staff in the 
facilitation of informed decision making around anti-D Ig. 
The literature review uncovered an overarching theme that research, evidence and 
policy concerning care for women with an RhD negative blood group is led by 
medical and scientific staff, despite the fact that midwives are the main care givers in 
relation to anti-D Ig. This was highlighted as significant as the midwifery profession 
tends to consider issues from a perspective that those other professions might not. 
However, formal published evidence from a midwifery perspective is greatly under-
represented in this field, meaning that a significant and important perspective on the 
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care of women with an RhD negative blood type is absent from the evidence base 
and subsequent policy and guidance documents.  
The literature review demonstrates the need for systematic, good quality midwifery 
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Chapter 4: Overview of design and methods 
used 
This chapter provides an overview of the design and methods used and why they 
were chosen. More details of the methods and further rationale for choosing them are 
given in the chapters devoted to each of the pieces of research: Chapters five, six and 
seven. 
4.1 Research design 
The overall aim of this work is to gain a midwifery perspective on policy and 
practice in relation to women with an RhD negative blood type. The design was 
multi-faceted, using three distinct pieces of research. The three pieces of research, 
their aims and objectives, and the aims and objectives of the overall research are 
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Figure 2: The research aims and objectives: individual phases and research overall 
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The use of three different methods of research was emergent, with each piece of 
research planned within the context of the findings of the previous. It is useful to 
consider how the research emerged and how the findings of each study led to 
development of the next.  
The first piece of research undertaken was a survey of all UK maternity units to 
determine implementation of the NICE (2002) recommendation for a policy of 
offering RAADP to all RhD negative pregnant women. The survey found that 
implementation of a policy of offering RAADP was widespread throughout the UK, 
determining that for the majority of midwives offering and administering anti-D Ig 
was now integral to the antenatal care that they offered. The findings also raised 
questions about organisational impact on midwives ability to provide individualised, 
woman centred care.  
Following completion of the RAADP survey the researcher had a two year break in 
studies. On returning to the work it was clear from personal experience that practice 
in this area had changed. For example, in Scotland the Scottish National Blood 
Transfusion Service (SNBTS) now only supplied single dose anti-D Ig for RAADP, 
and a new Scottish National leaflet, designed to support informed decision making 
for RhD negative women, had been made available to all Scottish maternity units. It 
was anticipated that practice in other parts of the UK in relation to the policy of 
RAADP were likely also to have changed and as a result it was deemed necessary to 
reconsider the nature of the subsequent research.  
Around this time the researcher was working with colleagues from the Serious 
Hazards of Transfusion (SHOT) haemovigilance scheme on an unrelated project. 
This resulted in an opportunity to request permission to access the SHOT anti-D Ig 
error database, and subsequently to development of the subsequent research ‘Anti-D 
Ig: analysis of midwifery errors reported to SHOT’. This research was designed to 
explore midwives’ practice by identifying the type of errors that midwives make 
when offering and administering anti-D Ig. The findings of the analysis of the SHOT 
anti-D Ig reports raised further questions about the way that midwives practice and 
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the findings, alongside those of the RAADP survey and of the evidence discussed in 
Chapter three, were used as the basis for the third and final piece of research. 
The researcher had always intended to gain midwives views through collection and 
analysis of qualitative data as this was deemed vital to the overall aims and 
objectives of the research. The intention of this third piece of work was to use focus 
group research to collect in-depth, qualitative data in order to elicit midwives views 
on care provide for women with an RhD negative blood type. It was intended that 
this qualitative data would both compliment and add depth to the information already 
gathered during the previous research.  
The findings of the focus group research, alongside other evidence described in 
Chapter three, provided context within which to consider the overall work. The final 
part of the research process was to draw together the three pieces of research and 
discuss the findings in this context. 
An overview of the specific aims, objectives, study designs and research methods 
applied to each piece of research are described below. The methods used are also 
described and discussed within each of the relevant chapters: five, six and seven. 
4.1.1 RAADP: a survey of policy and practice in the UK 
The aim of this piece of research was to establish current {2005} policy and 
procedures in the United Kingdom in relation to the National Institute of Clinical 
Excellence (NICE) recommendation for routine antenatal anti-D prophylaxis 
(RAADP) (NICE, 2002). The study design chosen was a cross-sectional descriptive 
survey.  
Polit et al (2001) consider that survey obtains information about prevalence, 
distribution and interrelationships of variables in a given population. The method is 
one of self-report with respondents answering direct questions and although it is 
highly flexible the information gathered is relatively superficial. The survey design 
here was cross-sectional, that is data were collected at one point in time.  
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Survey design can be either descriptive or analytical. There are two aspects to 
examining policy and procedure; the policy documented and the application of this 
into practice. The focus of this survey was to document the policy, rather than actual 
practice. This included aspects of policy such as: whether RAADP was offered, 
whether written information was provided for the pregnant women and what, if any, 
midwifery education accompanied implementation of RAADP. In order to achieve a 
National (UK) picture of RAADP a descriptive survey design was considered the 
most appropriate method as its purpose is to “count, rather than to explain”. 
(Oppenheim, 1992, Pg12) 
Polit et al (2001) state that the three most common methods of collecting survey data 
are: personal face-to-face interviews, telephone interviews and self-administered 
questionnaires. The method of data collection deemed most appropriate for this 
project was a postal questionnaire. The wide geographical spread of the population 
sample meant that face-to-face interviews were not feasible. Structured telephone 
interviews were considered as an alternative to postal questionnaires for data 
collection. The advantages of conducting telephone interviews would have been 
ability to clarify questions, limiting misinterpretation of questions or answers. 
Interviews would also have given control over who provided the information. 
However, the intention was to survey the entire population (UK maternity units) 
rather than a representative sample. Given the large number, 348 units, limitations on 
time and resources available meant that a telephone survey was not possible.  
Possible disadvantages of using questionnaires for this study were potential for low 
response rate, lack of control over who actually completed the questionnaire and no 
opportunity to check incomplete responses. These issues were addressed during the 
development of the questionnaire, and steps were also taken to maximise response 
rate, these are discussed in more detail in Chapter five.  
In addition a request was made for a copy of any written patient information to be 
returned along with the completed questionnaires.  
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Survey data was analysed using the computer software package SPSS. The origin 
and content of the leaflets received was also analysed. The method used is described 
in further detail in Chapter five: RAADP: a survey of policy and practice in the UK. 
4.1.2 Anti-D Ig: analysis of midwifery errors reported SHOT 
The aim of this research was to describe anti-D Ig errors made by midwives. The 
objectives were to gain a wider understanding of the types of mistakes commonly 
made and what factors might influence those errors. It was also hoped that the 
findings would inform the next piece of research: focus group research to gain a 
midwifery perspective. The analysis of midwifery errors reported to the Serious 
Hazards of Transfusion (SHOT) scheme used a qualitative approach to conduct 
secondary analysis of existing incident reports.  
Polit et al (2001, Pg469) describe qualitative research as “typically in-depth and 
holistic… using a flexible research design”. Describing in detail the types of 
incidents and the factors that might influence their occurrence was the main aim of 
this research, and a qualitative approach allowed this in a way that quantification 
could not have. Another important advantage of a qualitative approach is that it can 
be emergent, evolving and developing as the work progresses (Polit et al, 2001). 
Although the research had clearly defined aims and objectives, the nature of the work 
meant that the most effective form of data analysis would be that which was led by 
the findings as they emerged, allowing further exploration of any emerging themes.  
All recognised incidents involving anti-D Ig are submitted for inclusion in the 
Serious Hazards of Transfusion (SHOT) annual report. The published annual SHOT 
report contains summary data about categories of incidents and a small number of 
clinical vignettes describing actual incident reports. The researcher was granted 
access to all reports, in the anti-D Ig category, that had been submitted to SHOT for 
entry to the 2008 annual report. These were the full and complete reports as 
originally submitted to SHOT: data which encompassed all recognised anti-D Ig 
incidents that occurred in all UK maternity units during that time period.  
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As this research is about midwives, only those incidents that involved a midwife 
were included for analysis. A multi-layered approach to analysing the data was used, 
with the aim of describing the incidents in detail and identifying clinically relevant 
information that might allow a better understanding of why errors occur and what 
measures can be taken to prevent their recurrence 
4.1.2.1 Simple classification of incident reports 
Analysis began with simple classification and quantification of the incidents into 
broad categories. The classification mirrored the analysis performed by SHOT, but 
included only those reports where a midwife had been involved in some aspect of the 
incident. This was intended to provide information about the type and number of 
anti-D Ig incidents that involve midwives. 
4.1.2.2 Detailed description of reports 
The simple classification of incidents was followed by a more detailed analysis of the 
data that was based on critical incident technique. The aim here was to describe the 
incidents, identifying common themes and further categorising the data. It also 
allowed the identification of the proximal cause which had led directly to the adverse 
event. 
4.1.2.3 Identification of key aspects of the reports 
The final part of the data analysis was based on a framework that developed during 
this research. The method draws from Reason’s model of understanding adverse 
events, an approach to analysing incidents that encompasses both a ‘person’ and a 
‘systems’ perspective (Reason, 2000). Several authors now look beyond root cause 
analysis and many incorporate themes from Reason’s model to develop a more 
integrated approach to analysing incidents. Such models include The London 
Protocol, a systems analysis of clinical incidents developed by Taylor-Adams and 
Vincent (2004).  
The approach used here was influenced by Reason’s model and root cause analysis 
(RCA), but grew from and with this particular research. The result was a framework 
for analysis that was used to find the key aspects of the incident, those things that 
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directly influenced the errors. The framework identified that within the incidents 
there were three key aspects: a ‘proximal error’, ‘trigger events’ and ‘fallible 
practices’.  
4.1.2.4 An overview of the data analysis 
The pathway of analysis of the SHOT reports is illustrated in Figure 3, below 










The methods of analysis: simple classification, detailed description of incidents and 
identification of proximal errors, trigger events and fallible practices, were connected 
and complimentary and intended to build detailed understanding of the types of anti-
D Ig incidents that involve midwives, giving insight to common pathways that lead 
to errors and some of the factors that influence their occurrence. 
The methods used are described in greater detail in Chapter six: Anti-D Ig analysis of 
midwifery errors reported to SHOT. That Chapter also gives more detailed 
description of Reason’s model, root cause analysis and critical incident technique. 
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4.1.3  Focus group research to gain a midwifery perspective 
The aim of this piece of research was to explore midwives’ perspective on the care 
provided for pregnant women with an RhD negative blood group, with the objective 
of eliciting their views concerning the questions determined by the two pieces of 
research already undertaken. A qualitative approach, using focus group interviews 
was considered the most appropriate method. 
This research aimed to elicit midwives’ experiences, perspectives and attitudes as 
well as their ways of delivering clinical care. Porter (2000) states that qualitative 
research does not focus primarily on identification and explanation of facts, instead it 
can uncover the participant’s interpretation of facts. As a result it is most appropriate 
for describing the understanding and motivations of the research subjects. The 
research was designed in context of that already undertaken (Chapters five and six) 
which had uncovered a number of issues and raised several questions about practice. 
An important objective of the research was to attempt to put these issues into the 
context of current midwifery practice, by listening to the midwives themselves in 
order to understand the context within which the issues arise and to uncover factors 
that might influence them.  
The research method of choice was focus group interviews. Commonly focus groups 
are used to generate data or to test, for example a questionnaire to be used in a mixed 
methods approach. Kitzinger (1995, Pg299) describes focus groups as “a form of 
group interview that capitalises on communication between research participants in 
order to generate data”. However here the group interviews were used primarily to 
elicit answers about data already generated from the ‘real life’ scenarios described in 
the SHOT incident reports and from the issues raised by the RAADP survey.  
Alternative methods of data collection were considered. It would have been possible 
to conduct individual interviews, or even to use another survey, however  an 
advantage of group interviews is that the process might help people to explore and 
clarify their answers and encourage participation from those who might otherwise 
feel they have little to say on the topic of discussion (Freeman, 2006). This was seen 
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as a major advantage as a key objective was to explore the context and the cultural 
and organisational factors associated with the topic, and neither interviews nor a 
questionnaire would have allowed respondents a full opportunity to reflect on their 
responses. In addition it was acknowledged that the midwives have major constraints 
on their time, affecting ability to organise multiple interviews. Using a group 
interview approach would provide a practical means of gaining the views of a larger 
number of midwives than might be possible through individual interviews, but with 
the advantage of gaining richer data than might be gathered through another survey. 
The data analysis was also qualitative and is described in detail in Chapter seven: 
Focus group research to gain midwifery perspective. 
In reality achieving answers to specific questions within the constraints of practical 
factors such as time available for focus groups (described in detail in Chapter seven) 
required the imposition of significant structure on both data collection and 
subsequent analysis. It could be argued that the imposition of that structure, in 
particular the adoption of structured data analysis, may have compromised the 
qualitative approach, with the substantive findings reflecting questions that had been 
predetermined.  
In simple terms quantitative research can be described as focussing on numbers and 
qualitative research as focussing on words. However the methods are also understood 
to have more complex differences. Cormack (2000, Pg19) determines that qualitative 
research encompasses strategies that ‘seek to explain human behaviour in terms of 
the reasons people have for behaving the way that they do’. With Polit et al (2001, 
Pg208) considering the qualitative researchers generally ‘know what they do not 
know’ and qualitative researchers ‘don’t know what is not known’. As a result the 
first phase of many qualitative studies is to get a handle on what is salient about the 
phenomenon of interest. In this situation, the researcher already ‘had a handle’ on the 
salient points through conducting the previous research: the RAADP survey and 
analysis of the SHOT reports, and also from exploring existing evidence and 
literature.  
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The data collection method of choice was focus group research, a qualitative method 
(Kitzinger, 1995). In this case however, the structured nature of the data collection 
method meant that the method became more akin to semi-structured group 
interviews. Semi-structured interviews are also commonly considered to be a form of 
qualitative data collection however Porter (2000) warns that should they become too 
structured they risk reinforcing the researcher’s assumptions. In such a situation it is 
important for the interviewees to have input outside of the pre-determined structure 
to maintain the ability to explore adequately their views without the researcher 
unduly influencing them. During the focus group interviews conducted here, 
although specific questions were asked, the subjects did have an opportunity to freely 
discuss those questions, generating a large amount of transcript. This meant that 
although the major findings do relate to themes that were predetermined, the focus 
group interviews also did also elicit data other than that set out within the remit of 
the structured data collection and analysis.  
In reality both the data collection and analysis were influenced by the researchers 
established perspective: that is to a large extent ‘she knew what she didn’t know’, a 
stance with more in line with a quantitative approach. The compromise in methods 
used was necessary in order to achieve the aims of the research within the constraints 
of conducting research within the real world of clinical midwifery. It did mean 
however that, although the research design intended to provide qualitative findings, 
the methods used incorporate aspects of both qualitative and a more quantitative 
approach.   
4.1.4 The research as a whole 
The aim of the study design overall was to gain insight to policy and practice in 
relation to the care of women with an RhD negative blood type, from a midwifery 
perspective. Careful consideration was given to what each of the three separate 
pieces of research contributed to the work as a whole in order to achieve this. 
The aim of the RAADP survey was to determine actual implementation of a new 
recommendation. The survey formed the foundation on which to build the thesis by 
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determining whether RAADP had become an integral aspect of maternity care within 
the UK. The aim of the survey was to describe policy and not to explain findings, 
and so it raised important questions which were then used to inform the design of the 
subsequent research. The findings were also used to aid explanation of the findings 
of those research studies, Chapters six and seven. The second piece of research, 
secondary analysis of anti-D Ig errors involving midwives, identified both individual 
and organisational factors that impact occurrence of error. This piece of research also 
raised further questions about midwifery practice and those questions, along with 
those identified through the RAADP survey, formed the basis of the focus group 
research. The focus group research aimed to consolidate the findings of previous 
research by gaining direct input from midwives. This added substance to the findings 
of Chapters five and six and to the wider evidence base through investigation of the 
specific questions that had been raised by those pieces of research. It also allowed 
exploration of other aspects of care relating to women with an RhD negative blood 
type that emerged during the focus group interviews.  
The final task of bringing all three pieces of research together to establish overall 
findings is undertaken in Chapter eight where they are discussed in the context of 
each other and of the wider evidence base. 
4.2 Ethical considerations 
Ethics is a philosophical approach that addresses morality and allows judgement 
about whether something is right or wrong. Polit et al (2001, Pg 461) define research 
ethics as “a system of moral values that is concerned with the degree to which 
research procedures adhere to professional, legal and social obligations to the study 
participants.” There are a number of high profile cases of serious breaches of ethical 
principles such as the Tuskegee syphilis study (William and Curran, 1973) and more 
recently at Alderhey, Liverpool, when it was discovered that the organs of children 
who died had been removed and retained without consent (Department of Health, 
2001). The principles of modern day medical ethics have their roots with the 1947 
Nuremberg trials and subsequent Declaration of Helsinki which has as one of its 
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fundamental tenants that researchers’ primary ethical duties are to research 
participants and not to society. Within the healthcare setting a number of professional 
bodies have produced their own guidance on ethics, with the Nursing and Midwifery 
Council (NMC) producing ‘The Code’, a document that sets standards of conduct, 
performance and ethics for nurses and midwives. It is regarded as the foundation of 
good nursing and midwifery practice, and a key tool in safeguarding the health and 
wellbeing of the general public (NMC, 2008). 
The ethical dimensions of a study are usually subjected to external review and Polit 
et al (2001) consider that this is crucial as it may be difficult for researchers to be 
objective owing to their desire to conduct a valid study. In the UK there is a 
requirement to gain ethical opinion for research within the NHS, and in Scotland the 
Chief Scientists Office (CSO) oversees this process via Research Ethics Committees 
(RECs). RECs provide independent advice on the extent to which proposals for 
research comply with ethical standards, and ethical opinion from the appropriate 
NHS Research Ethics Committee is required for any research proposal involving, 
among other criteria: Patients and users of the NHS; Access to data of past and 
present NHS patients; The use, or potential access to, NHS premises or facilities; 
NHS staff recruited as research participants by virtue of their professional role. 
Within the context of the research as whole a number of ethical considerations were 
made. These included a commitment to publish and disseminate negative as well as 
positive findings, an open and consistent approach to the use of any statistical 
analysis in order to reduce potential bias, and transparency surrounding sources of 
funding and any potential conflicts of interest. The research as whole was undertaken 
with the intention of describing current practice, and the ultimate goal of being able 
to use the findings to inform future practice and policy. The study participants gave 
their time voluntarily on this premise and it was seen as an important to ensure that 
all steps were taken to disseminate findings and report back to those who 
participated. 
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Ethics were considered in relation to each of the three separate aspects of the project 
and within the context of the project as a whole. This was done within a framework 
of respect, confidentiality and non-harm and with consideration to the research 
governance framework and guidance provided by the CSO and NMC.  In this thesis 
it was applied to each particular piece of research in the following ways. 
4.2.1 RAADP: a survey of policy and practice in the UK 
This piece of research was undertaken within the context of contemporaneous 
practice within the Better Blood Transfusion Programme at SNBTS, where survey 
work was regularly conducted to gather information about clinical practice in relation 
to blood transfusion throughout the UK. This does not usually require researchers to 
seek formal ethical opinion.  
Although experience of previous similar projects suggested that a formal application 
to the Local Research Ethics Committee (LREC) would not be required, the 
researcher sought advice from the Chair of the Lothian Research Ethics Committee. 
The Chair was able to confirm that the project should be considered a service 
evaluation and as such did not require submission of a formal application for ethical 
opinion.  
4.2.2 Anti-D immunoglobulin: analysis of midwifery errors 
reported to SHOT 
The data for this research were collated by SHOT and provided to the researcher 
specifically for use in this study. Reports submitted to SHOT are provided on the 
premise that “SHOT undertakes research, studies and audit in the area of transfusion 
safety, and this may be solely, collaboratively or by commission.” (Bolton-Mags and 
Cohen, 2012). As an employee of the Scottish National Blood Transfusion Service 
(SNBTS), and within the role of a specialist midwife, the researcher had legitimate 
clinical rights to access this database. As such the data were provided in original 
form and contained information that would allow identification of individuals and 
organisations. In order to maintain confidentiality, the data were scrutinised and any 
identifying information was removed. A new database containing the anonymous 
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reports was created, allowing the researcher to fully share and discuss the data with 
supervisors and advisors without compromising confidentiality. 
4.2.3 Focus group research to gain a midwifery perspective 
This research involved conducting group interview research with midwives. No 
patients were involved, but as the participants were NHS staff and sessions would 
take place on NHS premises, advice was sought from the South East Scotland 
Research Ethics Service (SESRES).  SESRES requested submission of an outline of 
the project for consideration by the Scientific Officer. This resulted in advice that the 
research did not need NHS ethical review under the terms of the Governance 
Arrangements for Research Ethics Committees in the UK (Appendix 3). A copy of 
this letter was provided for the research governance teams at each of the participating 
NHS sites and no further action in respect to formal ethics review was required. 
However, additional steps were taken to ensure that the midwives understood the 
implications of participating in this project. The midwives were invited to attend on a 
voluntary basis and prior to attendance they were given an information sheet 
outlining that: they would be participating in research undertaken as part of the 
researcher’s PhD; the purpose and intended outcomes of the research; that the 
sessions would be audio taped to facilitate data analysis; that all information gathered 
would be anonymised and that after data analysis and write up were completed the 
audio recordings would be destroyed. 
4.3 Funding and contribution of others 
University fees were paid by the Scottish National Blood Transfusion Service and 
the work was completed in the researcher’s own time alongside employment as a 
Transfusion Specialist Midwife.  
The SHOT analysis was made possible through the willingness of SHOT to share the 
data they had collated. This was given freely and without condition for the purposes 
of the research as outlined to them.  
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Chapter 5: RAADP: a survey of policy and 
practice in the UK 
5.1 Introduction 
The aim of this research was to determine current policy in the UK in relation to the 
2002 National Institute for Clinical Excellence (NICE) recommendation for routine 
antenatal anti-D prophylaxis (RAADP). This was achieved through a postal survey 
of all UK maternity units conducted in July 2005. A formal break in studies was 
taken following completion of this piece of work and the resulting time lag between 
its completion and subsequent write up resulted in this chapter being a summary of 
the research findings. The survey was published in Transfusion Medicine in 2008, 
(Harkness et al, 2008, Appendix 1), and was also mentioned in the NICE review of 
RAADP guidance in 2008 (NICE, 2008, Pg7, Appendix 2). 
5.2 Methods 
The reasons for choosing a cross-sectional descriptive survey are detailed in Chapter 
four, and it was recognised that within the chosen method there were a number of 
factors to consider in order to achieve the stated aims. Atkinson (2000) observes that 
a major challenge of survey research is to reduce the chance of the findings being 
wrong and this is can only be achieved through attention to the study design. 
Particular attention is required when considering: sampling error; non-response error 
and response error (Atkinson, 2000, Oppenhiem, 1992). 
5.2.1 Population and sampling 
Atkinson (2000) states that using a descriptive survey allows the researcher to make 
statements about a study population. The aim of this research was to make a 
statement about clinical practice regarding RAADP throughout the UK. It was 
important to determine exactly who the study population were. In the UK a particular 
NHS Trust or Board may have more than one maternity unit and it would not be 
unusual for those maternity units to have differing policies and procedures. For that 
reason the target population was defined as individual maternity units, rather than 
NHS trusts or boards. 
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The sample for this study was the entire population: that is all UK maternity units. 
Surveying the entire population might be seen as a method of eliminating sampling 
error, however (Oppenhiem, 1992) states that unless a survey is designed properly 
and aimed at the correct target population, even a whole population survey cannot be 
used to draw conclusions or make comparisons.  
5.2.2 Response and non-response bias 
It was identified that there was a need to reduce any bias through response and non-
response errors. Non-response error occurs if decisions about whether or not to 
respond to the survey might be influenced by the respondents own behaviour. For 
example if a maternity unit does not offer care in line with recommended guidance, 
they might be less likely to respond. This leads to a potential for bias, in that an 
increased proportion of units that do offer RAADP might respond than those that did 
not, leading to an over estimation of implementation of the guidance.  Measures were 
taken to reduce this bias by encouraging respondents to provide the information 
requested. These included: careful consideration about who should complete the 
questionnaire; clear explanation of the purpose and importance of the study; careful 
construction of the questionnaire to motivate response; and anonymisation of source 
of data/maternity unit. 
Response error can be either random or systematic. In random response error there is 
usually a transcription or data entry error by the researcher. Atkinson (2000) believes 
that random response error does not usually cause bias as it will often correct itself 
statistically over the data field, that is a researcher would be just as likely to wrongly 
input a wrong ‘no’ answer as a wrong ‘yes’ answer. Measures were taken to reduce 
random response error through careful input of data and developing a system of 
random data checks. Systematic response error is potentially more likely to bias any 
findings. This type of error arises from the way data is measured or collected, for 
example through phrasing of a question at interview or questionnaire. The problem 
of systematic response error was carefully considered during construction of the 
questionnaire (section 5.2.3). 
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Another factor to take into consideration was who, within those maternity units, 
should be asked to complete the questionnaire. In order to limit the potential for 
response error, it was important that this was a person who was familiar with policy 
and procedure as well as the other issues that were to be addressed. Although the 
questionnaire primarily contained questions concerning RAADP policy, it also asked 
about information provided to RhD negative pregnant women and education 
provided for staff to support the implementation of RAADP. For this reason it was 
important that the staff member surveyed was a midwife, and that they were in a 
relatively senior position so as to be aware of policy. The person also needed to be 
closely associated with provision of antenatal care, surveying midwives who work 
solely on labour or postnatal wards for instance would not have been appropriate. For 
the reasons described, the person to whom the questionnaire was addressed was the 
‘senior midwife for antenatal care’, likely to be the charge midwife in an antenatal 
clinic, or the midwifery manager responsible for antenatal care depending on the 
management structure of that particular maternity unit.  
5.2.3 Questionnaire development and content 
A questionnaire was developed specifically for this survey and contained questions 
that were based on the NICE recommendations concerning administration of anti-D 
Ig, information provided to RhD negative women and staff education and training. 
The questionnaire also included a request for a copy of any written patient 
information about RAADP.  A copy of the questionnaire is included in Appendix 4. 
A number of factors within the design of a questionnaire are recognised as 
influencing response rate. These include: relevance of topic; general appearance; 
length and ease of completion. Strategies within the construct of the questionnaire 
were developed in order to minimise the impact of these. 
The first stage of the process of developing the questionnaire was to compile a list of 
the variables that were to be measured, and following that to consider the most 
appropriate types of questions or instruments, such as scales, to collect data that 
would allow accurate measurement of each of those variables. 
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5.2.3.1 Type of questions 
A closed question is one in which the respondents are offered a choice of alternative 
replies. The purpose of this research was to gain answers to predetermined questions. 
It was about policy and practice and did not seek to describe attitudes or opinions. 
For this reason the survey contained only closed questions with fixed responses. A 
potential disadvantage of this approach was that the responses offered may be too 
crude or not provide the option that the respondent would have chosen. This could 
introduce bias by forcing the respondent to choose a response that did not accurately 
reflect the true answer. An attempt to counter this was made by adding a ‘don’t 
know’ or ‘other, please specify’ option for some questions. In addition the questions 
were piloted among midwives to determine that their understanding of the questions 
and potential answers was the same as that of the researcher.  
Another advantage of closed questions is that the questionnaire is relatively quick to 
complete. This was seen as a major advantage in surveying so many busy 
professionals. It was also noted that closed questions would be easier to process and 
analyse. For the purpose of this research they were deemed appropriate and the best 
approach. 
5.2.3.2 Sequence of questions and layout 
Following that the sequence of questions within the questionnaire was considered 
carefully. This involved identifying groups of questions that related to each other and 
considering the order of questions to maximise response rate and offer the best 
chance of complete and accurate data. The overall aim was to develop a 
questionnaire that flowed in a logical order and made sense to the respondent 
completing it.  
The questionnaire layout followed a funnel type approach. With questions on a 
broader subject area, such as ‘Does your maternity unit currently have a policy of 
routine antenatal anti-D prophylaxis?’ followed by more specific questions about 
aspects of the policy. It also included ‘filter’ questions to exclude some respondents 
from a particular sequence of questions if they were irrelevant to them.  
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5.2.3.3 Wording 
A great deal of consideration was given to the wording of the questions. In particular 
use of jargon, terminology and technical terms were used only where absolutely 
necessary and when they were used an explanation was given. Other factors that 
were considered were: whether words used had alternative meaning or usage; 
whether questions might be loaded; care not to over-tax respondent’s memories; care 
not to use double-negative questions. Every effort was made to make the questions as 
short and straight forward as possible. 
5.2.3.4 Introductory paragraph 
Another measure taken to increase response rate and reduce response bias was the 
insertion of a paragraph at the start of the questionnaire that gave clear instructions 
for completing it, for example to tick in the circle, and an explanation of terms used. 
Additional information at the end of the questionnaire reinforced this and re-stated 
where to send completed questionnaires. 
5.2.3.5  Layout of questionnaire 
Oppenhiem (1992) stresses the importance of making the questionnaire and the 
answering process attractive. The layout, printing and choice of paper should all be 
carefully considered. All of those factors were taken into consideration prior to 
printing the questionnaires. 
5.2.4 Pilot of questionnaire 
A number of midwives were asked informally to comment on the questions to be 
used in the questionnaire. Changes were made following this and when the 
researcher was happy with the questionnaire questions and layout it was piloted 
among a small number of senior midwives. Those midwives were given the 
questionnaire to complete and following this the researcher went through the 
completed questionnaires with them clarifying their response and understanding of 
the questions. Minor changes were required to question wording following this. 
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In addition the questionnaire contained a field asking the respondent to complete 
their name and designation and to give an email address or telephone number. This 
was to allow the researcher to contact them with any queries about responses given 
or incomplete data.  
5.2.5 Administration of questionnaire 
The way the questionnaire was administered was regarded as integral to minimising 
response bias, by ensuring that it reached the intended person, and to maximising 
response rate.  
A number of factors were considered to maximise the chances of the envelope 
containing the questionnaire to be opened. These included: where possible the 
questionnaire was posted to a named person, rather than to ‘the senior midwife for 
antenatal care’; the envelope was an office standard envelope, sent via and franked 
by the Scottish National Blood transfusion Service (SNBTS) mail room. This was 
intended to increase credibility from the outset through association with another NHS 
organisation. Oppenheim (1992) calls this ‘sponsorship’ and describes it as a 
powerful motivator if the respondent views the organisation involved positively.  
The contents of the envelope to be sent were considered carefully in order to 
maximise the chance of a response. A covering letter was included, offering an 
opportunity to explain the purpose of the research. Murphy-Black (2000) considers 
that the survey topic and its relevance to the respondent, as a factor that might 
positively influence response rate: “the more relevant the topic is to the respondent, 
the more practical it is to answer, the better the response rate” (Murphy-Black in 
Cormack, 2000, Pg303). The covering letter also offered another opportunity to 
reinforce the credibility of the research through association with SNBTS and to 
establish its purpose, to survey all UK maternity units, reiterating the importance of 
individual responses within the overall study design. It also offered the reassurance 
of confidentiality and anonymity in terms of sharing and publication of any data from 
individual maternity units, deemed vital in reducing non-response bias. 
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A postage-paid, addressed return envelope was included, again in order to maximise 
response from a survey that was to be completed by an employee in their workplace. 
Questionnaires were posted to all 328 UK maternity units in July 2005. The 
maternity units included private birth units, GP and/or midwife led units and larger 
maternity units at district general and teaching hospitals. After six weeks non-
responders were sent a reminder with a further copy of the questionnaire.  
5.3 Data analysis 
The questionnaire included a request for a copy of any written patient information 
about RAADP. A basic analysis was performed of the origin and content of the 
leaflets returned. Origin was categorised as follows: 
1. Commercial: produced by the manufacturers of anti-D immunoglobulin 
2. NHS: produced by national NHS bodies such as NICE, NBS and SNBTS 
3. Local: produced by local NHS trusts, divisions or maternity units 
The content of the leaflet was profiled against twelve key pieces of information 
identified from the patient information issued with the NICE guidance. These are 
detailed in the results section, 5.4, (Table 6).  
Data were entered into a spread sheet by one researcher, checked and re-checked, 
and then analysed using the computer software package SPSS v13. 
5.4 Findings 
A formal break in studies was taken following completion of this piece of work and 
the length of time between its completion and subsequent write up within the thesis 
resulted in this chapter being presented as a summary of the research findings. The 
findings presented here are those that provide a general overview of the 
implementation of the RAADP guidance.  
Replies from 4 of the 328 maternity units surveyed stated that antenatal care was no 
longer provided at that site. Of the remainder, and following letter and phone calls to 
non-responders, 91% returned completed questionnaires (294/324).  
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5.4.1 RAADP 
Of all responding maternity units, 220/294 (75%), offered RAADP. In Northern 
Ireland all 12 maternity units offered RAADP, in England and Wales this figure was 
180/243 (74%) and in Scotland 28/39 (72%).  
In England and Wales a single dose regimen of RAADP was available as an 
alternative to the two-dose regime. This was offered by 35/180 (19%) of units 
offering RAADP.  
5.4.2 Paternal testing 
Routine paternal blood group testing was offered by 27/220 (12%) of maternity units 
that offered RAADP though in Northern Ireland this was 11/12. 
5.4.3 Education and training to support RAADP 
At 9% of units (20/220), implementation of RAADP had not been accompanied by 
staff education, while for another 9% (19/220) these data were missing. For the 84% 
of the 181 maternity units who did offer staff education at implementation, it took the 
form of group training sessions (in the majority of cases with provision of written 
information). On-going staff education was in place at 100 (45%) of the maternity 
units who offer RAADP, and this was more likely to be in those with more recent 
introduction of RAADP. 
5.4.4 Written information 
Of units offering RAADP, 214/220 (97%) provided written information about it for 
pregnant women and 147/214 (69%) returned copies of the information that they 
provide, 30 sending two different leaflets, and 6 sending three. There were 60 
distinct leaflets, of which 8 were produced by commercial manufacturers of anti-D 
Ig, 7 by national NHS bodies and 45 by local NHS trusts or maternity units. The 
most commonly used leaflets were firstly a commercial one (used by 35 maternity 
units), and second the NICE leaflet (26 units). Thirty-three leaflets were specific to a 
single maternity unit. 
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5.4.4.1 Analysis of leaflets 
Analysis of content of the leaflets showed that omission of key information ranged 
across the recommended key points from 73% to 7% (Table 6, below). Only 3/60 
(5%) contained all 12 key pieces of information, while 16 (27%) contained 6 or 
fewer key points, 3 containing just 3. Considered across the units surveyed and 
returning leaflets (n=147), the coverage of the leaflets being used was less 
comprehensive in those units where RAADP had been introduced ‘early’ (up to year 
2002) (Mann Whitney U p≤0.001; n=31, 105), regardless of whether, in the case of 
units returning more than one leaflet, the coverage score used in the analysis was that 
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Table 6: Key information used to analyse content of patient information leaflets 
 
Key Information Expected 
 
Number (%) of leaflets that  
omitted the information 
 





• Indicate the actual incidence of Haemolytic 




• Explain that if the father’s blood type is also RhD 




• Give sources of further information about 


















• Explain potentially sensitising events(PSE) and 













• Explain why the problem occurs  
4/60 (7%) 
 
• Explain RAADP and how it differs from anti-D 






This survey found that there has been widespread implementation of the NICE 
recommendation for RAADP in the UK. However it also found variation in relation 
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to specific aspects of policy and the support provided to healthcare professionals 
whose practice was affected.  
5.5.1 Strengths and limitations of this study  
A major strength of this survey was the very high response rate (91%), with the 
findings representing data from almost all of the UK’s maternity units. As such the 
research presents work based on a highly representative sample. The survey also 
generated a large amount of correspondence which suggests that RAADP was, at that 
time, a subject of particular interest and relevance to the respondents. This could be 
regarded as enhancing the quality of the information provided, as those completing 
the questionnaires were engaged with the subject and motivated to respond. 
Weaknesses of the study included lack of control over who completed the 
questionnaire and potential inaccuracy in the information provided. Measures were 
taken to reduce the potential impact of the recognised weaknesses, and these were 
described earlier in this chapter (section 5.2). The principal question was whether or 
not RAADP was offered at the maternity unit. This question was very 
straightforward and referred to current practice meaning that responses were likely to 
be accurate. However some of the questions, in particular those regarding the 
information and education offered at the time of implementation, may have been 
more difficult to answer. This might be particularly true of those maternity units 
where RAADP had been policy for a number of years, and so respondents were 
referring to events that occurred sometime previously.  
The survey questionnaire was intentionally short and simple. This approach was 
intended to enhance the response rate, however it did mean that the number of 
questions was limited and those that were asked did not attempt to explore issues in a 
way that might have added meaning to the results. The intention of this survey was to 
gain straight forward information about specific aspects of current policy and 
practice. As well as answering those questions it provides a foundation on which to 
base further research, although it should be taken into consideration that the research 
was conducted in 2005 and is a representation of care provided at that time. 
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5.5.2 Discussion of findings 
Clinical guidelines have the potential to improve patient care, reduce regional and 
local differences in available treatment, and are recognised as a key method for 
dissemination of best practice. There is however evidence that implementation of 
National guidance can be patchy (Sheldon et al, 2004). In May 2002, when NICE 
issued its recommendation for RAADP, it was estimated that only around 12% of 
maternity units offered the intervention (Chilcott et al, 2004). This survey found that 
by July 2005 the majority of maternity units (75%) had implemented a policy for 
RAADP. This represents a substantial move to widespread implementation of the 
policy within a relatively short period, and comes despite the fact that 
implementation had clinical, financial, and training and educational implications. 
Implementing a policy of RAADP requires significant local level multidisciplinary 
review of policies and practices and allocation of funding and resources to match. 
This work did not explore what the perceived barriers or enablers for implementation 
were, but this is an important question for future research regarding on-going 
delivery of RAADP policy. 
The survey identified that not all maternity units were offering RAADP, and also 
found significant local and regional variations in practice among those maternity 
units that did offer RAADP. Those variations included how many doses of anti-D Ig 
are offered and whether or not paternal testing was offered. Variations were also 
apparent in the education and/or training offered to clinicians to support this change 
in policy, and in the information provided to pregnant women who are offered 
RAADP.  
The most notable difference in policy among those units that did offer RAADP was 
whether one or two doses of anti-D Ig were offered. At the time the survey was 
conducted English and Welsh maternity units had a choice of buying RAADP as two 
separate injections of 500 IU, given at 28 and then 34weeks gestation, or of a larger 
single dose of 1250 IU given at 28 weeks gestation.  The single dose regimen is 
simpler in terms of administration and may have an improved compliance rate 
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compared to the two-dose regimen (MacKenzie et al, 2011), but on reviewing the 
evidence NICE concluded that it might be slightly less effective in preventing silent 
sensitisation (NICE, 2002) {NB: The 2008 NICE review and update changed this 
advice to state that both regimens are acceptable. This advice did not apply at time 
this survey was carried out}. This survey found that in England and Wales around 1 
in 5 maternity units offered the single dose regimen, although in Scotland and 
Northern Ireland anti-D Ig was only offered as a two-dose regimen. Such variation in 
practice has important implications for those women who move between maternity 
units during a pregnancy as they might miss a required second dose of anti-D Ig if 
the area they move to has a policy of single dose RAADP.  If clinicians are to offer 
all RhD negative women the most appropriate care and advice, they need to be aware 
that practice may vary in other areas. Variations in policy also have important 
implications for midwifery practice in terms of midwives responsibility and 
accountability, and these are discussed in more detail below (section 5.5.3).  
Another aspect of practice considered by this survey is the issue of paternal blood 
type testing. If the father of the baby is RhD negative, then the baby must also be 
RhD negative and so there is no need to give anti-D Ig during pregnancy: either 
RAADP or following a potentially sensitising event during pregnancy. As such, 
identifying the father’s blood type as RhD negative could prevent unnecessary 
administration of anti-D Ig. There appears to be general reluctance towards doing 
this, with reasons often cited anecdotally as potential misidentification by the mother 
of the father and the extra costs and administration involved in obtaining paternal 
samples. This is reflected by the fact that just 12% of maternity units routinely offer 
to test paternal blood type. However, 11 of the 12 maternity units in Northern Ireland 
(92%) offered routine paternal blood typing. It is interesting to note that transmission 
of Hepatitis C through contaminated anti-D Ig occurred in Ireland during the 1970’s 
and 80’s. The Northern Irish population have close geographical and cultural links 
with Ireland, and those events may have influenced the decision to offer a test that 
reduces the number of women who are exposed to anti-D Ig. This may also be 
influenced by the cognisance of the NHS in Northern Ireland of its organisational 
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responsibility and accountability, and could also reflect heightened awareness among 
the general population, pregnant women and healthcare professionals of the potential 
risks of anti-D Ig as a blood product 
The emerging potential for testing fetal blood type through DNA extracted from 
maternal blood samples may mean that usefulness of paternal testing becomes 
obsolete. However, the experience of those maternity units that already offer routine 
paternal testing could provide valuable insight to the practicalities of offering this 
test and is an area of research that could be explored further. 
5.5.3 Implications for midwives 
The findings of this survey have important implications for midwives. The survey 
uncovered a number of situations where midwives’ sense of personal and 
professional responsibility and accountability might be at odds with her obligation as 
an employee to fulfil her employer’s organisational responsibilities. These reflect the 
evidence based, population focused, nature of the recommendation for RAADP, and 
the variations in practice that were apparent throughout the UK.  As an example, if a 
midwife was aware of the NICE recommendation for RAADP and the potential 
benefits that might have for an RhD negative pregnant woman, but the organisation 
within which she worked did not have a policy to routinely offer it, this might result 
in perceived conflict with her professional responsibility to “deliver care based on 
the best available evidence… ensure any advice you give is evidence based.” (NMC, 
2008, Pg6). The same dilemma might apply to the knowledge that it is possible to 
test for paternal blood group. 
 The NICE recommendation is such that should a woman ask for RAADP, then the 
maternity unit would be obliged to offer it. This was put to the test in 2008 when the 
Welsh ombudsman upheld a complaint from a pregnant woman whose local health 
board did not offer RAADP (Public Services Ombudsman for Wales, 2009). 
However, although an NHS Trust might be obliged to provide RAADP if a woman 
requests it, there is no legal responsibility to offer it in the first place. This creates a 
situation where only those women who are well informed and already aware of the 
Policy and Practice Concerning Women with an RhD Negative Blood Type:              
A midwifery perspective 
Chapter Five: RAADP: a survey of policy and practice in the UK 101 
intervention have it as an option.  Maternity units are not obliged to provide paternal 
blood group testing to determine RhD status, and many will only perform the test if 
parents were willing to pay for it. This further complicates the ethical dilemma in 
that the test is only available to those parents who request it and who can afford to 
pay for it.  
Another area of midwifery practice for which the findings of this survey are relevant 
is that of facilitation of informed decision making for women. NICE (2002) 
reiterated the importance of informed decision making within their guidance 
document. Informed decision making is important in relation to RAADP, not only 
because of the balance of risks and benefit, but also because it is an evidence-based 
recommendation that is based on a population perspective. The recommendation 
does not take into account individual factors such as whether the woman plans to 
have a future pregnancy, or whether the baby’s father is RhD negative. The literature 
reviewed in Chapter three suggests that such routine interventions may lead to a 
culture of compliance rather than fully informed consent. Although there is no 
research evidence concerning RhD negative pregnant women’s perspective on the 
maternity care they receive, there is a great deal of evidence that “informed choice is 
unusual in maternity care and compliance is common” (Kirkham, 2004, Pg xvii). The 
survey gathered information on two factors that influence informed decision-making: 
provision of written information about RAADP and the education given to key care-
givers.   
Facilitation of informed decision-making, and appropriate administration of anti-D Ig 
in line with guidance, will depend upon the clinician’s knowledge and understanding 
of the issues involved. The majority (82%) of maternity units did offer staff 
education at the time of implementation of RAADP, but only 45% replied that they 
offered on-going education. On-going education is important in order to maintain 
staff knowledge and understanding in light of further developments and to address 
staff turnover. Midwives’ have a responsibility to ensure that they “keep their 
knowledge and skills up to date throughout their working life” (NMC, 2008, Pg6). 
Equally employers have responsibility to support staff and do all they can to ensure 
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that the midwives they employ are fit to practice (NMC, 2008).  Within the 
limitations of this survey it is impossible to make any judgements about the content 
or quality of the education offered, but this is another important question for future 
research. 
With the lengthening list of issues to discuss at antenatal appointments and the 
pressure on time available for appointments, clinicians are increasingly dependent on 
written patient information. This may be particularly true of an intervention such as 
RAADP where the risks and benefits are complex and vary depending on an 
individual’s circumstances. The survey found that the overwhelming majority of 
maternity units provide written information, however the content of the leaflets 
varied considerably and almost all omitted at least some of the information that is 
considered of key importance. The information that was most commonly omitted 
was that which might have led a woman to decide that, based on her own individual 
circumstances, the risks of RAADP outweighed the benefits (Table 6).  
On issuing its recommendation for RAADP, NICE (2002) stated that high quality 
information, validated and produced at National (UK) level, must be made available 
to RhD negative women. They produced their own patient information leaflet, but at 
the time of the survey the NICE leaflet was used by just 15% of those units that 
returned leaflets. Locally produced leaflets were being used by nearly a third (32%). 
This raises the question: why did so many maternity units opt to produce their own 
leaflets? A time consuming and expensive option, particularly when a leaflet that was 
produced by the NICE expert group on RAADP was widely available (the leaflet can 
be downloaded from the NICE website). Analysis of the content of the leaflets found 
that that key information was omitted in the non-NICE leaflets used by 73% of 
responding maternity units. The fact that the locally produced leaflets were less 
likely to contain information that might lead women to decide to decline RAADP, 
raises the difficult question of whether the maternity units were inclined to produce 
leaflets that they felt supported their policy for RAADP. The literature reviewed in 
Chapter three suggests that some healthcare professionals resist providing detailed 
written information for women through fear of creating anxiety. This could be a 
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reason for omission of some of the key information when leaflets were produced by 
the maternity units. These questions are beyond the scope of this research, but again 
are important and relevant for midwives who rely on written information as tool for 
facilitation of informed decision making. 
The issue of quality around locally produced leaflets does not just concern content, it 
is also raises the question of whether expertise in written communication for patients 
was available to those producing ‘local’ leaflets. Women’s ability to understand and 
process the information contained within the leaflets, in a manner that enables an 
informed decision about RAADP, is as important as the content. This survey did not 
address this question, and similarly did not explore whether the midwives engaged 
further with the women to discuss RAADP in greater detail than was apparent from 
the leaflets. The varied content and quality of the leaflets highlights further the 
disparity in care provided by different maternity units and suggests a need for a co-
ordinated national approach for the production and dissemination of high quality 
information for pregnant women. 
Interestingly, those implementing RAADP after NICE issued their guidance used 
more comprehensive leaflets. On-going staff education was also more likely in 
maternity units that had implemented RAADP more recently. This suggests that the 
NICE guidance has had a positive impact on the information available to patients, 
both written and through care-givers. However this also raises concern as to whether 
those maternity units where RAADP was introduced prior to 2003 have reviewed 
and updated their information and staff training in light of the new guidance.  
5.5.4 Implications for further research 
The survey findings highlight a number of questions that are important for future 
research. They include: 
• What are the perceived barriers and/or enablers to implementation of a policy 
to offer RAADP? 
• What is the present state of implementation? 
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• What is the experience of women, their partners and midwives at those 
maternity units where paternal blood type testing is routinely offered? 
• Are maternity units still producing their own leaflets regarding anti-D Ig? 
And if so… 
• What drives the choice to produce written information locally when there is 
nationally produced and validated information readily and freely available? 
• How have changes to maternity service provision since 2004 impacted on 
delivery of a policy of RAADP? 
This survey also raised a number of questions about midwifery practice that the 
researcher will explore further during this thesis. In particular it was considered 
important to explore what education and/or training midwives received in relation to 
RAADP and anti-D Ig in general. Although the survey found that most units did 
offer education it was not clear what form this took, nor what impact it had on 
midwives’ knowledge, understanding and practice. Additionally the survey showed a 
wide variation in the type of written information provided for pregnant women with 
an RhD negative blood type. The literature review in Chapter three suggests that 
midwives are increasingly dependent on written information to support informed 
decision making. The researcher was keen to explore further what part written 
information played in the process of informed decision making around this issue. 
This was considered particularly relevant given the emphasis placed on decision 
making around RAADP by organisations such as NICE, the Royal College of 
Obstetricians and Gynaecologists and the Royal College of Midwives.  At the heart 
of both of these issues are important questions about midwives’ personal and 
professional responsibility and accountability. Midwives’ knowledge and 
understanding of the issues is key to their ability to provide appropriate care for 
women, and this clearly extends to supporting a woman to make a decision about 
RAADP based on her individual circumstances.  
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This research demonstrated that RAADP has become a routine aspect of maternity 
care throughout the UK, and in doing so highlighted the increased involvement that 
midwives have in the administration of anti-D Ig. The research presented in the 
following Chapters, six and seven, is designed within the context of the findings 
presented here and the questions those findings raise. 
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Chapter 6: Anti-D Ig: analysis of midwifery 
errors reported to SHOT 
Anti-D immunoglobulin (Ig) is offered to all pregnant women with an RhD negative 
blood type, around 1 in 6 UK maternity patients. Failure to administer anti-D Ig in 
line with guidance has potentially serious consequences and all adverse events 
relating to anti-D Ig should be reported for inclusion in the Serious Hazards of 
Transfusion (SHOT) annual report. This information is useful in identifying trends 
and, alongside observations from a small number of ‘stand out’ error reports, allows 
SHOT to make recommendations for practice based on data observed over a number 
of years. The extent to which other potential contributory factors are explored is very 
limited.  Although midwives have a key role in the administration of anti-D Ig, there 
is not a midwife involved in the analysis of the SHOT data and the data are not 
considered from a clinical midwifery perspective. 
This research builds on the SHOT approach to analysis, considering the data from a 
midwifery perspective and seeking to identify clinically relevant issues. The aim of 
this part of the thesis is to describe the type of anti-D Ig errors made by midwives 
and the factors that lead the midwives to make them. It was hoped that this would 
allow better understanding of why errors happen and what can be done to prevent 
them from happening in the future. It also gathered data to inform the next stage of 
this research: Anti-D Ig: focus group research to gain midwives’ perspective. 
6.1 Background  
Some evidence relevant to this chapter was presented in Chapters two and three, 
however it is useful to discuss here some of the policies, procedures and ways of 
working that are particularly relevant to this chapter. 
6.1.1 Anti-D Ig 
Administration of anti-D Ig sits within a complex framework where laboratory, 
medical and midwifery staff, and the woman herself must interact effectively in order 
to ensure that the correct woman receives the correct dose of anti-D Ig according to 
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her individual clinical circumstances. Midwives in particular have a key role in 
administration of anti-D Ig, this is detailed in section 2.4, with the policy for anti-D 
Ig administration and associated blood testing in Table 1, section 2.2.  
Anti-D Ig is a human blood product, and as such, is strictly controlled. All anti-D Ig 
should be fully traceable from recipient back to donor (via a batch number). In the 
UK, prior to the introduction of routine antenatal anti-D prophylaxis (RAADP), all 
anti-D Ig was held by the hospital blood bank or transfusion laboratory and issued to 
the clinical area as required and on a named patient basis. That is the correct dose of 
anti-D Ig was sent directly from the laboratory to the area requesting it, with 
documentation linking that vial or vials, to the named patient for whom it had been 
requested. The introduction of RAADP, offered to all RhD negative women during 
pregnancy, meant that some maternity units found this arrangement impractical and 
began holding stock of anti-D Ig in clinical areas. This allows anti-D Ig to be used as 
required by staff without directly involving the blood bank or transfusion laboratory. 
This arrangement is particularly useful for staff holding clinics out-with the hospital 
setting, for example at GP surgeries. Although holding remote stock makes the anti-
D Ig more accessible it also removes the extra control that the laboratory have over 
its issue and it has been argued that it may increase the likelihood of errors. It is not 
known how many maternity units have an arrangement to hold ‘remote stock’ of 
anti-D Ig, but not all do. Anti-D Ig should be stored in a validated medicine or blood 
fridge. 
6.1.2 Incident reporting 
The first step in learning from mistakes, in order to reduce the risk of recurrence, is 
to collect information about any adverse incidents that occur. This enables errors that 
impact patient care to be monitored, managed and reported via risk management 
process and then linked to professional and organisational learning through NHS 
Boards and clinical governance structure. Reporting systems are seen as crucial to  
“Providing a core of sound, representative information on which to base analysis and 
recommendations” 
DOH (2000, Pg ix). 
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Local reporting systems should provide the bedrock for onward reporting to regional 
or national systems.  
The report ‘Organisation with memory’ (DOH, 2000) found that all NHS trusts, in 
England and Wales, had established effective reporting systems at local level. 
Clinical governance and risk management standards depend on systematic 
identification and treatment of risk, with incidents recorded and reviewed as part of a 
system of risk management. Clinical errors and incidents should be analysed and 
used as basis for improving quality of treatments, services and premises. Systems can 
be paper based or electronic/web-based e.g. DATIX or Safecode. The National Audit 
Office report (National Audit Office, 2005) found that incidents were often analysed 
at local level with relevant information passed onto one or more of around 30 
organisations, including the Serious Hazards of Transfusion haemovigilance scheme 
(SHOT), Figure 4, below. 
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Figure 4: Incident reporting from trust to national level 
 
Source: National Audit Office (2005, Pg3). Copyright National Audit Office 
6.1.3 Anti-D Ig incident reporting 
Any errors involving blood components, including anti-D Ig, must be reported to 
SHOT. Formal systems for recognising and reporting errors will differ between 
geographical areas and maternity units, however anti-D Ig errors are commonly 
recognised by the laboratory staff who conduct blood testing and issue anti-D Ig, the 
clinicians delivering care, either at point of error or afterwards, or occasionally by the 
woman herself. Initially these errors should be submitted via the local formal 
incident reporting system in the laboratory or clinical area, such as DATIX. Any 
incidents that meet criteria for reporting to SHOT will then usually be identified by 
hospital transfusion practitioners (criteria for reporting anti-D Ig errors are described 
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in Table 7). Some may also be reported to SHOT directly by the clinicians, medical 
and midwifery or laboratory staff involved. A standard reporting online form, 
available through the SHOT website to registered users, is used to collate the reports.  
In the past reporting  to SHOT was voluntary but in recent years a number of quality, 
inspection and accreditation organisations and government bodies within the UK 
have made reporting to SHOT a requirement. These include: The National Patient 
Safety Agency (England and Wales), Department of Health (England), Welsh 
Assembly Government, Department of Health and Social Service and Public Safety 
Northern Ireland and NHS Quality Improvement Scotland (QIS, now HIS). This 
means that all errors and incidents involving anti-D Ig, in the UK, should be captured 
by the SHOT database. The SHOT scheme is confidential. 
SHOT publish an annual report, within which the errors are categorised according to 
whether the primary error occurred in the laboratory or the clinical area and 
according to type of error (Table 7). In the 2008 SHOT annual report the definition 
of an adverse event relating to anti-D immunoglobulin is given as:  
‘An event relating to the prescription, administration or omission of anti-D Ig that has the 
potential to cause harm to the mother or foetus immediately or in the future.’ 
 
(Taylor et al, 2009, Pg82) 
 SHOT collate errors in four broad categories. The error categories and their potential 
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of anti-D Ig 
 
• Anti-D Ig is omitted 
completely, or 
administered more than 
72hours following 
potentially sensitising 
event (PSE), delivery of 
an RhD positive baby or 
as RAADP. 
 
Failure to administer anti-D Ig within 
72hours of a PSE or delivery of an 
RhD positive baby puts the woman at 
risk of sensitisation with anti-D 
antibodies. Her future pregnancies may 
be at risk of Haemolytic Disease of the 









of anti-D Ig 
 
• Anti-D Ig is administered 
to an RhD negative 
woman known to have 
anti-D antibodies or 
known to have an RhD 
positive baby. 
 
• Anti-D Ig administered to 
an RhD positive woman. 
 
• Anti-D Ig administered to 
the wrong person. 
 
If anti-D Ig is administered to an RhD 
negative pregnant woman 
unnecessarily, there are no known 
physiological consequences, however 
she will have been unnecessarily 
exposed to a human blood product. 
Anti-D Ig is considered exceptionally 
safe, but transmission of known or as 
yet unknown blood borne viruses 
cannot be completely ruled out. 
If anti-D Ig is administered to an RhD 
positive woman she is exposed to the 
same risk associated with a blood 
product. In addition there is a risk that 
the anti-D Ig will cause some 
haemolysis of her RhD positive red 
blood cells, although this is highly 




Wrong dose of 
anti-D Ig given 
 
• Inappropriate dose of anti-
D Ig administered: 
according to gestation 




Failure to administer the correct dose 
of anti-D Ig puts the woman at risk of 
sensitisation, her future pregnancies 
may be at risk of HDFN. 
 
Administration 





• Anti-D Ig should be should 
be administered on or 
before the expiry date 
stated in the vial.  
 
Failure to do this may result in reduced 
effectiveness of the product and 
subsequently place the woman at risk 
of sensitisation with anti-D antibodies. 
Her future pregnancies may be at risk 
of HDFN.  
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The report also gives some specific examples of errors that have occurred and 
provides recommendations for practice based on errors within that reporting year and 
on cumulative data and trends observed over a number of years.  
6.2 Method 
The researcher was given access to all 136 SHOT incident reports that had been 
submitted for inclusion to the 2008 annual SHOT report (Taylor et al, 2009). These 
were provided in their original form, on an Excel spread sheet. Data collection is an 
extremely important aspect of the overall study design, however in this case the data 
had already been collected and so the researcher had no control over this. The 
researcher had, instead, to determine whether the data collection had been robust and 
to consider any aspects of the collection process that might influence the data’s 
suitability for use within this study design. 
As already discussed, there is a strong culture of using incident reports throughout 
the National Health Service (NHS). Reporting is now mandatory when an adverse 
event occurs, and onward reporting to SHOT is also mandatory. The data available 
for analysis contained all recognised adverse events relating to anti-D Ig that 
occurred within UK NHS organisations, and were reported to SHOT, during a 12 
month period in 2007/2008. Although Taylor et al (2009) acknowledge that SHOT 
does not receive all possible error reports, this data set represented the most complete 
information available concerning errors relating to anti-D Ig in the UK  
A major factor when considering use of the SHOT error reports was that there was 
no information about who conducted the initial report and investigation, or how that 
was undertaken.  The reports came from across the UK and so would have been 
completed by a number of different people. Varied approaches to investigation and 
information gathering will have been used, resulting in inevitable, but unknown, 
biases. The reporting system was an online questionnaire and the 2008 SHOT annual 
report acknowledged that the system in use when this data were collected was not 
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user friendly. Completing the online questionnaire was a lengthy process often 
involving scrolling through multiple pages to find questions relevant to a particular 
type of report (Taylor et al, 2009). This too may have impacted on the content and 
quality of the data contained within each form.  
The information contained within the SHOT incident reports contained fixed 
responses to closed questions as well as free text narrative. The individual incident 
reports describe details of the incident, the findings of any investigation held and an 
outline of any action taken as a result. The investigation undertaken is most often 
based on root cause analysis. Root cause analysis (RCA) is now the main way that 
medicine investigates mistakes and tries to prevent future mistakes (Wu, 2008). It 
has its origins in manufacturing industries and was first used in a healthcare setting 
by the Veterans Affairs Hospitals in the United States (Heget et al, 2002). It is used 
across a number of countries including the UK, where it has been adopted by the 
National Patient safety Agency (National Patient Safety Agency, 2011). RCA is a 
problem solving method that provides a structure to the retrospective analysis of 
errors. The process can take different formats, but usually a clinical team who were 
not involved in the incident investigates what happened, with the aim of identifying 
the causes of the incident and developing recommendations for change (Iedema et al, 
2008). It should be a systems based approach, rather than focussing blame on an 
individual.  Wu (2008) describes the RCA process as designed to answer three 
questions: what happened, why did it happen, and what can be done to prevent it 
happening again? 
Flanagan (1954) suggests that the primary aim of scientific techniques are to ensure 
objectivity of the observations being made and reported, and that this can only 
happen if all observers are following the same set of rules. It is important to 
acknowledge that it was beyond the researcher’s control to determine whether the 
data collection and reporting was robust.  In fact, it was likely that the means of 
collecting and collating the information made it susceptible to significant bias. 
However, the data available for analysis represented a unique opportunity to conduct 
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research using the most complete information concerning clinical errors relating to 
anti-D Ig which was available in the UK.  
6.3 Data analysis 
The spread sheet contained 136 incident reports but on further reading one of the 
reports was a duplicate, leaving 135 complete reports. For this research only 
incidents where a midwife was involved at some point in the process were included.  
Some of the errors included in this research as midwifery errors had originally been 
categorised as ‘laboratory’ errors in the analysis completed by the SHOT team. An 
example of this is where the laboratory issued anti-D Ig in error to a woman with an 
RhD positive blood type, but the midwife administered it anyway: although the 
laboratory made the initial error, the midwife made her own error by failing to 
complete checks that would have picked up the mistake and prevented administration 
of the anti-D Ig. There were also eight cases where SHOT had categorised the error 
as ‘clinical’ but a midwife was not involved. These included errors occurring in 
accident and emergency departments and gynaecology wards (areas where nurses 
rather than midwives practise) and other reports where it was clear that only medical 
staff were involved. Those eight reports were excluded. 
In a small number of the reports it was not clear precisely who had been involved in 
the error and it could have been a member of medical or nursing staff rather than a 
midwife. When the information contained in the report was sufficient to determine 
the clinical context and that the error could possibly have been made by a midwife, it 
was decided to include those cases and assume for the purpose of this project that a 
midwife had been involved.  
The reports were read and re-read and any reports where a midwife was involved in 
the error were identified. There were 105 such reports but 3 contained insufficient 
information to allow any meaningful analysis, leaving 102 reports suitable for 
analysis. The process for deciding to include or exclude reports is detailed in Table 8, 
below. 
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Table 8: Exclusion process for SHOT error reports  
  
Number of Reports 
 
 
Total: all available reports 



















Other Reasons/Staff groups 





Not enough information 
available to determine 






Midwife involved but not 











Total Included Cases 





The errors were allocated ‘case numbers’, with each incident having a unique 
number from 1 through to 102.  
The data analysis was multi-faceted, with three aspects:  
1. Simple classification of the incidents  
2. Detailed description of the incidents  
3. Identification of key aspects of the incidents  
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These methods were interconnected and complimentary, each describing different 
aspects of the incidents. The methods were focussed, but also evolved and adapted as 
the analysis progressed, taking into account findings as they were emerged. They are 
described in further detail below. 
6.3.1 Simple classification of incidents 
The SHOT reporting scheme categorises the reports they receive into type of anti-D 
Ig incident and according to staff group deemed responsible for the error. In the first 
instance the data were analysed using an approach similar to that used by the SHOT 
reports: identifying categories and quantifying the error reports according to the 
numbers and types of incident. Although the approach mirrored the SHOT approach 
to data categorisation, the design differed in that it only included those errors that 
involved a midwife.  
6.3.2  Detailed description of the incidents 
The aim of this aspect of the analysis was to look at each incident in more depth in 
order to describe them in more detail and to identify common themes among the 
errors. The methodology employed for this part of the research used an interpretative 
approach based on critical incident technique (CIT). This allowed identification of 
similarities and/or common elements leading to category formation.  
CIT is a qualitative research approach that can be used to analyse clinical incidents 
and errors, with Wright et al (1991, Pg 676) defining a critical incident as “an 
occurrence that could have led (if not discovered and corrected in time), or did lead, 
to an undesirable outcome’. It has its roots in the military, where psychologists used 
the method to better understand pilot behaviour during the Second World War, and 
was further developed by the psychologist Flanagan during the 1950’s. Flanagan 
(1954) determined that the method was extremely flexible and likely to have many 
types of applications, and it has since been successfully applied in the healthcare 
setting, particularly in specialities such as anaesthesia and critical care (Donchin et 
al, 2003).  CIT is not a rigid research methodology, rather it is a flexible set of 
principles that can be modified and adapted for specific situations (Flanagan, 1954). 
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This flexibility is particularly useful for analysing and interpreting data collected 
from the ‘real’ situation of clinical practice. Understanding ineffective clinical care is 
crucial to promoting effective clinical care: by looking systematically for areas of 
weakness that may have contributed to an undesired outcome, it is possible to 
identify errors that are both clinically significant and prevalent. Many health care 
organisations now see the value of incident reporting as a multidisciplinary approach 
to reorganising care in a way that will make it safer and more effective. It offers a 
robust and systematic approach to clinical problems and Iedema (1991) describes the 
intent of CIT as being to shape work practices rather than making judgements about 
the actions of specific individuals. It allows a better understanding of how the 
systems and routines of practice contributed to what went wrong and to what extent 
they could be redesigned.  
As with any research methodology, CIT has advantages and disadvantages. One 
disadvantage of CIT is that it relies on the recall and report writing skills of the 
respondents, and may also be limited by the format in which people are asked to 
report: for example the questions they are asked on the reporting form, or by the 
amount of time that has elapsed between the event occurring and the report being 
compiled. The report may also suffer from personal bias from the person doing the 
reporting, although having a standard incident report form can help to ease this bias. 
For this particular research the main advantage of CIT is that the reporting of 
incidents involves descriptions of actual events, rather than of events as they should 
be. This is particularly helpful when applying the findings to effect change in 
practice, or to inform educational content for clinicians. The aim of this aspect of the 
data analysis was to provide a detailed description of the incidents. An approach 
based on CIT methodology was used to identify major categories which were then 
related to common themes, within which smaller categories and then sub-categories 
are identified. These were all related back to the broader categorisation that had been 
conducted initially. The number of each category and subcategory were then 
recorded. Cormack (2000, Pg332) describes this as an inductive classification of 
incidents with the “classification system constructed as the data are being analysed, 
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rather than before”.  Flanagan (1954) also describes the process of creating the 
categories as inductive and relatively subjective, but considers that once the 
classification system is in place, objectivity can be achieved in placing incidents in 
defined categories. This was achieved by reading and re-reading the incidents, 
identifying emergent categories and themes and then re-reading the reports further to 
confirm categories. Cormack (2000) suggests creating categories until all incidents 
have been classified, leading to a two or three tier system that starts with a very 
general description and progresses to become increasingly more specific. By 
following this process it was possible to map common occurrences and general 
themes among the reports. 
In addition the data were examined in order to discover the absolute cause: the 
definitive, final error made by a midwife that resulted in the incident. When all other 
factors and influences were disregarded it was possible to identify just four ‘proximal 
errors’. 
6.3.3 Identification of key aspects of the incidents 
The initial categorisation and the detailed description of the incidents were used to 
shed light on the types and frequency of anti-D Ig incidents that involve midwives 
and to describe common details of those incidents. It describes the facts of the errors: 
that is what had actually happened, the process and the mistakes made. Another aim 
of this research was to try to describe factors that influence the errors, in particular 
the key aspects of the error that might be identified in advance and changed to 
prevent recurrence. In order to do this an approach to analysis, drawing from 
Reason’s model of understanding adverse events (Reason, 2000), was developed 
specifically for this research. The approach focused on uncovering three elements of 
the errors named ‘proximal errors’ ‘trigger events’ and ‘fallible practices’. They were 
regarded as interactive, contributing in varying degrees to the likelihood of the error 
occurring and are described in detail below.  
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a) Proximal errors 
The detailed analysis identified that in all of the incident reports the final error lay 
with the midwife acting or failing to act. This was termed a ‘proximal error’.  The 
proximal error was often the final opportunity to prevent an adverse incident, without 
which it would not have happened. The proximal errors reflect the work of Reason 
(2000) in which he describes a person approach that focuses on the unsafe act and 
views it as resulting from human issues such as forgetfulness, poor motivation, 
carelessness or recklessness. Reason (2000) considers that these ‘active failures’ can 
be hard to predict, the person approach regards them as the cause of the error and 
looks no further. 
In almost all of the incidents other factors had direct and/or indirect influence on the 
proximal error. Reason (2000) also describes a system approach to error, here the 
important question shifts from who made the mistake to how and why barriers and 
defences failed. The proximal errors formed the foundation of the analysis, with the 
researcher working back through each incident to identify the ‘trigger events’ and 
‘fallible practices’ that impacted the errors.   
b) Trigger events  
Trigger event is the term coined to describe the event(s) or situation that directly 
influenced the error. For example, in the case of administration of date expired anti-
D Ig, the trigger event might be that a vial of date expired anti-D Ig was available for 
use in the fridge in the clinical area. Trigger events are similar to Reason’s (2003) 
error traps and identification and elimination of trigger events or situations is key to 
preventing an adverse event. The trigger events are errors in themselves but would 
not necessarily always lead to an adverse event. It is likely that in most cases the 
trigger event would be recognised and rectified before an adverse event occurred, but 
if the midwife fails to recognise the trigger event because she makes her own 
proximal error, then an adverse event will occur. The error reports were examined, in 
order to identify trigger events.  
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c) Fallible practices 
Analysis also identified policies, procedures, practices or documents within the 
clinical area that were flawed in such a way that they permitted, or even encouraged, 
a trigger event to happen. These were termed ‘fallible practices’. Fallible practices 
essentially allow the trigger events, and ultimately the error, to happen.  
Following on the example of administration of expired anti-D Ig, the fallible practice 
would be an inadequate procedure for checking anti-D Ig stock held in the clinical 
fridge. This leads to the trigger event, in this case that date expired anti-D Ig is 
available in the clinical area fridge. In turn if the midwife makes her proximal error 
and does not check expiry date an adverse incident, the woman receiving date 
expired anti-D Ig, occurs. Had an adequate procedure for checking stock been in 
place any anti-D Ig close to expiry date would have been returned to the laboratory 
and either disposed of or issued directly by the laboratory to be given within its 
expiry date. In this example, if the fallible practice had been addressed the trigger 
event or situation would not have existed and so even if the midwife fails to complete 
her checks, it would not lead to an adverse incident.  
The relationship between fallible practices, trigger events and proximal errors varies 
depending on the incident. In some cases there is a very straightforward link with 
fallible practices having a direct influence on the proximal error. However the 
relationship between the factors can also be more complex.  
All of the incident reports were analysed in the context of this framework. With the 
proximal errors as a starting point it was possible to re-examine the incident reports 
and identify trigger events and fallible practices. These were considered in the 
context of the individual incident report, and in addition the most common 
frameworks, the interaction of fallible practices, trigger events and proximal errors, 
were also identified. Figure 5 illustrates the use of the model to identify the key 
aspects of an incident where date expired anti-D Ig is administered. 
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Figure 5: Key aspects of incident: administration of date expired anti-D Ig 
 
6.4 Findings 
6.4.1 Simple classification of the incidents and root cause 
analysis to determine proximal errors 
Initially the 102 error reports were categorised using the four main SHOT categories: 
Inappropriate administration 47 (46%); Late/Omitted anti-D Ig 44 (43%); Wrong 
dose of anti-D Ig given 8 (8%) and expired anti-D Ig given 3 (3%).  
During the analysis four proximal errors were identified:  
• Failure to complete appropriate checks, 53 (52%)  
• Failure to follow up care, 34 (33%)  
• Misinterpretation of results, 7 (7%)  
• Failure to follow guidelines, 7 (7%)  
In one additional error report the proximal error could have been either failure to 
complete appropriate checks or failure to follow guidelines, this was not clear from 
the information provided within the report.  
Although the proximal errors were identified during the detailed description part of 
the analysis, they are reported here to allow the findings to be related to classification 
of incidents.  
i) Inappropriate administration of anti-D Ig 
The findings are summarised in Table 9, below. 
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Table 9: Categorisation of error reports: inappropriate administration of anti-D Ig 
 
























In this category there were just two proximal errors: failure to complete appropriate 
checks, either confirming the woman’s identification or confirming test results 
formally, 42 (89%); and misinterpretation of results, either misunderstanding the 
meaning of results or straight forward misreading or mishearing of a report 5 (11%).  
ii) Late/omitted anti-D Ig 
The 44 late and omitted anti-D Ig errors were categorised according to type of 
incident: anti-D Ig given late, 34 (77%), or omitted completely, 10 (23%).  
In the majority of cases, 34/44 (77%), failure of the midwife to follow up on care 
was the proximal error. This was either failure to follow up results of samples taken, 
or failure to administer anti-D Ig that was required. Other proximal errors were: 
failure to follow guidelines, 6; failure to complete appropriate checks, 2; 
misinterpretation of results, 2. 
iii) Wrong dose of anti-D Ig given 
In eight of the reports a wrong dose of anti-D Ig was given. In seven cases the wrong 
dose was given unintentionally. There was one case where the wrong dose of anti-D 
Ig was given deliberately due to misunderstanding of guidelines for administration 
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following a potentially sensitising event in close proximity to the 28 week routine 
antenatal anti-D Ig injection. 
The proximal error was failure to complete appropriate checks in six cases, failure to 
follow policy/guidelines in one and in the other one case it could have been either of 
those root errors but it was not clear from the information contained within the 
report. 
iv) Date expired Anti-D Ig given 
There were three cases in this category. All three reports were very similar and 
described midwives taking anti-D Ig from stock held in the clinical area and failing 
to check the expiry date prior to administration. 
6.4.1.1 Source of anti-D Ig 
The error reports were reviewed to determine the source of anti-D Ig involved in the 
error. That is whether it was anti-D Ig that had been issued by the laboratory for a 
named patient, or anti-D Ig taken from stock held in the clinical area.  
Of the 102 reports, in 61 (60%) the anti-D Ig had been issued by the laboratory, in 28 
(27%) it came from clinical stock and in 12 (12%) it was unclear from the report 
what the origin of anti-D Ig had been. In one other case it had been issued by a 
pharmacy. Figure 6 shows source of anti-D Ig according to the type of error made. 
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Figure 6: Source of anti-D Ig according to error classification 
 
 
6.4.1.2 How the error was detected 
The SHOT error reports contained a field: ‘How was error detected?’ describing the 
way the error has been discovered. There were four categories: laboratory staff noted 
an error; clinical staff noted the error; the patient noted the error and other. The 
means of detection of error were categorised according to type of incident. The 
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6.4.1.3 Routine antenatal anti-D prophylaxis (RAADP) 
The 102 error reports were analysed to determine how many errors were related to 
administration of RAADP. In 74 (73%) of error reports, the incident definitely did 
not involve RAADP. In 13 (12%) the error definitely did involve RAADP. In the 
remaining 15 (15%) cases it was possible, but not explicit, that the error could have 
involved RAADP. 
6.4.2 Detailed description of the errors 
The data analysis identified common situations, processes and/or actions among the 
incident reports. There were ten sub-categories of errors which are described below. 
In addition charts are used to illustrate pathways of errors according to classification 
of type of error: figures 7, 8, 9 and 10 (below). 
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a) Misinterpretation of results 
All of these cases involved a woman who was RhD positive mistakenly receiving 
anti-D Ig. They resulted from misreading of written reports, telephone report of 
results being misheard or wrongly transcribed and blood sample results accessed 
electronically and wrongly interpreted.  
b) Results not available  
In some incidents the midwife did not know the woman’s blood group for sure but 
gave anti-D Ig anyway, the women were then subsequently revealed to be RhD 
positive. In other cases anti-D Ig was given to postnatal mothers before the baby’s 
blood type result was available, and the babies were in fact RhD negative.  
c) Transcription error/wrong documentation in notes.  
In all but one of these errors the woman’s blood type had been incorrectly 
documented as RhD negative in her notes, either hand written or using a stamp or 
sticker. In the other case a woman was mistakenly booked into an RAADP clinic and 
received anti-D Ig without anyone checking her blood group. 
d) Failure to complete identification checks. 
There were a number of cases where a woman received anti-D Ig that was not 
intended for her and where it was clear that identification checks were not completed 
at point of administration. 
e) Primary error by another health care professional.  
The errors in this category included instances where RhD positive women, mothers 
of RhD negative babies, and women who were already sensitised received anti-D Ig. 
In the majority the laboratory mistakenly issued anti-D Ig and the midwife gave it 
without undertaking further checks. Other cases saw medical staff incorrectly 
prescribe anti-D Ig which was then given by a midwife who did not confirm the 
woman’s blood group, two of those three cases involved General Practitioners. There 
were also cases where the laboratory erroneously issued the wrong dose of anti-D Ig 
and midwives administered it without noticing the error. 
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f) Anti-D Ig not collected from laboratory or left unnoticed in clinical 
area fridge 
This was a very common error and in most reports there was little further 
information about why the anti-D Ig was not collected.  
g) Blood sample or request form error 
There error reports where a problem with a blood sample or request form meant that 
the laboratory did not complete the test and consequently the results were not 
reported and anti-D Ig was not issued. These included cases where delivery samples 
were not sent for testing, the request form was incorrectly completed and laboratory 
staff did not realise samples were from a pregnant RhD negative woman who might 
require anti-D Ig, and in one case a sample took 12 days to reach the laboratory. 
h) Misinterpretation of instructions/guidelines 
The cases in this category involved potentially sensitising events during pregnancy, 
postnatal prophylaxis and the other two the circumstances were not clear from the 
report.  
i) Unneeded second injection of anti-D Ig given 
In these cases the midwife had been unaware that anti-D Ig had been given and 
requested further anti-D Ig which the laboratory issued. 
j) The wrong dose of anti-D Ig selected from stock 
In all of these reports the midwives selected the wrong dose of anti-D Ig from stock 
held in the clinical area. 
6.4.3 Illustration of pathways of errors  
The following figures are used to illustrate the pathways of error, according to 
classification type. 
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Figure 7: Pathway of errors, inappropriate administration 
 
Policy and Practice Concerning Women with an RhD Negative Blood Type:              
A midwifery perspective 
Chapter Six: Anti-D Ig: analysis of midwifery errors reported to SHOT 129 
Figure 8: Pathway of errors, late or omitted anti-D Ig 
 
Figure 9: Pathway of errors, wrong dose of anti-D Ig administered 
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Figure 10: Pathway of errors, date expired anti-D Ig administered 
 
6.4.3.1 General themes emerging from the data 
It was also possible to identify common themes among many of the error reports. 
i)  Presence of immune anti-D antibodies 
It is estimated that between 1.2% and 1.8% of RhD negative women in the UK have 
immune anti-D (NICE, 2008). This work found that 8 of 102 (8%) of errors reported 
to SHOT involved women with anti-D antibodies, making them significantly more 
likely to be subject to an anti-D Ig error than non-sensitised women. 
ii) Communication failures 
This was noted across the four main SHOT error categories. Failure of staff to pass 
on messages was seen between laboratory staff and midwives; between medical staff 
and midwives; between hospital based midwives and community midwives and 
between midwives working in the same clinical area. Communication failures were: 
written, with failure to document care given; via telephone, with messages not passed 
on; and through misinterpretation of results due to unfamiliar or confusing 
documentation.  
ii) Reliance on the system  
Another common theme across the categories was a reliance on the system to have 
worked correctly. For example: In cases where blood samples were taken, failure to 
receive results often meant women were not followed up and when blood samples 
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should have been taken but were not, lack of results again meant appropriate care did 
not occur; when the laboratory issued anti-D Ig it was given without formally 
checking blood test results and when a woman had an ‘RhD Neg’ sticker on her 
notes, or attended an ‘RAADP clinic’ she was assumed to be RhD negative and the 
person administering anti-D Ig did not check her blood type formally. 
iv) Reliance on others  
As well as relying on the system, the midwives also made mistakes after relying on 
another healthcare professional. The biggest category for this was when laboratory 
staff issued anti-D Ig in error: midwives did not check a woman’s blood results if the 
laboratory had issued the anti-D Ig. Likewise, when medical staff prescribed anti-D 
Ig, midwives did not complete their own checks before administering it. 
6.4.4 Identification of key aspects of the incidents 
6.4.4.1 Trigger events 
As already described, the proximal cause of the error could always be narrowed 
down to a final, definitive, error on the part of the midwife, the ‘proximal error’.  
However it was also possible to identify ‘trigger events’, events or situations without 
which the adverse incident is unlikely to have happened.  
The following trigger events were identified: 
• Expired anti-D Ig available in remote fridge 
• Blood group incorrectly transcribed in notes 
• Blood test results not readily available in clinical area 
• Anti-D Ig that is issued by the laboratory placed in ward/clinical area fridge 
rather than administered immediately 
• Issued anti-D Ig not collected from the laboratory  
• Blood samples (especially delivery samples) not sent or incomplete/incorrect 
request made 
• Laboratory issue anti-D Ig in error  
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• Blood group report misinterpreted: antibody negative misread as RhD 
negative 
• Potentially sensitising event occurs in close proximity to RAADP 
administration 
• RhD negative woman moves between areas e.g. Labour suite to postnatal 
ward to community, before blood test results available or anti-D Ig issued 
• Discharge from hospital more than 72hours after delivery 
6.4.4.2 Fallible practices 
It was also possible to identify fallible practices (FP): policies, practices and 
documents that were flawed in such a way that they might lead to a trigger event. 
These are shown in Tables 11, 12 and 13, below, alongside associated trigger events 
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Table 13: Fallible practices, trigger events and proximal errors: Omission or late administration 
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6.5 Discussion 
6.5.1 Strengths and limitations of this research 
A major strength of this work was that the researcher had access to all anti-D Ig 
errors that had been reported to SHOT in a twelve month period. This data represents 
the most comprehensive record of recognised clinical errors involving anti-D Ig that 
is collated in the UK. Ironically the limitations of the research were also primarily 
due to the large scale collection of the data. The reports were collated by a number of 
different people and, due to the confidential nature of the SHOT reporting scheme, it 
was impossible to further question or clarify the information provided. This meant 
that the most significant limitation of this research was the lack of control over the 
data collection. The reports came from all over the UK and could each have been 
made by a different person. There was no information available about the person 
who completed the report form, nor about the initial investigation that led to their 
conclusions. It is possible that some of the reports were based on first-hand accounts, 
however others may be the result of an investigation by an individual such as a 
transfusion practitioner who had no midwifery or obstetric background and who did 
not work in the clinical area where the incident took place.  
The fact that all of the reports were entered onto the same data collection form, with 
the same questions and the same opportunities for free text should have gone some 
way to addressing the potential for error. However, the content of the reports varied 
considerably. Some contained copious amounts of free text giving detailed 
explanation of the event, others provided very minimal information. The aim of this 
research was to analyse the data in a different, more in-depth, manner than that 
reported by SHOT. The content of some of the reports meant that this was 
challenging. In a small number of reports it was not possible to draw firm 
conclusions about precisely what had happened. However analysis was possible for 
the majority of reports and the structured approach to data analysis allowed findings 
to be drawn.  
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One of the major strengths of this study is that the errors here represent all 
recognised errors involving anti-D Ig that had been formally reported. As reporting is 
compulsory and there are strong systems for onward reporting within the NHS, it is 
expected that these do in fact represent the vast majority of recognised errors 
involving anti-D Ig that occurred in the UK during that twelve month period. The 
incidents reflect real situations and events, and despite its limitations, access to such 
a vital database provides a unique insight to actual clinical practice in this area. 
6.5.2 Observations concerning the data analysed 
The SHOT annual report has seen a gradual rise in the number of errors involving 
anti-D Ig in recent years. During the twelve months that this data was collated there 
were a total of 135 such errors reported. Given a UK birth rate of around 800,000 
live births per year, and that around 16% of pregnant women have an RhD negative 
blood type, it is estimated that more than 205,000 doses of anti-D Ig are administered 
for RAADP, potential sensitising events during pregnancy and postnatal prophylaxis 
in the UK each year. This means that for the period of data collection, 2007/2008 an 
error happened in approximately once for every 1500 episodes of administration, 
suggesting that practice in this area is in fact very good. However, there are two 
important questions to consider:  
• Are all recognised errors reported to SHOT?   
• How many anti-D Ig errors go unrecognised? 
The research completed here cannot answer these questions but it does provide some 
insight as to the types of errors that may be less likely to be recognised and reported. 
It also highlights some situations where analysis of the data suggests that there might 
be under-reporting. In particular the findings raise some interesting questions about 
the way that errors are recognised.  
Laboratories are very process driven and have procedures in place that increase the 
likelihood of identifying errors. However in clinical areas it is not routine practice to 
actively search for errors. It would seem that when there is no laboratory 
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involvement in the process of anti-D Ig administration errors might be less likely to 
be recognised. The findings of this research show broadly similar numbers of errors 
detected by laboratory and clinical staff. On the face of it this contradicts the theory 
that errors are less likely to be detected by clinical areas, however looking more 
closely at the types of error reported to SHOT questions are raised about clinical 
areas recognition of errors. One example of this is an error where anti-D Ig was 
deliberately omitted following a potentially sensitising event during pregnancy due 
to a misunderstanding of guidelines. This type of error would only be recognised and 
reported if another clinician reviews the case and recognises that an error has been 
made. In another example, if postnatal anti-D Ig is omitted for a woman in an area 
where anti-D Ig is given from clinical stock, it is easy to see how such an error would 
go unrecognised. The people who are involved are unaware that they have made an 
error and there is no mechanism in place to bring it to light. This observation is 
supported by the finding that none of the errors reported in the late/omitted category 
involved anti-D Ig held in clinical stock. There is no plausible explanation as to why 
an error would be more likely using anti-D Ig issued by the laboratory. What is most 
likely is that when anti-D Ig is held in remote stock it is easier for the person making 
the mistake to remain oblivious to their error as there is no laboratory involvement 
that might uncover the error.  
Data collated by SHOT suggests that very few errors involving anti-D Ig are made, 
however it is important to consider whether, in fact, many errors are difficult to 
recognise and go unreported. The 2008 annual SHOT report acknowledges that they 
receive “only a fraction of the possible reports” (Taylor et al, 2009, Pg2), but 
consider that those they do receive reflect overall trends. Further research is required 
to explore whether the SHOT error reports do in fact reflect the actual trends of type 
of error involving anti-D Ig. Maternity units should also consider implementing 
procedures that would detect such errors, particularly when anti-D Ig stock is held in 
clinical areas. 
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6.5.3 Midwives and anti-D Ig errors 
The research described here considered SHOT error reports concerning anti-D Ig 
from the point of view of midwives. By excluding errors where there was no 
midwifery involvement, for example errors resulting from laboratory failures that 
would have been impossible to identify in the clinical area, or those solely by 
medical staff and nurses working in gynaecology or accident and emergency 
departments, the focus of the research became midwives. This meant that it was 
possible to identify the errors that hold particular significance for midwifery practice, 
the ways that midwives contribute to errors and what might be done, by midwives, to 
reduce the likelihood of recurrence.  
The simple classification of errors essentially repeated categorisation of errors 
undertaken by SHOT, but only included those errors where a midwife was involved. 
It was important to recategorise the errors as SHOT reported a number of errors as 
‘laboratory’ that did in fact involve midwives. A common example of this was cases 
where the laboratory issued anti-D Ig in error to an RhD positive woman, but the 
midwife administered it without checking the woman’s blood type. Although on the 
face of it this would seem like a simple error on the laboratory part, it was within the 
midwife’s power to prevent administration of anti-D Ig through completion of 
routine checks.   
The research sought to identify the proximal cause of the errors, and found just four, 
one of which was present in every error report. These were: 
• Failure to complete appropriate checks 
• Failure to follow up care 
• Misinterpretation of results 
• Failure to follow guidelines 
They represent the final act or omission that allowed, or led directly to, the error 
happening. Although the errors were made by a midwife, it is important to reiterate 
that in most cases there were a number of significant contributing factors that 
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influenced the error. Often those were organisational factors that directly influenced 
the likelihood of an error occurring. It is also notable that the midwife who 
administered anti-D Ig assumed ultimate responsibility even if there was a line of 
process involving others who also made mistakes. This research only looked at errors 
that involved midwives, and so the proximal errors here were always midwife errors. 
The same factors could easily apply to other professions were they scrutinised in the 
same manner. 
The proximal errors, or causes, were often influenced by other factors, but in 
themselves they are an important tool in understanding how errors happen. In 
particular they are a useful starting point for midwives to use in reflection on why the 
error happened and how that relates to her professional responsibility. The proximal 
error may represent an event that is very difficult to influence, for example simple 
human error such as forgetting to check a detail. However, there will be other cases 
where checks were not carried out because policies or procedures were not fully 
understood or were unfamiliar. Equally, it may be that the midwife has an element of 
shared responsibility with her employer, who may have an established culture of 
practices that influenced the error, or shared responsibility with a colleague who was 
involved in an earlier part of the process. Using the proximal errors as a foundation 
for understanding what happened is an important way for an individual to address the 
event and consider how recurrence can be avoided.  
When discussing this work, it is useful to consider the errors according to type. In the 
following section (6.5.4), within those headings, the findings are discussed in relation 
to analysis of ‘proximal errors’ and the detailed description of the errors.  
6.5.4 Inappropriate administration of anti-D Ig 
Inappropriate administration was the most common anti-D Ig error made by 
midwives, and almost all of the cases were due to midwives failing to complete 
appropriate checks. Although some errors in this category also involved other staff, 
for example laboratory staff who issued anti-D Ig in error or medical staff who 
prescribed anti-D Ig for the wrong woman.  
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The cases where anti-D Ig was administered inappropriately raise questions about 
why the midwife went ahead with administration of the anti-D Ig and how she 
involved the woman in the decision to administer it.  A common reason for 
inappropriate administration of anti-D Ig was failure to complete adequate 
identification checks prior to administration. This raises the question of whether 
midwives understand policy and procedure in relation to these checks, and also of 
how midwives view administration of anti-D Ig. Do they view it as similar to 
administering medication, or the more involved process of checking prior to 
administration of a blood transfusion? Their views on this may influence the rigour 
with which they approach checks. The midwife is responsible and accountable for 
her actions when administering anti-D Ig. It is her professional responsibility to 
ensure that she is familiar with policies and procedures, including those checks that 
are required prior to administration of anti-D Ig. She should also understand the 
reason for giving anti-D Ig in a specific situation. 
The woman herself should be included in the process of offering and any subsequent 
administration of anti-D Ig, in particular identifying herself as the correct recipient, 
but also in explaining the need for anti-D Ig and gaining verbal consent prior to 
administration. The midwives’ code states that ‘you must ensure that you gain 
consent before you begin any treatment or care’ (NMC, 2008, Pg3). Administration 
of anti-D Ig to women who are RhD positive, raises important questions about how 
the midwife involved the woman in either of those aspects of the process. 
Exploration of this was beyond the scope of this research but is an important area to 
consider for future work. 
Another common reason for giving anti-D Ig inappropriately was a transcription 
error. These errors included writing the woman’s blood group in the notes, and the 
use of stickers on the notes to convey blood type. As already discussed, it is the 
midwife’s professional responsibility to complete the necessary checks prior to 
administration of anti-D Ig. However, if it is common practice within an organisation 
to rely on informal means to convey blood type, then some of the responsibility for 
the error must be borne by that organisation. This would be an example of what 
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Reason (2000) would describe as a ‘latent condition’, and what in this research is 
described as a ‘fallible practice’. They are often relatively easy to rectify and this 
greatly reduces the likelihood of an error, by filling another hole in the Swiss cheese. 
However this requires effort at organisational level. 
There were a very small number of cases in this category where the midwives 
administered anti-D Ig in a situation where they were unable to formally confirm the 
woman’s blood type, but thought it to be RhD negative. On the face of it this seems 
irresponsible, however the reports suggest that the midwives had made a considered 
decision to administer the anti-D Ig. An example of this was a situation where a 
woman had a poor history of attendance for antenatal care. The midwife was faced 
with a situation where she was unable to confirm the woman’s blood type formally, 
but knew that she might not attend again to receive anti-D Ig. In this case it would 
appear that the midwife made a decision to provide care out with standard policy and 
procedure as she felt it was in the best interest of the woman. Unfortunately the 
woman was in fact RhD positive and the anti-D Ig administered was unnecessary. 
This situation raises the dilemma that a midwife might face between her professional 
accountability and her responsibility to her employer to provide care within their 
guidelines. Her professional responsibility is to provide care ‘using her professional 
knowledge and based on evidence for best practice and in the woman’s best interests’ 
(NMC, 2008, Pg6). In the situation described above a midwife would have to be very 
confident of her knowledge and practice to act in a way that she believed was in the 
woman’s best interest but which was contrary to her employer’s policy. It was not 
clear in this case why the midwife could not formally check the woman’s blood type 
as these should be readily accessible. There is limited information available on the 
particular circumstances of this event, however in such situations it may be worth 
considering the organisation’s responsibility to ensure that staff are able to access 
results readily.  
It is interesting to note that within this category of error there were a number of 
women with immune anti-D antibodies who received anti-D Ig. Anti-D Ig is given to 
prevent formation of immune anti-D antibodies and so there is no point in giving it to 
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women who are already sensitised. Doing so exposes her unnecessarily to a blood 
product. Only around 1-2% of RhD negative pregnant women are sensitised, but 
around 8% of the errors involved women who were sensitised. It is not clear from the 
findings here why this should be the case. It may simply reflect failure to complete 
appropriate checks prior to administration of anti-D Ig, but also raises questions 
about midwives’ knowledge and understanding of the significance of anti-D 
antibodies and perhaps of the ways that they are reported and documented within 
maternity notes.  
6.5.5 Omission or late administration of anti-D Ig 
This category of error is particularly important as they are the type of error that are 
most likely to lead to maternal sensitisation. As already mentioned there were only 
10 cases where anti-D Ig was omitted altogether, but there were 34 where it was 
given late, raising the question of whether this is a category of error that is 
particularly susceptible to underreporting due to failure to recognise that an error has 
been made. It also raises the question of whether the errors reported here represent 
those most commonly made, or whether they represent those most likely to be 
noticed and reported. 
The main proximal error in this category was ‘failure to follow up’. This makes it 
particularly difficult to pinpoint an individual who was responsible for the error, and 
to determine exactly how the error came about. NHS maternity care is structured in 
such a way that there is unlikely to be continuity of carer as a woman is transferred 
between clinical areas following delivery. The move from labour suite to postnatal 
ward and then home to the community service might all happen during the 72 hours 
following delivery when anti-D Ig should be offered and administered. During 
pregnancy a woman may receive her routine care from a number of different 
midwives working in the same team, and from other midwives and obstetricians 
should she experience a PSE and attend hospital. Given the potential for a large 
number of carers, it is unsurprisingly the majority of errors in this category have 
failures in communication as a significant contributor.  
Policy and Practice Concerning Women with an RhD Negative Blood Type:              
A midwifery perspective 
Chapter Six: Anti-D Ig: analysis of midwifery errors reported to SHOT 144 
There were a very large number of cases in this category of error where anti-D Ig 
was simply not collected from a laboratory area fridge, or was delivered to the ward 
or clinical area and left unnoticed in the fridge. This highlights serious failures in 
communication: both documentation and direct communication between laboratories 
and clinical areas, or between midwife and midwife. It also reinforces the need for 
strong formal procedures to ensure that administration of anti-D Ig is not overlooked 
when responsibility for care is passed between midwives working in different areas 
or covering different shifts within the same area. 
Midwives’ reliance on the system to highlight the need for intervention was also 
evident. Examples of this include a situation where sending delivery blood samples 
to the laboratory leads to the laboratory issuing anti-D Ig, with its delivery to the 
ward being the prompt for midwives to administer it. When delivery samples were 
not received by the laboratory, this prompt was lost and anti-D Ig not administered. 
Midwives’ hold responsibility for ensuring that a woman receives appropriate care, 
however in an organisation that sees a number of different midwives assuming 
responsibility for a woman’s care within the short window of time that anti-D Ig 
should be offered and administered, it may not always be clear which particular 
midwife that responsibility lies with. In such situations organisational factors such as 
the quality of documentation and the use of procedures such as handover and 
discharge checklists all assume increased importance. Here the organisation has 
significant influence over the provision of care as it is responsible for the way that 
care is organised and for policies procedures and documentation that are in place to 
support staff in the provision of care. 
Misinterpretation of results was the other ‘proximal error’ found in this category. 
Some of the cases may have been due to human error, however analysis also raised 
questions about midwives’ knowledge and understanding of the issues surrounding 
the requirement for anti-D Ig and its administration. Additionally a number of error 
reports in this category demonstrated the direct impact that documentation may have 
on anti-D Ig errors. In those errors the paper laboratory report documented RhD 
status as ‘positive’ or ‘negative’ in close proximity to an antibody test result also 
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reported as ‘positive’ or ‘negative’. The design of this documentation was such that it 
contributed to the error because of the high risk of misreading blood type as antibody 
status, and vice versa. 
In common with the errors already discussed in the inappropriate administration 
category, there were a number of errors where blood test results were wrongly 
transcribed in notes. These errors further illustrate an organisational culture in some 
maternity units where the midwives’ are willing to administer or omit anti-D Ig 
based on transcribed notes rather than checking the formal blood bank report or 
telephoning the laboratory directly. 
Interestingly anti-D Ig was most likely to be given late, or omitted altogether, during 
the postnatal period, despite the fact that anti-D Ig is given more often during 
pregnancy. As postnatal anti-D Ig is more likely to be issued directly by the 
laboratory, rather than given from clinical stock, it may more likely that a postnatal 
error is recognised and reported. Involvement of the laboratory in the process, 
coupled with the use of discharge checklists may mean that postnatal errors are more 
likely to be recognised and reported to SHOT. This provides further evidence that 
there may be under reporting of anti-D Ig errors to SHOT. 
6.5.6 Wrong dose of anti-D Ig administered 
The errors where a wrong dose of anti-D Ig was administered broadly reflect the 
ways in which errors occurred in the other categories. Failure to complete adequate 
checks was again the most prominent ‘proximal error’. In addition failures in 
communication and reliance on others to have completed their part in the process 
correctly were strong themes.  
The case where the wrong dose of anti-D Ig was given intentionally is interesting. It 
again raises the potential for under reporting of this type of error as those involved 
believed that they were acting appropriately. It also illustrates a case where the 
situation was complicated by a potentially sensitising event during pregnancy 
occurring around the same time that RAADP was required. One of the reasons given 
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to help explain the steady rise in anti-D Ig errors reported to SHOT is the widespread 
introduction of RAADP and the subsequent increase in number of women receiving 
anti-D Ig during pregnancy. This research found that RAADP was involved in just 
12% of error reports, despite accounting for as many as half of all cases of 
administration of anti-D Ig. As such RAADP would not appear to be a significant 
factor in the increase of reporting to SHOT. It may be that practice is particularly 
good around this very routine aspect of clinical practice, but it is worth noting that 
most RAADP is given from clinically held stock. This means that it is another aspect 
of clinical care where an error, particularly an omission, may easily go unnoticed and 
unreported. 
6.5.7 Date expired anti-D Ig 
This category of error had only three cases and it is difficult to draw any firm 
conclusions from them. All three cases happened as a result of failure to complete 
appropriate checks, and all three involved anti-D Ig from clinically held stock. This 
raises the organisational level issue of controlling stock held clinically to ensure that 
date expired anti-D Ig is not available for use. It also raises, yet again, the question of 
whether there is potential here for failure to recognise an error. Common sense 
would dictate that the three cases where the midwives realised their error after 
administration of anti-D Ig are unusual. It would seem far more likely that if the 
expired date was not picked up at a check prior to administration, it would remain 
unnoticed and so unreported. 
6.5.8 Themes common to all four categories of error 
There were a number of common themes that ran through all four categories of error. 
They are discussed within those categories, but it is worth reiterating them here. 
They include failures in communication, the potential for under-reporting of errors 
and reliance on both the system to prompt action, and on other staff to act 
appropriately. Although the error could always be narrowed down to a final 
‘proximal error’, it was clear from analysis of the error reports that there were a 
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number of factors out with the midwives’ control that influenced the likelihood of an 
error occurring. 
In all four of the error categories responsibility for the error often fell between the 
organisation within which the midwife provided care, and the midwife herself. The 
following section discusses the key aspects of the error report: the clinical situations 
that might give rise to an error and the organisational factors that influence them.  
6.5.9 Identifying key aspects of the reports: trigger events 
and fallible practices 
This aspect of the analysis and findings has the most direct clinical relevance for 
midwives. By highlighting ‘trigger events’ and the ‘fallible practice’ that can lead to 
its manifestation, midwives, medical and laboratory staff, and the organisations that 
they work for, can identify such factors within their own areas of practice. Through 
addressing these it should be possible to greatly reduce the risk of an error occurring. 
The theory for this aspect of the analysis was based on the work of Reason (2000). In 
his anatomy of an organisational accident he describes failures at organisational level 
cascading through to a department to create conditions that promote occurrence of 
errors.  
This research identified a number of specific fallible practices and trigger events 
(Tables 11, 12 and 13) with the clinical detail of these discussed in relation to the 
analysis of detailed description of the error reports (above). It is anticipated that 
identification of specific fallible practices and trigger events can be used by 
midwives and managers to examine whether similar factors and situations are present 
within a particular organisation and clinical area. They will also be helpful in 
structuring an investigation into future errors, enabling the investigator to use this 
framework to identify factors that might be changed. 
The most significant theme to emerge from this analysis was the emphasis on shared 
responsibility between the employing organisation, and the midwife employee. The 
organisation has a responsibility to develop and support working practices, cultures, 
documentation, processes and procedures that limit the scope for error. Likewise the 
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midwife must address her professional responsibility and develop the knowledge and 
skills to underpin her practice. This should include understanding of the rationale for 
administration of anti-D Ig in whatever clinical situation arises. It also encompasses 
familiarisation with relevant policies and procedures, including the appropriate 
checks to be completed, before administering anti-D Ig.  
6.5.10 Informing the next piece of work: focus group 
research to gain a midwifery perspective 
This study, secondary analysis of SHOT anti-D Ig error reports, and the previous 
work, the RAADP survey, both raise important questions about midwives practice in 
relation to anti-D Ig. These questions and issues are outlined here with the intention 
that they will inform the next piece of research: focus groups to gain a midwifery 
perspective. The focus group work is intended to explore these issues further with the 
aim of clarifying some of the questions raised. 
Midwives’ knowledge and understanding about anti-D Ig and what their sources of 
information, education and training are is incredibly important. Analysis of the 
SHOT error reports highlights the need for midwives to underpin their practice with 
sound knowledge and understanding of clinical situations and rationale for care. 
Additionally they must understand the local and national policies, procedures and 
practices which safeguard against error and steer appropriate care. There were a 
number of errors where midwives’ lack of knowledge and understanding about anti-
D Ig itself, or about policy and procedures, may have influenced events. Midwives 
also require good knowledge of the issues involved in order to facilitate informed 
decision making, particularly in light of the variations in practice and in the variable 
quality and content of written information that was uncovered by the RAADP survey 
The RAADP survey found that most organisations provided education or training at 
the time that RAADP was implemented, although it did not explore what form that 
took or the impact it had. Midwives’ have a professional responsibility to maintain 
their knowledge and skills, however their employers also have responsibility to 
support them in maintaining their skills, and to ensure that they have the knowledge 
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and skills necessary to practice safely and effectively. It is considered relevant to 
explore with the midwives what form the education they receive takes, how they feel 
about the education they access, what support they receive from their employer in 
this respect and whether they feel it is sufficient to meet their learning needs. In 
addition the researcher would like to explore their level of knowledge on some of the 
issues pertinent to facilitation of informed decision making and provision of 
appropriate clinical care. 
Another important theme to emerge from the analysis of the errors reported to SHOT 
was communication. This encompassed communication between midwives in 
different clinical areas, laboratory staff, medical staff and pregnant women with RhD 
negative blood group. It also extends to documentation used. It was considered 
another important area for further exploration and will be addressed within the focus 
groups. 
The analysis of the SHOT error reports raised important questions about the 
recognition of anti-D Ig errors by clinical staff. The focus group research will also be 
used to explore further what the midwives know about the SHOT reports, and also if 
they understand the process for reporting an error to SHOT.  
The most important theme to emerge from the findings of the research already 
undertaken is midwives responsibility and accountability in relation to anti-D Ig. As 
already stated, this responsibility extends to their knowledge and understanding of 
the issues involved as well as their clinical skills. It also encompasses awareness of 
policies and procedures that should be undertaken to ensure safe and effective 
practice and minimise the risk of error. In the analysis of the SHOT error reports, this 
was apparent across all categories of error, but is complicated by the organisational 
factors that imposed on the way that they work. There were a number of situations 
where organisational factors significantly influenced midwives’ practice, yet their 
professional accountability remained. Similarly, the survey on implementation of 
RAADP policy found considerable variation in that policy throughout the UK. This 
may impact on midwives’ practice, in particular it highlighted some situations where 
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midwives’ personal and professional responsibility and accountability may be at 
odds with her obligation as an employee to fulfil her employer’s organisational 
responsibilities. Midwives’ must maintain professional responsibility but balance this 
with their responsibility as an employee working for an organisation that has its own 
policies and subsequent responsibilities that will influence midwifery practice.  
The questions and issues outlined above were used to inform the research presented 
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Chapter 7: Focus group research to gain a 
midwifery perspective 
7.1 Introduction 
The overall aim of the third piece of research was to explore midwives’ perspectives 
of the care provided for pregnant women with an RhD negative blood type. The 
objectives were to elicit their opinions and experiences of topics that had been 
identified through published evidence and the research already undertaken in 
Chapters five and six. There were four broad research questions: 
1. How do midwives understand their responsibility when offering and 
administering anti-D Ig? 
2. Do midwives understand the risks and benefits of anti-D Ig? 
3. Are midwives able to recognise and report an error involving anti-D Ig in a 
manner that will lead to onward reporting to SHOT? 
4. What education and/or training do midwives receive in relation to anti-D Ig? 
7.2 Choice of method 
A number of methods were considered, including in-depth interviews and survey. 
However, as described in Chapter four, section 4.1.3, a qualitative approach was 
deemed most appropriate, and focus group interviews were the data collection 
method of choice.  
There is a strong history of using qualitative approach in nursing and midwifery 
research and qualitative methods lend themselves to exploration of many of the areas 
that are of particular interest to nurses and midwives. Within the midwifery 
profession there are many examples of focus group interviews used as method of 
eliciting qualitative data. In particular the method has been used to describe midwife 
and student midwife experiences, the factors that influence the ways in which they 
deliver care and to  describe midwifery culture in particular settings, context or in 
relation to specific situations or practices (Brooke-Read et al, 2012, Teate et al, 2012, 
Jones and Wylie 2008, Fox-Young et al,2012) . These examples include focus groups 
Policy and Practice Concerning Women with an RhD Negative Blood Type:              
A midwifery perspective 
Chapter Seven: Focus group research to gain midwives’ perspective 152 
used as the sole method of data collection, and other studies where they are used in 
conjunction with other methods. 
Focus group research can be very specific and focus in on a relatively narrow topic 
area. Jones and Wylie (2008) for example, used focus groups to elicit very specific 
information from student midwives about stress related to clinical placements.  Other 
researchers have started off with a much broader topic and used focus groups to elicit 
more specific themes within the broader topics in order to inform further research. 
There are also numerous recent examples of midwifery research that uses focus 
group research as one aspect of a larger study. For example Teate et al (2012) used 
focus groups within a mixed methods approach. In their research they collected data 
using focus groups, surveys and checklists and combined this to describe midwives’ 
experiences of becoming pregnancy centring facilitators. Another example is that of 
Brooke-Read et al (2012) who combined data collection through survey research and 
focus groups to describe student midwives’ experiences of using electronic health 
records. 
Barbour (2005) describes a number of research studies that use focus groups to 
research healthcare professional’s attitudes, opinions and experiences of education 
initiatives. Barbour (2005) notes that focus groups are particularly appropriate when 
researching a previously unexplored topic, or one that is poorly understood or ill-
defined, and often has the ability to “reach parts that other methods cannot reach” 
(Barbour, 2005, P 745). An example given by Barbour (2005) is the research of Saidi 
and Weinding (2003) where focus groups were used to evaluate a new education 
initiative for paediatricians. The focus groups were used to identify barriers to 
accessing the initiative and establish staff groups with particular difficulties. The 
method also allowed the researchers to elicit more subtle, but equally important ways 
in which the paediatricians considered that their clinical practice had changed as a 
result of the educational initiative (Barbour, 2005). 
Focus group interviews comprise group discussion between individuals, guided by a 
moderator using a topic guide developed from a well-defined research objective. A 
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key feature is facilitation of discussion on the topic of interest, and a key 
characteristic of focus group interviews is group interaction. Capitalising on 
communication between research participants allows the subjects to talk to one 
another “asking questions, exchanging anecdotes and commenting on each other’s 
experiences and points of view” (Kitzinger, 1995, Pg 299). For this research the 
broad topics of interest had been identified, but the research aim was to discover 
actual views and experiences of midwives within those topic areas. For this reason 
the interaction between participants in a group interview setting was seen as an 
advantage of using this method, although it was not the primary incentive. The 
potential for group discussion on the topic areas was considered likely to produce 
richer information than could be gained through one on one interview or 
questionnaire research, it also offered an opportunity for the midwives to agree or 
disagree with each other’s perspectives and points of view. In this way providing a 
form of validation of the information gained, at least within the context that group of 
midwives.  
A potential disadvantage of this method is that some people may be uncomfortable 
expressing their views or describing their experiences in front of a group. In 
particular Kitzinger (1995, Pg 299) states: “the articulation of group norms may 
silence individual voices of dissent.” This could be pertinent in a setting where 
midwifery colleagues know one and other and already have an established formal or 
informal hierarchy. In this research this might be especially significant as the topics 
to be explored included areas of practice that might be regarded as contentious or 
‘against policy’. However Kitzinger (1995) also considers that groups can provide 
mutual support in expressing feelings that they share but consider contentious. 
Barbour (2005) also describes focus groups as an inherently flexible method of data 
collection and believes they have an ability to dilute the power balance between 
researcher and subjects through the naturally occurring peer group, encouraging 
uninhibited discussion. 
For this particular research an advantage of using focus group interviews was that 
they allow data from multiple respondents to be collected in a much shorter time than 
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individual interviews would. At the time that this study was conducted, the NHS in 
Scotland was under considerable financial pressure. Persuading managers to allow 
staff time to participate in non-clinical sessions can be extremely difficult. It was 
certainly easier to arrange one-off sessions that saw a number of staff attend together. 
In addition the group interviews were held, deliberately, in geographically 
widespread sites. This meant that the researcher had to travel long distances to attend 
the sessions and holding one session in a morning or afternoon, rather than a number 
of sessions to conduct individual interviews, offered better use of the limited time 
and resources available. These factors combined to make this method the most 
practical method of collecting data from this group of healthcare professionals within 
the resource constraints of this project.  
Although there were some potential problems with this method, the researcher felt 
that the advantage of gaining the views of a number of midwives, coupled with 
potential for some discussion and clarification within a group, outweighed those 
disadvantages. In order to mitigate inhibition among group participants, steps were 
taken to foster an atmosphere where the midwives felt able to participate freely and 
without censure 
7.2.1 Focus group interview method applied to this research 
Focus group interviews were considered the most appropriate method of data 
collection for this research. However due to the specific nature of the information to 
be collected and the limited time available for the sessions, it was recognised that 
within the focus groups a structured approach with less emphasis on discussion and 
more emphasis on answering  specific questions would be necessary. Oppenhiem 
(1992) describes group interviews as useful method when the topic is relatively 
straightforward, but cautions that a number of issues should be considered in order to 
facilitate an effective session. In many respects group interviews are similar to focus 
groups, with Polit et al (2001, Pg 462) defining focus group interviews simply as “an 
interview with a group of individuals assembled to answer and discuss questions on a 
given topic”. The method used for this research held much in common with focus 
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group research but was very structured, with more emphasis on the midwives 
answering questions from a predetermined ‘topic guide’ and less on generating in-
depth qualitative data from any discussion developing from those topics. The level of 
structure the moderator would impose on the session was recognised as important 
when considering this method. Morgan (1997) considers that a more structured 
approach is especially useful when there is a strong pre-existing agenda for the 
research. Another advantage of a structured approach is that it may help groups at 
different sessions discuss the issues in a relatively comparable fashion.  
The use of a topic guide was an important tool to achieve a structured approach to 
the method used and its development was regarded as key to achieving the aims of 
the research. The topic guide consisted of both stand-alone questions and scenarios 
with associated questions (Appendix 5). The scenarios were based on actual SHOT 
anti-D Ig error reports and were used in an attempt to illustrate clinical care in a way 
that was relevant to the midwives, providing a platform from which the midwives 
could answer questions about the topics of interest. Kitzinger (1995) describes a 
range of group exercises that may be used to facilitate discussion or return to topic 
and states that ideally the discussion should be tape recorded and transcribed, 
allowing the moderator to concentrate on their task rather than taking notes. These 
factors were taken into consideration when planning the focus group sessions. 
There was a well-defined research objective, with a focus on specific topics and it 
was hoped that the use of focus group interviews would provide data to enhance 
understanding of these particular issues and topics and identify other as yet 
unapparent issues that are relevant to the midwives, to their clinical practice and to 
their relationship with the women they provide care for. 
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7.3 Practical considerations in the use of focus group 
interviews 
7.3.1 The role of the moderator 
There is agreement among authors that the role of the moderator is key to the success 
of focus group interviews, with the ability to put people at ease, encourage them to 
talk to each other and foster an atmosphere of respect and openness regarded as 
crucial. Oppenhiem (1992, pg79) suggests that when conducting group interviews 
the leader should be as non-directive as possible while maintaining control of the 
group. This hinges on an ability to adopt a form of “structured eavesdropping” where 
the researcher guides the participants to talk about the topic of interest without 
participating in the discussion themselves (Kitzinger, 1995).  
In this instance the researcher did not have direct experience of conducting group 
interviews or of focus group research, but the importance of the role of the moderator 
was recognised and a number of steps were taken to prepare for this. These included 
attendance at a three day course on qualitative research methods that offered detailed 
insight into focus group interviews as a data collection method in healthcare 
research. The course also provided an opportunity to discuss the proposed research in 
detail with qualitative researchers who had experience of using this research method. 
An important aspect of the researcher’s role as a Transfusion Specialist Midwife with 
the Scottish National Blood Transfusion Service was the development and 
facilitation of face to face learning for midwives and medical staff through seminars 
and workshops. This meant that the researcher was experienced in conducting group 
learning and facilitating discussion on specific topics. These sessions were 
particularly useful as the researcher was able to utilise time at the end of a number of 
such sessions to ‘practice’ moderator skills and facilitate discussions on topics 
similar to those that would be explored formally through the focus group interviews. 
This allowed development of moderator skills prior to undertaking the actual 
research. 
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7.3.2 Resources 
Morgan (1997) warns that focus groups are potentially expensive with costs 
including: moderator’s salary, rental of research site, travel to site, payments to 
participants, and producing and transcribing the tapes. The financial resources 
available for this research were extremely limited and played a significant part in 
planning the group interviews. The researcher was the moderator, so no salary 
payment was necessary, similarly the researcher transcribed the recordings of the 
sessions. There were no funds available to pay for either renting a research site or 
paying participants to attend. For this reason it was decided to seek permission from 
Heads of Midwifery to hold the group interviews at the chosen NHS maternity units 
and for midwives to attend during work, rather than their own, time. 
7.4 Arranging and conducting the sessions 
Two focus group interviews were conducted and it was decided that the participants 
should be midwives currently practising within NHS maternity units. The two 
maternity units were chosen as they seemed typical of Scottish maternity units, both 
were similar in size, with between 3500 and 4000 deliveries per year. They did 
however serve quite different populations: Maternity Unit A being a maternity unit 
within a general teaching hospital, serving both urban and semi-rural populations and 
received tertiary referrals of higher risk pregnancies. Maternity Unit B was a stand- 
alone maternity unit several miles from the nearest general hospital and offered 
lower risk care, serving a mainly rural population. 
The Heads of Midwifery at the chosen maternity units were contacted, provided with 
an outline of the research, a copy of the letter obtained from South East Scotland 
Research Ethics Committee (Appendix 3) concerning the ethics of the research, and 
permission was sought to conduct a group interview within their unit. In both cases 
the Heads of Midwifery then provided the contact details of a senior midwifery 
manager in their unit with whom the researcher should liaise to arrange the sessions.  
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7.4.1 Sampling 
Morgan (1997) considers that random sampling is rarely practical within focus group 
interviews due to the small number of participants, meaning that it is highly unlikely 
that you would ever achieve a truly representative sample of your population. He 
does however state that group composition should “ensure that the participants in 
each group both have something to say about the topic and feel comfortable saying it 
to each other” (Morgan, 1997, p36). Background variables are important in 
developing a group that will feel free and able to speak freely. In this instance the 
main factor that might inhibit the group was considered to be their work relationship, 
in particular whether any of the midwives were managed by another participant. It 
was important that all of the midwives should feel free to describe the actual way 
they practice and their true views on a number of topics and issues, some of which 
might be influenced by line managers.  
In the event both of the midwifery managers who were helping arrange the group 
interviews expressed concern about being able to release midwives from their 
clinical duties to attend sessions. For this reason practical considerations dictated the 
sampling strategy to a great extent. Following detailed discussion with them both, it 
was decided that they would set a date, time and venue for the sessions and ask 
midwives from community and hospital settings to attend if they were willing and 
able to do so at the time. The researcher also offered to hold an education session on 
anti-D Ig following each group interview. 
Written information outlining what was involved in the group interviews and the 
research as a whole was made available to the midwives who might participate. 
Oppenhiem (1992) suggests that group interviews might have between eight and 
twelve participants and Freeman (2006) describes a typical focus group as consisting 
of between 6 and 10 participants. However, Kitzinger (1995) describes an ideal 
number of participants as between four and eight people. It was decided that the 
focus groups should go ahead with a minimum of four and a maximum of ten 
participants, midwifery managers would not be invited to participate. 
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7.4.2 Format of the group interviews 
Literature review and previous research had identified a number of topics that the 
researcher wanted the midwives to discuss during the group interviews. Factors out 
with the researcher’s control meant that there would be fairly limited time available 
for discussion and it was important that the identified issues were discussed during 
the sessions. For this reason the plan was to conduct structured group interviews 
rather than traditional focus groups. 
A topic guide was developed, a copy of the topic guide is in Appendix 5. It 
incorporated a number of exercises that included scenarios, based on actual SHOT 
incident reports, and questions about those scenarios to be used to elicit information 
about the relevant topics. 
The moderator’s topic guide for Maternity Unit A consisted of: 
• Openers/information: intended to welcome the participants, explain the format 
and purpose of the session, put them at ease and reassure them of confidentiality. 
• Risks and benefits of anti-D Ig: scenarios, exercises and questions designed to 
elicit views on the risks and benefits of anti-D Ig 
• Identification of errors: Questions of anti-D Ig errors and reporting mechanisms 
• Professional responsibility: A scenario and exercises designed to elicit views on 
their understanding of professional responsibility 
• Education: questions to prompt discussion on their education and training in 
relation to anti-d Ig and care of RhD negative pregnant women 
 
The topic guide was a ‘guide’ and the moderator did not always stick rigidly to it, for 
example if questions had already been addressed through earlier discussion or where 
time was short and there was a need to prioritise some questions over others. 
 
7.4.3 Conducting the group interviews 
In both maternity units the sessions took place in a quiet room within the hospital, 
with chairs placed around a large table or group of tables pushed together. It was 
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important to create an atmosphere that was relaxed and comfortable, and one in 
which the midwives were able to talk freely without fear of recrimination or ridicule.  
Refreshments were provided by the moderator at the beginning of each session and 
the midwives were encouraged to relax and chat informally amongst themselves and 
with the moderator prior to the start of the session. The researcher then introduced 
herself and gave a brief overview of the purpose of the session, and the participants 
had an opportunity to ask questions. All participants were encouraged to be as open 
and honest as possible even if they disagreed with their colleagues. At this point they 
were also offered the opportunity to leave if they wished. It was ascertained that none 
of the midwives was each other’s line manager and that they worked in diverse areas 
of practice but all might be required to administer anti-D Ig and/or advise a woman 
regarding anti-D Ig. The midwives were also told that information was being 
collected anonymously and anything said during the session would be treated 
confidentially. They were informed that the moderator intended to record the session 
using a digital sound recorder, and were asked if they had any objections. None did. 
Due to restrictions on the midwives’ time, the sessions were planned to last for one 
hour. At the end of the session all of the midwives were asked to complete a very 
short questionnaire providing details of their length of  time working as a midwife, 
whether they had administered anti-D Ig in the past 6 months and if they had been 
directly involved in an anti-D Ig error. It also provided room for free text where they 
could add any further comments about the topics discussed during the sessions.  
7.5 Data analysis 
The data analysis was qualitative and thematic in nature with aspects of the 
framework approach used to provide a more focussed and structured approach to the 
analysis. The framework approach was developed in the 1980’s by social policy 
researchers. Originally a tool for applied policy research (Ritchie et al, 2003) it has 
been used in healthcare research (Smith and Firth, 2011). The framework approach is 
a structured and focussed approach that allows a systematic analysis of qualitative 
data and in this way it “contrasts with entirely inductive approaches such as 
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grounded theory” (Smith and Firth, 2011). Srivastava and Thomson (2009) believe 
that the framework approach is best adapted to research that has specific questions. 
Pope et al (2000, Pg 116) also describe the framework approach as starting 
“deductively from pre-set aims and objectives”. The main aim of this research was to 
answer specific questions that had been identified through the two previous pieces of 
research, described in Chapters five and six, and through literature discussed in 
Chapter three. Although the framework approach is more often associated with 
analysis of large data sets it was deemed appropriate to base the analysis on this 
framework in order to impose structure. Using thematic analysis with this structured 
process was considered to be a method of analysis that would allow the researcher to 
focus on those issues and questions, but would also allow identification of any new 
themes that became apparent. 
Another potential advantage of the method was that it would allow qualitative 
exploration of data but also enable the researcher to “track decisions, which ensures 
that the links between original data and findings are maintained and transparent, 
enhancing the validity of the findings” (Smith and Firth, 2011, g 62). Thorne (2000, 
Pg 70) goes as far as to say that many researchers have concluded that “systematic, 
rigorous, and auditable analytical processes are among the most significant factors 
distinguishing good from poor quality research”. 
The framework approach incorporates interconnected stages, with description of the 
stages varying between authors. The process was adapted to suit the aims and 
objectives of this research and the stages used here were: 
1. Familiarisation with the data, leading to identification of initial categories, 
assignment of pieces of data to those initial categories and refinement and 
establishment of key themes. 
2. Refinement of the initial categories and development of final themes and core 
concepts. 
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3. Understanding the core concepts and final themes, in order to explain them in 
relation to other themes and in the context of what is already known about the 
subject. 
Definition of the terms used:  
Key Themes: Important themes within the data, some of which were pre-determined by the 
researcher 
Initial Categories: Represent themes and concepts derived from similar sections of 
transcript  
Refined categories: More focussed categories, derived from the initial categories 
Final Themes: Themes that describe data in relation to a particular key theme 
Core concepts: Overarching ideas or concepts that permeate the research as a whole and 
allow the findings to be placed in a wider context 
The first stage of the analysis was familiarisation with the data and development of 
key themes and initial categories. The recordings of the sessions were listened to 
several times and were then transcribed into Word documents. This took place as 
soon as possible following each focus group interview so that the sessions, and 
participating midwives, were fresh in the researcher’s mind. The transcription was 
undertaken by the researcher which was time consuming but had the advantage of 
further enhancing familiarisation with the data collected. The transcripts were then 
read several more times, allowing the researcher to become very familiar with the 
data.  
The researcher had previously identified a series of key themes, topics of interest 
related to the key questions within the research aims. Initially these were: risks and 
benefits of anti-D Ig; identification of anti-D Ig errors; professional responsibility 
and accountability and education and training. However, the familiarisation process 
led to refinement of the ‘pre-determined’ key themes and emergence of additional 
key themes. This process also led to identification of initial categories: “a list of what 
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appear to be important themes and concepts within the data” (Ritchie et al, 2003, 
Pg222). 
The next stage was to organise the data, and passages of text that related to each of 
the key themes and the initial categories. This was done through what Bernard 
(2000) describes as ‘pawing’ through the text, marking passages with different 
coloured pens. An example illustrating an excerpt of transcript with relevant key 
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Table 14: Allocation of an excerpt of transcript to key themes and initial categories 
Excerpt of transcript: 
MW3b: “So it {RAADP} isn’t one of the big important things that you’d really think ‘oh we 
have to get her in its desperately important’. We were here the years when they never got it 
before” 
MW1b: “Yes, that’s right” 




Preliminary thoughts Initial Categories Key Themes 
 
 
So it isn’t 










The midwife doesn’t 
regard RAADP as a 
priority. Not an 
important intervention –
is this because it is not 
of particular benefit? 
Implication is that they 
would not rush to follow 
up care to ensure a 
woman receives her 
anti-D Ig.  
Is it difficult to arrange 
for the woman to 
attend? 
No mention of involving 
the woman in this 
process. 
 
• Perception of benefits 
of anti-D Ig 
• Importance/significance 
of RAADP 
• Midwives’ sense of 
responsibility in relation 
to anti-D Ig  
• Involving women in 
their care 




perceptions of the 





• Sources of 
information and 
education in 









• Informed decision 
making in relation 
to anti-D Ig 
 
 
• Midwives and 







RAADP was not 
offered. Implication is 
that the women didn’t 
used to receive it so is 
it that important? 
• Importance of RAADP 
• Midwives’ personal 
experience of RAADP 
 
Unless 
they had a 
bleed 
The midwives would 
act differently if a 
woman had a PSE. 
This is seen as 
important and 
something to invoke 
action. 
• Importance significance 
of anti-D Ig following 
PSE 
• Midwives’ sense of 
professional 
responsibility in relation 
to anti-D Ig 
Preliminary Thoughts: The first thoughts and ideas that the researcher had when reading 
the text. 
Initial Categories: Represent similar themes and concepts derived from similar sections of 
transcript 
Key Themes: The important themes within the data, some of which were pre-determined by 
the researcher 
{It should be noted that the tables in this section are used to aid explanation of the method of data 
analysis, rather than to illustrate findings. The findings are presented and discussed in detail in 
Section 7.6} 
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In the example above (Table 14) some pieces of transcript were allocated to more 
than one key theme and/or category, this was common to many pieces of transcript. 
The categories were colour coded and linked to every key theme to which they 
related, sometimes more than one. The process was repeated for all sections of 
transcript that had been identified as belonging to a particular key theme. The 
process was also repeated across all of the key themes using all pieces of transcript 
that had been allocated to that theme. The researcher did not have another person 
who was able to look, in depth, at the data. Repetition of the process of allocation of 
categories, from different starting points, was an attempt to ensure that no passages 
of text, and/or categories, relating to each key theme were missed. 
In reality the processes within this first stage of the data analysis were fluid and the 
researcher moved back and forth between them, with the key themes evolving and 
being refined as the categories were developed and vice versa. The data analysis 
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The next stage of the data analysis was to make sense of the categories of data within 
the key themes, leading to establishment of the final themes. This process involved 
indexing sections of text according to category and key theme. The researcher also 
created a chart for each key theme in which categories and final themes were placed 
in context of that particular key theme. Figure 12 (below), illustrates this process for 





Familiarisation with data: refinement of 
key themes and development of initial 
categories 
Allocation of pieces of transcript to 
each key theme and category 
 
(a piece of transcript may be allocated to more 
than one theme or category) 
Development of initial categories 
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• Uncertain of the benefits of RAADP 
• Certain of importance of anti-D Ig following PSE and delivery 
• Distinction between RAADP and anti-D Ig following delivery 
 
Further refinement of the categories to produce final themes that categorise the data in relation to the ‘key 
theme’ 
 
Key Theme: midwives perception of the benefits of anti-D Ig 
 
Data organised in relation to specific ‘key theme’: allocation and organisation of all categories of 




• Description of RAADP as prophylactic 
• Midwives personal experience of RAADP 
• Women refuse RAADP 
• Importance/significance of RAADP 
• Perception of benefits of anti-D Ig 
• RAADP policy new/might change again 
• Importance/significance of anti-D Ig following a PSE or 
delivery 
 
Initial Categories are refined to smaller number of more focused categories, in relation to 
the ‘key theme’ 
 
Final Themes: 
• Midwives view RAADP as less important than anti-D Ig 
following PSE or delivery 
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The final aspect of this research was to make sense of the categories and themes in 
context of the situations within which they emerged. In doing this the researcher was 
also able to identify core concepts, that is underlying ideas or concepts that underpin 
the research and allow the findings to be placed into a wider context. This mapping 
and interpretation of the findings was completed through creation of descriptive 
accounts, and it involved referring back to the original transcripts, the indexing and 
the categories and charts that were created. This was done within the context of the 
key themes, which represented the important questions that were central to the 
research aims, and also within the context of the core concepts. 
7.6 Findings and discussion  
7.6.1 Description of study sample 
The midwives were asked to complete a short questionnaire at the end of the 
sessions. The questionnaire had four questions: 
1. Since 2000, for how many years have you worked as a qualified midwife? 
A: 1yr, 2yrs, 3yrs, 4yrs, 5yrs, 6yrs, 7yrs, 8yrs, 9yrs, 10yrs 
2. During the past 6 months, approximately how many times have you, yourself, 
given and anti-D injection? 
A: None or      times 
3. Have you ever been directly involved in an anti-D incident?   
A: yes or no 
4. Is there anything else you would like to add about any of the issues raised during 
the focus group, or about anti-D in general? 
A: Free text 
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Table 15: Findings of midwives' questionnaire 





Since 2000, for how many 
years have you worked as 














During the past 6 months, 
approximately how many 






























Have you ever been 























There were no ‘free text’ comments from any of the midwives. 
7.6.1.1   Group 1: Maternity Unit A 
There were seven midwives in the session held at maternity unit A. They were all 
very experienced, most having spent over ten years working as a midwife since 2000. 
They had all completed their initial professional training prior to the introduction of 
RAADP.  Two of the seven had not administered anti-D Ig within the past 6 months, 
3 had administered it infrequently (less than once a month) and the remaining two 
regularly administered anti-D Ig. This may be explained by the mix in areas that the 
midwives were currently practicing in, they were from labour ward, where it would 
be unusual to administer anti-D Ig, although the midwives there would be expected 
to take cord and maternal blood samples for the RhD programme at delivery and 
subsequently explain to women the rationale for doing so and that the outcome might 
be that they require anti-D Ig. Rarely the same midwives might be expected to 
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administer anti-D Ig should a woman be discharged home early from labour ward 
following delivery, as the blood test results would most often delay administration. 
There were also community midwives present. In this maternity unit those midwives 
would be expected to discuss RAADP with pregnant women and offer and 
administer it at 28 weeks gestation. They might also occasionally administer 
postnatal anti-D Ig to women who were discharged from hospital prior to the baby’s 
blood group being established through cord blood testing. In addition these midwives 
might also be a first point of contact for women who experience potentially 
sensitising events such as vaginal bleeding, deciding on appropriate advice and 
onwards referral for testing and anti-D Ig. The final group of midwives in attendance 
at the focus groups were midwives working in the day assessment unit. In this area 
they look after women with a problem relating to pregnancy on an out-patient basis. 
This would include women who attend hospital following a potentially sensitising 
event such as vaginal bleeding, and the midwives would assess these women, refer 
them to medical staff and administer anti-D Ig if it was prescribed by medical staff. 
This group was therefore fairly diverse in terms of the current area of practice of the 
midwives, although all would be involved in the process in some way, they were 
often dealing with different aspects of the process and different circumstances in 
which anti-D Ig might be required. Only one of the midwives had been directly 
involved in an anti-D Ig incident. 
In this group the midwives appeared comfortable in each other’s company and there 
were no over powering influences or obviously negative influences on the group 
dynamic. The midwifery manager gave permission for them to be away from their 
clinical commitments for one hour, giving around 45 minutes for the focus group 
session and 15 minutes for an anti-D Ig educational update. 
7.6.1.2 Group 2: Maternity Unit B 
At maternity unit B, on the day that the session was held only four midwives were 
able to leave their clinical areas to attend. It became apparent early on that delivery 
of care at this maternity unit differed significantly from those in other areas as all 
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RAADP was administered at a special clinic held in the hospital building. This was a 
change from practice common in other areas where RAADP is given during a routine 
antenatal appointment at 28weeks by the community midwife.  
Again the midwives attending the session were all very experienced, with all of them 
having trained prior to introduction of RAADP. In this group it transpired that only 
one of the midwives had administered anti-D Ig within the past six months, this 
midwife worked in the hospital antenatal clinic and administered RAADP there. The 
other midwives all worked in the community and because of the set-up of care, with 
the RAADP clinic, they did not administer any anti-D Ig antenatally. They did 
however have responsibility for discussing RAADP with the women, referring them 
to the clinic, and following them up if they did not attend for RAADP.  
The fact that one of the midwives in the group regularly administered anti-D Ig and 
worked in a specialist environment undoubtedly affected the dynamics of this 
session. It was clear that the other midwives deferred to the clinic midwife and 
allowed her to answer many of the questions as the perceived expert among them. 
They also turned to her for clarification if they made points or described policy and 
practice. This limited the information and quality of data from this session. 
For the purpose of reporting findings the quotes from midwives are identified as 
belonging to either group A or group B, with individual midwives given numbers. 
For example midwife 1 from group A is (MW1a) and midwife 1 from group B is 
(MW1b).  
7.6.2 Focus group findings: key themes 
The first phase of the data analysis resulted in formation of key themes and 
categories. The initial presentation of findings is superficial, with very straight 
forward description of the key themes and the categories that were present within the 
data relating to those themes. This is followed by descriptive account of the findings 
offering a much more in-depth exploration of what the findings mean in context of 
the core underpinning concepts. Discussion of how the focus group findings relate to 
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the research completed in chapters five and six and to the wider evidence base is 
presented in Chapter 8: Discussion. 
The structured nature of the focus groups and the use of the topic guide, meant that 
some of the key themes reflected the research questions and topics that had been 
determined prior to conducting the focus groups. However it is of note that during 
the first phase of data analysis, familiarisation, the ‘pre-determined’ themes were 
refined and other new key themes emerged. 
Seven key themes were identified 
1. Sources of information and education in relation to anti-D Ig 
2. Midwives’ perception of the benefits of anti-D Ig 
3. Midwives’ perceptions of the risks of anti-D Ig 
4. Recognition and reporting of anti-D Ig incidents 
5. Midwives and responsibility and accountability in relation to anti-D Ig 
6. Midwives practice 
7. Informed decision making in relation to anti-D Ig 
 
7.6.2.1 Sources of information and education in relation to anti-D Ig 
The focus group topic guide included questions about formal sources of education 
and training in relation to anti-D Ig. In addition, during the familiarisation phase of 
the data analysis, it became apparent that the midwives also sought information from 
less formal sources. As a result this theme emerged to take into account both formal 
sources of training and of informal sources of information. After refinement of initial 
categories relating to this key theme, there were three final themes: training and 
information is policy focused; the midwives were happy with the learning they 
received and the midwives access informal sources of information 
The midwives’ in both focus groups described receiving training around the time of 
introduction of RAADP. The training was described by them as being focussed on 
the changes to policy in light of the introduction of RAADP and the midwives 
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recounted being provided with little information outside of policy changes. In one 
focus group, a midwife who worked in an RAADP clinic did describe being given 




Her description was very superficial, and at the time the moderator did not explore 
further whether her understanding was greater than it appeared from this small piece 
of conversation. 
The midwives recalled the training as being provided during face to face sessions, 
although midwives in both groups mentioned that some of them had been unable to 
attend. Other means of dissemination of policy changes were described and these 
included passing on information at team meetings and by pinning a letter outlining 
the changes to a board in staff areas. 
In general the midwives were happy with the level and content of the training that 
they received. Although there was one midwife in one group who felt that she would 
like to know more. She was challenged by the other midwives in the group who 
seemed happy with the frequency and level of training that they received. 
The training provided around the time that the policy for RAADP had been 
introduced was the most recent received by both groups. The midwives, in general, 
did not see any reason for more frequent updates. They mostly felt that they would 
only want to have further training if there were significant changes to policy in this 
area of practice. The midwives also indicated that they felt confident in their own 
knowledge in this area. They did not identify a need to improve their knowledge or 
understanding of anti-D Ig, out with being familiar with policy and procedures. 
In addition to formal training and dissemination of policy changes, the midwives 
frequently described seeking advice and information from other sources. They 
“They said that some of them had been missed and not known that 
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referred to using product and patient information sheets, and also spoke about calling 
the blood transfusion service (BTS) laboratory, and also identified specific members 
of midwifery or medical staff who they would contact.  
The BTS laboratory was the most frequently mentioned source of information and 
advice for the midwives. They not only called to confirm blood test results, but also 
described a number of situations where they called the laboratory to seek clinical and 
policy advice concerning particular women. The midwives appeared to have a strong 





The relationship the midwives described with BTS contrasted significantly with that 
with their medical colleagues. The midwives in both groups stated that they did not 
generally turn to medical staff for advice regarding the use of anti-D Ig. The 
exception to this were specific individual consultant obstetricians who were 
considered experts in this aspect of care. In fact there were also times when they 
reported challenging doctors who they felt were not fully cognisant of policy. 
Midwives in both groups described using BTS laboratories to ‘back them up’ when 
they felt the need to challenge medical colleagues. 
7.6.2.2 Midwives’ perceptions of the benefits of anti-D Ig 
It was considered important to explore what the midwives knew and understood 
about anti-D Ig and, in particular, its clinical benefits and potential risks. This is 
important in terms of midwives understanding their practice and actions in relation to 
the care of RhD negative women, and also in order to facilitate informed decision 
making. This key theme of ‘Midwives’ perceptions of the benefits of anti-D Ig’ 
emerged following the exploration of the issues, facilitated by the focus group topic 
“Because things are changing all the time, you don’t know if 
somebody’s amount of knowledge they’ve got or whatever. So I tend 
to phone the lab and say ‘this is what I’ve got, what do you think?’ 
You know because they’re dealing with it all the time whereas our 
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guide. It is followed in the next section by another theme ‘Midwives’ perceptions of 
the risks of anti-D Ig’. 
The very strong final theme within this key theme, was that the midwives who 
participated viewed anti-D Ig given as routine antenatal anti-D prophylaxis 
(RAADP) as less clinically significant than anti-D Ig given following a potentially 
sensitising event (PSE) during pregnancy. This finding was based on refinement of 
the initial categories to two refined categories: uncertainty over benefits of RAADP 
and certainty about importance of anti-D Ig following a potentially sensitising event 
after delivery. 
None of the midwives were able to articulate what they thought the clinical benefits 
of anti-D Ig were for a woman. This was particularly true of RAADP. They all 
referred to RAADP as ‘prophylactic’, and used the term to distinguish RAADP from 
anti-D Ig given following delivery or a PSE. In fact all anti-D Ig is given 
prophylactically in an attempt to prevent maternal sensitisation. The term 
prophylactic is usually understood to describe prevention rather than treatment, and 
the midwives appeared to regard the routine antenatal dose of anti-D Ig as preventing 
something that may or may not happen, in contrast to anti-D Ig given following a 
PSE or delivery as ‘treating’ an actual event.  
All of the midwives who participated had practiced prior to the introduction RAADP 
and they frequently referred to a time when they did not offer RAADP. This was 
done in a manner that seemed to question the importance of the intervention and was 
often done in relation to questions about risk and benefit. The fact that some women 
decline RAADP was regularly mentioned in the same context. This may be partly 
explained by the fact that that sensitisation is a very rare outcome and it is unlikely 
that the midwives would have had direct experience of any clinical benefit following 
the introduction of RAADP.  
A typical extract of conversation was: 
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Although the midwives appeared unsure of the benefits of RAADP, they seemed 
clearer that anti-D Ig following a PSE such as ‘a bleed’ during pregnancy was 
important and significant. They made a clear distinction between the benefits of anti-
D Ig in this situation from RAADP. 












“Is there a risk to the woman in not having it {RAADP}?” 
Moderator 
 
“Well for years we didn’t give it prophylactically.” 
MW6a 
 
“And women are refusing it, and when they deliver we do check and if 
they require it again” 
MW2a 
 
“{the benefits to the woman of receiving anti-D Ig} Depends on whether 




“So it {RAADP} isn’t one of the big important things that you’d really 
think ‘oh we have to get her in its desperately important’. We were 
here the years when they never got it before.” 
MW3b 
 
“Yes, that’s right.” 
MW1b 
 
“Unless they had a bleed” 
MW3b 
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7.6.2.3 Midwives’ perceptions of the risks of anti-D Ig 
It was also important to consider how the midwives regarded the risks of anti-D Ig. 
Again their understanding of this issue has important implications for the way they 
practice and also for any discussion they might have with women who are offered 
anti-D Ig. This was a topic of interest to the researcher and had been included in the 
focus groups topic guide. The one final theme, refined from initial categories, was 
that midwives viewed anti-D Ig as having low risk. A refined category was that 
midwives’ viewed the risk of anaphylaxis as small but significant.  
When asked about the potential risks of anti-D Ig, the midwives in both groups 
mentioned anaphylaxis and they regarded this as the most significant potential risk of 
the product. The midwives described clinical procedures and practices that were 
taken in precaution of anaphylaxis. These included carrying ephedrine, and asking 
the women to wait at the hospital or clinic for 20 minutes after administration of anti-
D Ig. 
The midwives tone when discussing risk, and in particular anaphylaxis, was very 
relaxed. Although they described taking precautions and were prepared to treat 
anaphylaxis should it occur, they did not appear to consider it a very likely outcome. 







“There’s minimal risk in receiving it {anti-D Ig}. I’ve never seen 






“But we take our ephedrine just in case! (laughing)” 
MW5a 
 
“That’s right! Laughter” 
Others 
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Another refined category was lack of clarity on the risk associated with anti-D Ig 
being a blood product. The midwives had earlier mentioned unprompted that anti-D 
Ig was a blood product, and it appeared that most, if not all, were aware of this. 
However when discussing the risks of anti-D Ig, the midwives did not mention that it 






Although they appeared aware that it was a blood product, they were not at all clear 





The midwives’ clearly regarded anaphylaxis as the most significant risk of anti-D Ig, 
and did not appear to have much understanding at all about any risks associated with 
it being a blood product. In general they did not appear to consider it a particularly 
risky product, and reported that they did not usually discuss risks associated with 
anti-D Ig with women. This is explored further under the broad theme ‘Informed 
decision making’. 




“Is it something you discuss with the women?” 
Moderator 
 




“I mean I used to say that it’s screened like any other blood but there 
is that small risk. I would imagine? It is a blood product” 
MW2b 
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7.6.2.4 Informed Decision Making 
This was a very important theme to emerge during the data analysis. Although this 
was an area identified as of interest to the researcher through literature and previous 
work, it was not something that the midwives were asked about directly during the 
focus group sessions. The researcher had felt that the topic was too large in itself to 
explore adequately during a session with limited time and a number of other 
important issues to cover. However the midwives did discuss this aspect of care, both 
directly and indirectly, and it emerged as a key theme. There were three final themes 
associated with this key theme. These were: the use of written information; limited 
discussion of risks of anti-D Ig; midwives’ lack confidence to facilitate informed 
decision making around anti-D Ig 
The midwives mentioned the use of written information a number of times during 
both focus group sessions, specifically product information sheets and patient 
information leaflets. They described using these to provide information for women 
and as a source of information for themselves when they were unsure of something. 
It was reported that women were given a leaflet about anti-D Ig towards the start of 
their pregnancy and midwives mentioned discussing and answering questions in 
relation to the process of consent for RAADP.  It was not clear what form that 
discussion took, but when questioned, midwives in both groups admitted that it did 
not include discussion of the risks of anti-D Ig. The midwives stated that they felt 
that the information provided to the women focussed on the benefits, or reasons for 
accepting anti-D Ig, and did not cover the risks associated with it. 
It seemed that the midwives were not generally confident talking about the risks of 
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The midwives did not appear to be confident in discussing the risks of anti-D Ig, in 
particular the risks associated with it being a blood product: It was unclear whether 
or not the midwives routinely informed women that anti-D Ig is a blood product. 
Although one of the midwives stated that she mentioned to the women that anti-D Ig 
is a blood product, the same midwife during a different conversation implied that she 
thought that women did not generally realise that it was 
The process of providing written information and receiving formal, written, consent 
seemed well established when offering RAADP. In particular documentation of 
refusal of consent was considered important. However consent and discussion were 
not mentioned at all in relation to anti-D Ig following a PSE or delivery. There was 
some evidence that the midwives expected that anti-D Ig had been discussed during 
pregnancy and did not expect to discuss it again if further anti-D Ig was required. For 
example, a labour ward midwife assumed that the midwives who provide antenatal 











“And do you feel able to answer those questions?” 
Moderator 
 




“We tend not to really {discuss anti-D Ig with women}. By the time 
they get to us on labour ward they’ve had all the stuff and they know 
pretty much, and they require it. {To another midwife} You are 
probably dealing with it more than we are?” 
MW1a 
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This midwife also states that anti-D Ig following delivery is ‘required’, the 
implication being that there is not a decision to be made, unlike for RAADP. 
There were a few miscellaneous observations about the way that midwives talked 
about their discussion with women, including that they described conveying the need 
for anti-D Ig as it was policy, rather than explaining the benefits or reasons for giving 
it to the women. The midwives also stated that the women did not really ask many 
questions about anti-D Ig, and interestingly they always referred to ‘giving anti-D’ 
rather than ‘offering anti-D’. However, it is difficult to know how significant the use 
of one phrase or the other might be. 
The midwives in one of the focus groups also talked about testing a woman’s 
partner’s blood type. This started as a very light hearted conversation, but the 
midwives became more serious and conveyed that they felt there was value in having 
the baby’s father tested. However, they did not appear to view it as their 
responsibility to either offer the test or to arrange a test if it was requested. They 
firmly placed responsibility for this with the parents. 
7.6.2.5 Midwives’ responsibility and accountability in relation to anti-D 
Ig 
The midwives’ responsibility and accountability was apparent in almost every aspect 
of their conversations during the focus groups, and became a ‘core concept’ of the 
findings. The more specific nature of the midwives’ understanding and application of 
responsibility and accountability also emerged as a key theme. This was a topic that 
had also been identified as important from previous research presented in Chapters 
five and six, and from literature.  
The complexity of the inter-related responsibilities was extensive. To aid 
understanding of the findings the description of initial categories and themes that was 
mapped during data analysis is illustrated in Table 16 (below). 
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Table 16: Midwives' responsibility and accountability, initial categories and themes 
 
Initial Theme 
Midwives’ responsibility and accountability in relation to anti-D Ig 
 
Initial Categories Refined Categories Final Themes 
 
• Clear about their responsibility and 
accountability when administering anti-D Ig 
• Clear on their responsibility for following 
policy/protocol  
• Responsibility to report errors is clear and 
well understood 
• Strong sense of professional responsibility 
• Lack of clarity over who is responsible 
when care is shared/transferred 
• Sense of accountability if care is not given 
according to policy 
• Relate anti-D Ig error to that of a 
drug/medicine error 
• Documentation of care and conversations 
is regarded as important aspect of 
responsibility 
• Documentation can be used to end/transfer 
responsibility 
• System can impact ability to follow policy 
• Midwives would like women to take more 
responsibility for their own care 
• Delegation of responsibility to other 
midwives and medical staff 
• Seek advice from trusted sources when 
uncertain 
• Do not always trust knowledge/practice of 
colleagues to whom they delegate care 
• Frustration when have to delegate to 
untrusted colleagues 
• Happy to delegate to trusted colleagues 
 
• Clarity of 
professional 
responsibility in 
relation to policy 
 
• Clarity of 
responsibility in 

















• System impacts on 
who is responsible 




• Midwives have a 
strong sense of 
own professional 
responsibility in 
relation to policy 
 
 
• Lack of clarity when 
delegation/sharing 









On some aspects of practice the midwives were very clear about their professional 
responsibility. For example when administering an injection of anti-D Ig there was 
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This was closely linked to their sense of responsibility and accountability to follow 
policy and procedures. There were a number of separate occasions when they 
equated an anti-D Ig error with a drug error. 
Documentation also emerged as an important aspect of the midwives responsibility. 
This included documenting consent for anti-D Ig, checking blood test results and 
signing prescriptions. Signing for something, putting ‘it on the board’, or writing 
things down, were all described by the midwives as ways of ending her individual 
responsibility in relation to a particular woman’s care, or this aspect of her care. This 
was not a direct hand-over of care and relied on an assumption that the person taking 
over responsibility would look for, find and act upon whatever had been written. 
It was also apparent, however, that in some situations there was lack of clarity over 
who was responsible for care. This appeared to be happen most frequently when 
women transferred between clinical areas, or between maternity units. Lack of clarity 
during handover of care also appeared to be related to procedures, or lack of 
procedures and to the documentation used.  
In both focus groups the midwives described a system of care where they shared 
responsibility for a woman’s care in relation to being RhD negative and 
administration of anti-D Ig. This was often with other midwives who worked in 
different clinical areas, and with medical staff who assumed responsibility for certain 
aspects of care. 
“At the end of the day you’re giving it so you are accountable for it.” 
MW1b 
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In this situation the midwives described having colleagues who they trusted and who 
they were happy to delegate responsibility to. However they also described situations 
where it was clear that they were not completely comfortable in handing over care. 
When discussing referring women to hospital based midwives following a potentially 
sensitising event (PSE) during pregnancy, for example, they expressed doubt about 
their midwifery colleague’s knowledge of policy. However they did not report taking 
any further action in that instance. When the same situation arose but it was medical 
staff to whom the midwives were to delegate responsibility for care, the midwives 
appeared to extend their responsibility to ensuring that the women did receive 
appropriate care. They did this through challenging the doctors, sometimes involving 





The midwives in one of the groups did not prescribe anti-D Ig as, in that particular 
maternity unit, this was the responsibility of medical staff. However they described 
an informal shared responsibility with the midwives telling the medical staff what to 
prescribe for whom. 
Another important theme to emerge during both focus groups was the midwives’ 
conflict over delegation of responsibility to women. The midwives expressed 
frustration that women did not always make themselves available for appointments at 
around 28 weeks gestation, when RAADP was due to be given. The midwives called 
for women to share some of the responsibility, but also understood that they would 
be held accountable if the woman did not receive her anti-D Ig: 
 
“…because some of the doctors don’t agree with it at every bleed. 
That’s when you’ve got to involve blood transfusion and they insist on it 
at every bleed.” 
MW6a 
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It was apparent throughout the focus group findings that the midwives’ responsibility 
and accountability in relation to RhD negative pregnant women was impacted by the 
organisation within which they worked. This was due to policy, procedures and the 
organisation of care. The findings relating to this are presented in the following 
section 7.6.2.6 Midwives’ practice. 
7.6.2.6 Midwives’ practice  
It became apparent during the familiarisation phase of data analysis that there were a 
number of factors that influenced midwives’ practice in relation to anti-D Ig, and that 
policy and procedures often impacted on delivery of care. 
Although the midwives were familiar with policy and procedures in their own 
clinical area, for example the antenatal clinic, labour ward or community, they were 
often not at all clear on procedures relating to anti-D Ig in other clinical areas. This 
might not seem important in terms of delivering care, and one of the midwives 
acknowledged that were she to go and work in another area she would make sure she 
was familiar with policy relating to that clinical area. However, it became apparent 
that the process of deciding that anti-D Ig was required, prescription and subsequent 
administration relied on actions and procedures in different areas, and that these were 
interdependent.  
”But on the other half when you’ve got this kind of situation, we are 
told that we are responsible to see that they get their care as well. It’s 
a difficult line to walk.” 
MW2b 
 
“Yes, it is really because if she doesn’t get it and there’s a problem 
and leads to isoimmunisation they’re going to say ‘well why didn’t 
you follow her up?’” 
MW4b 
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There were also instances where the midwives felt that they had to follow policy and 
procedures, even if this inconvenienced the pregnant woman. The system that they 







The midwives also described situations where the women’s behaviour or lifestyles 
impacted on their ability to provide care. This was often tied to unfamiliar patterns of 
behaviour or documentation, making it much harder for the midwives to provide care 
in line with established procedures. 
The midwives’ expressed frustration at times when the system that they worked 
within impacted on their ability to provide care in line with policy and procedures.  
7.6.2.7 Recognition and reporting of incidents 
Given the previous research findings, the researcher considered it important to ask 
the midwives about recognition and reporting of anti-D Ig errors. As a result this also 
emerged as a key theme within the data. There were two final themes here: 
recognised errors are likely to be reported to SHOT and recognition of errors may be 
difficult.  
The midwives were asked directly if they had heard of the Serious Hazards of 
Transfusion (SHOT) report, and most had not. When prompted with an explanation 
of what SHOT was, some did recognise the organisation, but related it to online 
“They come up to the GP or {hospital}. If they come up without their 
notes we’d send them away and they’d make another appointment 
and get it another time.” 
MW2b 
 
“If you take their blood at the time, you need the bit of slip to take the, 
to you know, for their bloods. It’s just too complicated if you haven’t 
got the stuff there so it’s just not worth doing any of it.” 
MW3b 
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transfusion training and seemed to associate SHOT with blood transfusion rather 
than anti-D Ig. 
Although the midwives were not aware of SHOT’s role in relation to anti-D Ig error 
reporting, they were very familiar with their own local policies for error reporting. 
These would, through organisational processes, lead to onward reporting of any anti-
D Ig errors to SHOT. The midwives were very clear about their responsibility to 
report errors, and felt strongly that if an error was apparent to them or to their 
colleagues, that this would definitely be reported. This research was quite limited in 
this respect as clearly the midwives knew that they should report an error and would 
be unlikely to state that they would act contrary to this.  
The midwives were not asked directly about their experience of anti-D Ig errors, or 
how they would recognise them, however there were conversations where they 
highlighted situations where they felt an error could happen, or where they had heard 
of an error occurring. Midwives in both groups recounted stories about such 
situations, although from the short questionnaire completed at the end of the session, 
it was apparent that only one midwife had been directly involved in an anti-D Ig 
error. 
The situations that the midwives described as potentially leading to error all involved 
care being transferred between clinical areas or maternity units, with difficulties in 
clarifying who was responsible for administering anti-D Ig and communication 
issues compounding the situation. The midwives also felt that it would not always be 
clear from the notes that an error had been made, with documentation also cited as 
making it difficult to recognise when an error had occurred. These conversations 
focussed particularly on omission of anti-D Ig. 
The broad themes provide the foundation of the findings of this research. However it 
is also important to consider these themes in context of each other and how this lead 
to the identification of underpinning core concepts.  
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7.6.3 Focus group findings: core concepts and descriptive 
accounts 
The final phase of the data analysis was to make sense of the themes that had been 
identified. This was done through development of descriptive discussion based 
around the three ‘core’ underpinning concepts that were identified. This allows for a 
much more in-depth understanding and of application of meaning to the findings in 
context of the core concepts and what was already known about the issues. 
Core concepts are the underpinning ideas or concepts that add meaning to the 
findings and allow the researcher to place them into context. There were three core 
concepts identified: 
1. Responsibility 
2. Knowledge and understanding 
3. Organisational influence 
 
The core concepts were identified during the initial data analysis and, naturally, run 
through many of the different findings and frequently overlap with each other.  The 
findings here are presented in relation to each of the core concepts, starting with 
explanation of how each core concept developed. In the following chapter, Chapter 
eight: discussion, the findings are discussed in relation to the thesis as a whole and in 
context of relevant evidence. 
a) Responsibility 
The concept of responsibility was central to the findings. It impacts on almost every 
aspect of the work and overlaps significantly with the other core concepts. This is not 
perhaps surprising as responsibility, and accountability, sit at the heart of provision 
of quality health care: professional and personal responsibility of those providing 
care and the responsibility of the organisation to adequately support them in its 
delivery. 
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There are a number of important factors that influence midwives’ responsibility and 
accountability in relation to anti-D Ig. The literature reviewed in Chapter three found 
that policy and formal guidance on the care of pregnant women with an RhD 
negative blood type is formed by medical and scientific staff with little midwifery 
input. Yet midwives are key providers of care and an important source of 
information for women. The analysis of SHOT error reports, Chapter six, found 
failures in care involving midwives were often due to failure to follow policy or 
guidance, or because assumptions were made that others such as medical or 
laboratory staff would have carried out appropriate checks. The researcher had 
identified midwives’ responsibility and accountability as one of the predetermined 
issues for exploration during the focus groups. The topic guide contained a number 
of scenarios and follow up questions that related to professional responsibility and 
accountability. These referred to different issues surrounding anti-D Ig including 
situations where midwives might consider deviating from policy or procedure, and 
specific clinical scenarios where midwives might be expected to share responsibility 
with other professionals. In addition the sessions elicited further isolated passages of 
conversation where the midwives made comments that were considered relevant to 
this topic. Given this and the wide reaching consequences of responsibility, it is not 
surprising that it merged as both a key theme within the initial analysis and also as a 
core concept underpinning the entire findings 
b) Knowledge and understanding 
The second of the three core concepts was that of the midwives’ knowledge and 
understanding. One of the pre-determined issues for discussion during the focus 
groups had been midwives’ education and training in relation to anti-D Ig. This 
evolved into the key theme of ‘sources of information and education in relation to 
anti-D Ig’. When considering the initial findings it was clear that midwives’ 
knowledge and understanding impacted on almost every aspect of the conversations 
during the focus groups. This perhaps should not be surprising as our knowledge and 
understanding of a subject is bound to influence what we say, feel and how we 
behave. However establishing it as a core concept allowed the findings to be 
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explained in context of midwives knowledge and understanding of issues around 
anti-D Ig.  
c) Organisational Factors 
The SHOT anti-D Ig error report analysis, Chapter six, and the RAADP Survey, 
Chapter five, both found that organisational factors impacted significantly on care 
provided by midwives. However this was not one of the pre-determined issues for 
exploration during the focus groups and it did not emerge as a key theme during the 
initial analysis of the conversations. During the later stages of analysis, when 
considering the focus group analysis in greater depth and applying meaning to the 
findings, it was clear that organisational factors impacted greatly on many aspects of 
the findings and it became one of the three core concepts which allowed the findings 
to be placed into context.  
7.6.3.1 Descriptive account of findings 
The following descriptive account considers the findings of the focus group research 
within the context of the three core concepts.  
7.6.3.1.1 Midwives’ Focus on Policy and Procedure 
A significant finding of the focus group research was that the midwives considered 
following policy and procedures as key to their clinical practice. The three core 
concepts were integral to understanding and explaining this finding. The midwives 
described a strong sense of professional responsibility to know, understand and 
follow the policy and procedures that directly affect care that they provide. It was 
also apparent that the situations where midwives described a strong understanding of 
their professional responsibility were those where the consequences of failure to act, 
or to provide appropriate care, were explicit and easily understood. One example of 
this is that the midwives regarded getting the process of administration of anti-D Ig 
right as incredibly important.  The conversations that the midwives had about this 
demonstrated not just a sense of responsibility but also an understanding of their 
accountability in relation to providing care that was not in line with local policy. The 
sense of accountability and responsibility in relation to errors in administration of 
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anti-D Ig was further demonstrated with the midwives likening an anti-D Ig 
administration error to a drug or medication error.  Accountability was clearly 
important to those who participated, with midwives frequently mentioning fear of 
being held responsible should an adverse outcome arise. 
In the UK midwives have three formal aspects to their accountability: professional; 
contractual and legal. Their professional accountability relates to their status as a 
registered midwife and requires them to provide care in line with the standards 
outlined by the Nursing and Midwifery Council (NMC). Contractual responsibility 
refers to their responsibility to their employer. This requires them to follow the 
policy and procedures set out by the organisation within which they work. Legal 
responsibility requires them to provide care within the legal framework, the most 
significant aspect being not to do harm to another person. 
Contractual accountability means that the organisation within which midwives work 
will significantly influence the way that they practice through specific policies and 
protocols that they are expected to adhere. Provision of care will also be impacted by 
the way that care is organised and through the culture fostered by the organisation 
and its employees. Woman centred care has been an integral aspect of government 
level maternity care policy in the UK for several years, and it is recognised that 
working in partnership with women enables them to make choices about their 
maternity care that are appropriate to their individual circumstances, achieving better 
outcomes (DoH, 1993, Maternity Services Action Group, 2011). However, the 
midwives here described providing care that was centred on local policy and 
protocol, rather than on the needs of the individual woman. They recounted 
situations where they felt compelled to follow procedure even if that led to 
inconvenience for the woman, or might expose the woman to potential failures in 
care. An example was when midwives described delaying administration of anti-D Ig 
as they did not have the appropriate paper work in the clinic area. When this 
happened, women were not given anti-D Ig and were asked to return on another date. 
This may cause significant inconvenience, requiring re-organising childcare, 
transport or further time off work, and it may also give the impression that anti-D Ig 
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is something that can be delayed, lessening the impetus to return specifically to 
receive it. However the midwives clearly felt bound by their responsibility to follow 
procedures and the way that care was organised appeared to make it difficult for 
them to act in any other way in this situation. The midwives in effect described an 
inability to be flexible in their approach to provision of care because of procedural 
requirements set by the organisation within which they worked, and due to the way 
that care was organised and required to be delivered. The core concept of knowledge 
and understanding was also important when trying to understand this finding. 
Authors such as Wray (2000) and Wickham (1999b) have suggested that healthcare 
professional’s knowledge in relation to the care of RhD negative pregnant women, 
and the use of anti-D Ig in particular, is lacking. With some suggesting that poor 
understanding of the issues involved might influence failures in care. The midwives 
knowledge and understanding of issues around care provided for RhD negative 
pregnant women and anti-D Ig was not formally tested during this research. 
However, it was very apparent from the focus group findings that the midwives’ 
knowledge centred on local policy and procedures, and that they lacked 
understanding of the wider issues and evidence that underpinned the care they 
provided.  
7.6.3.1.2 Education and Sources of Information 
Midwives have a professional responsibility to understand the care that they provide 
(NMC, 2008). In order to provide safe and effective care they need to know policy 
and protocols, but they should also understand the rationale for their actions and be 
able to explain the care that they offer to women. The midwives here were asked 
about the education that they received and, on the whole, they did not feel a need for 
further education or training beyond dissemination of policy changes. Failure to 
acknowledge this responsibility and failure to recognise the significant gap in their 
knowledge and the impact it might have on the care they provide may simply reflect 
their poor understanding of the issues, although it was not possible from this research 
to explore this any greater depth.  
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The midwives’ own responsibility for their professional development is critical, 
however the organisation that employs them also assumes responsibility to support 
midwives to provide evidence based practice. The focus groups found that provision 
of education and training on anti-D Ig and the care of pregnant women with and RhD 
negative blood type was limited. For both groups it had been over two years since it 
was last offered, and on that occasion there had been dissemination of changes to 
policy and procedure with minimal information about the rationale or evidence base 
behind RAADP.  The midwives also reported that not all of them had been able to 
attend the education sessions offered. Instead they received information on the policy 
change through colleagues, at meetings and via written correspondence. It appeared 
that, at an organisational level, there was no requirement for them to attend a session, 
and the education had been organised and provided in such a way that it had not been 
possible for them all to do so.  It would also seem that the opportunity to provide 
more in-depth background information and understanding that presented with the 
introduction of RAADP  had not been exploited, further reflecting an apparent 
culture of dissemination of policy rather than providing education that would impart 
understanding of underlying issues and evidence. There was an apparent failure at 
organisational level to recognise a requirement to provide care beyond the basic 
clinical recommendations outlined in the NICE guidance.   
The midwives’ description of clinical practice that prioritised adherence to following 
procedure ahead of provision of woman centred care, illustrates the complex 
relationship between their professional responsibility, their knowledge and 
understanding of the issues involved and the influence of the organisation within 
which they work.  
7.6.3.1.3 Woman centred care and informed decision making 
The conflict between the midwives responsibility to provide care in line with 
procedures determined by their organisation and provision of individualised person 
centred care was also apparent in the relationship that they described having with 
women in their care. They expressed frustration that the women often failed to attend 
appointments to receive RAADP, and described this behaviour as ‘irresponsible’, 
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stating that women should share responsibility for this aspect of their care. However, 
women cannot fully share responsibility for their maternity care if they do not have 
information about the choices available to them and the midwives here did not 
engage with the women in order to discuss RAADP. Despite their rhetoric, the 
midwives maintained a strong sense of the need to fulfil their professional 
responsibility to the women in such cases although this was linked to their 
understanding that they would be held accountable should there be a subsequent 
failure in care, as opposed to concern over provision of evidence based care.  
Informed decision making is integral to the provision of woman centred care, and is 
important in relation to anti-D Ig for a number of reasons. The evidence described in 
Chapter three, highlights the significance of information in empowering women and 
enhancing the quality of the maternity care that they receive. Additionally, with anti-
D Ig, the efficacy of both RAADP and anti-D Ig following PSE is dependent on 
receiving it at the correct time. In both cases the women must be able to recognise 
the need for anti-D Ig and attend to receive it. This requires partnership between care 
givers and the woman in order to impart that information and support provision of 
appropriate and timeous maternity care.  
A number of authors have linked the underlying knowledge and understanding of 
healthcare professionals to their ability to provide informed decision making 
(Kirkham, 2004, Oliver et al, 1996). This research uncovered significant limitations 
in midwives’ knowledge and understanding about anti-D Ig, which the midwives’ 
themselves gave as a reason for their failure to fully engage with women in 
discussion about the intervention.  Exploration of the focus group findings about 
informed decision making in relation to the core concept of midwives knowledge and 
understanding about anti-D Ig aids understanding of some of the issues raised. In 
particular the midwives were unclear about the risks and benefits of anti-D Ig, 
focussing on the immediate clinical consequences of administration, such as the risk 
of anaphylaxis. Although they clearly took the potential risk of anaphylaxis very 
seriously, they also described being unwilling, and feeling unable, to engage in 
discussion with the women about the other risks, even stating that they actively avoid 
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discussion of this type. The risks and benefits of anti-D Ig are complex and difficult 
to quantify. This complexity is enhanced by the fact that a woman’s individual 
circumstances impact on them. However they also form an extremely important part 
of a woman’s decision about whether or not to accept anti-D Ig and it is vital that 
women are offered an opportunity to discuss the risks and benefits of anti-D Ig in 
relation to their own individual situation if informed choice is to be achieved.  
Organisational factors also emerged as an important influence on the provision of 
informed decision making. The focus on provision of education around policy and 
procedure, rather than developing a wider understanding of the underpinning 
evidence base and issues impacting women’s decisions, impacts midwives 
knowledge and subsequent ability to provide informed decision making. However it 
was also clear from the focus groups that while the midwives recognised that they 
did not have the knowledge to engage in this depth of conversation with the woman, 
they did not see a need for this, or regard it as important that they did so. The 
midwives in the focus groups reported a shared culture of failure to engage in 
discussion about the risks of anti-D Ig. Instead they described the use of written 
information to provide women with information about anti-D Ig. They used both 
patient information sheets and also the product information sheets provided with 
anti-D Ig. Product information sheets are intended to give details about the product 
from a pharmacological perspective rather than provide information that might allow 
a woman to consider whether anti-D Ig is appropriate for her. The midwives here 
however, reported using them to inform the women and as a source of information 
for themselves. The focus groups did not explore content of the leaflets used by these 
midwives although previous research, the RAADP survey described in Chapter five, 
found that patient information leaflets vary considerably in quality and content.  The 
midwives also stated during the group discussion that the information they provided 
did not cover the risks of anti-D Ig but rather focussed on the benefits, providing 
further evidence of a culture of avoiding imparting the risks of anti-D Ig to women.  
This research found that the midwives were dependent on written information as a 
source of information for themselves too, reinforcing their lack of knowledge and 
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understanding about the information that they were required to impart. This raises 
questions about the quality of information available to women and health care 
professionals to aid decisions about care, and the influence that individual maternity 
units and individual midwives have upon that. 
It is also interesting to consider the provision of informed decision making within the 
context of responsibility. Midwives have a professional responsibility not only to 
provide women with choices, but also to inform them of potential risks that an 
intervention might hold. The midwives here centred their responsibility on obtaining 
written documentation of consent required by local policy, rather than engaging in a 
process that would allow women to make a decision based on individual 
circumstances. This may be regarded as prioritising their obligation to their employer 
to document that procedure has been followed, rather than responsibility to women to 
provide individualised care.  
These findings raise questions about organisational influence on knowledge and 
understanding and on the cultural context within which care is offered. There may 
also be organisational factors that directly influence the midwives ability to provide 
this care, such as time available during appointments, however the midwives here did 
not mention any such factors as impacting on ability to achieve this. 
The midwives’ did mention a process of consent in relation to RAADP although, as 
already discussed, this was centred on documentation of the woman’s agreement to 
receive anti-D Ig.  They did not mention consent at all in relation to anti-D Ig given 
for postnatal prophylaxis or following a PSE in pregnancy. Their conversation 
implied that these were situations where they regarded anti-D as simply required 
rather than to be offered, with an assumption that the women had had an opportunity 
to discuss anti-D Ig during the antenatal period. However, the anti-D Ig is being 
offered for a different clinical reason and the woman may have different criteria for 
deciding to accept or decline it. The midwives have a responsibility to discuss it 
again in the context of the current clinical situation. Without understanding the basis 
Policy and Practice Concerning Women with an RhD Negative Blood Type:              
A midwifery perspective 
Chapter Seven: Focus group research to gain midwives’ perspective 197 
and underlying evidence relating to the policy the midwives may neither appreciate 
this, nor be able to do so.  
Oliver et al (1996) state that the call for more choice in maternity care has not been 
accompanied by corresponding investment in training professionals or organising 
health care to make time available for this. This reflects the concerns of the Royal 
College of Midwives when RAADP policy was first proposed (RCM, 1999) and 
raises questions about the extent to which the recommendation from NICE that 
implementation of a policy of RAADP should be accompanied by staff training 
(NICE, 2002) has been achieved. The survey conducted in Chapter five found that 
the majority of maternity units did in fact accompany introduction of a policy of 
RAADP with staff training or education. However the findings in this chapter raise 
the question of whether that was at a level that would allow meaningful engagement 
with women about the risks, benefits and alternatives associated with anti-D Ig. 
Provision of informed decision making is an important aspect of care provided to 
pregnant women with an RhD negative blood type. Midwives ability, and 
willingness, to facilitate this is influenced by the organisation that they work within, 
their knowledge and understanding of the issues involved and by their own 
interpretation of their responsibilities to women and of the responsibility required of 
them by their organisation. 
7.6.3.1.4 Midwives interaction with other healthcare professionals 
This research also gave insight to midwives’ relationship with other healthcare 
professionals with whom they shared aspects of care provided for women with an 
RhD negative blood type. In particular the midwives described having an important 
relationship with the blood transfusion service (BTS) laboratory staff, frequently 
relying on the laboratory staff to provide clinical advice concerning the women in 
their care.  
The midwives were happy with this arrangement and they did not seem to consider 
that it conflicted with their responsibility to know and understand significant aspects 
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of the care that they carried out. It is of note that it is not always clear who the person 
they speak to in the laboratory will be. In some instances it may be a medical 
laboratory assistant (MLA), a person who is unqualified and trained only to provide 
assistance within the laboratory setting, other times it could be that a registered 
biomedical scientist (BMS) would answer the phone. BMS’s should be very familiar 
with policy and procedures in relation to testing and issuing of anti-D Ig, however 
they are not expected to understand and advise on specific clinical situations. If 
midwives are relying on laboratory sources for clinical advice it is important that 
they understand the limitations of any advice they receive, and must also be aware 
that they remain responsible for any action they take as a result. This research didn’t 
explore this further but it is an area of the midwives’ practice, and their 
understanding of responsibility linked to that practice, which warrants further 
exploration.  
The findings here describe a culture where the midwives were happy to access 
clinical advice this way and that the laboratory staff appeared to be available and 
willing to provide it. The findings of this research suggest that the midwives here 
regularly accessed information to inform their practice from informal sources such as 
BTS staff and from product information inserts that were not intended for that 
purpose. This would suggest that they did not have access to, or know how to access, 
more formal and reliable sources of information. The organisation within which 
midwives work has an obligation to ensure that they have access to such sources of 
information. 
This was not the only situation where other healthcare professionals practice 
impacted on the care that midwives provided. The way that maternity care is 
organised means that administration of anti-D Ig is often part of a process involving 
other healthcare professionals. For example medical staff might make a decision to 
give a certain dose of anti-D Ig to a particular woman and then write the prescription, 
the laboratory staff will often select the correct product and dose and issue it to the 
clinical area, with the midwife administering it to the woman. The responsibilities of 
individual professions will vary between maternity units according to local policies 
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and procedures. Although the person who administers the anti-D Ig is ultimately 
responsible for their action, the degree to which there is shared responsibility across 
the process is complex and medical and laboratory staff may also be held 
accountable for their actions. Analysis of SHOT error reports, described in Chapter 
Six, identified a number of situations where the lines of responsibility and 
accountability were not clearly defined. In particular when medical colleagues 
erroneously prescribed anti-D Ig or where laboratory staff issued the wrong dose to 
the clinical area and a midwife offered and administered it. However, the focus group 
research found that the midwives were clear in understanding that they were 
responsible, and would be held accountable, if they administered anti-D Ig as part of 
a process where others were involved.  
When sharing care with other professionals, the research uncovered situations where 
the midwives described extending their professional responsibility to take on 
personal responsibility for a woman’s care. Personal responsibility reflects a person’s 
own sense of what is right or wrong and how they should behave, with Mander 
(2004) regarding it as the highest form of accountability that a person holds. An 
example of the midwives sense of personal responsibility came when they described 
situations where they felt that medical staff, to whom they were required to delegate 
care, did not fully understand policy. In such situations the midwives described going 
beyond their professional responsibility to ensure that the women received what they 
considered appropriate care. Interestingly this did not extend to midwifery 
colleagues, instead they described a sense of resignation and frustration at having to 
hand on care to them, but did not act further to intervene. It is interesting that the 
midwives perceived a hierarchy of their responsibility where they felt unable to 
challenge another midwifery colleague but they would challenge a member of 
medical staff who held a different role within their organisation and had different 
professional responsibilities. It is of note that the midwives in this research were all 
very experienced and had been practising as midwives for a number of years. It was 
not possible to explore here whether their willingness to assume responsibility over 
colleagues was linked to professions or was influenced by other factors such as 
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perception of experience or competence of individual clinicians within those 
professions. This would be another interesting aspect of the research to explore 
further. 
Another example where the midwives’ sense of personal responsibility saw them 
work beyond the policies dictated by their employer was when they discussed 
paternal blood type testing. They clearly thought that it would be advantageous for 
women to know their partners blood type, and potentially avoid receiving anti-D Ig, 
but did not consider it within the scope of their role or responsibility to offer it.  
Instead they described informally advocating testing by advising the father to donate 
blood to find out their blood type. Although the midwives intention was sound this 
unofficial method of testing, without formal reporting of results, may be unreliable 
and is unlikely to provide a result before the woman’s pregnancy reached a stage 
where RAADP would be offered. The midwives’ failure to understand the 
implications of the advice they gave, again highlights failure to fully understand the 
wider issues that influence decision making around anti-D Ig. It also demonstrates 
the difficult situation that midwives are in when they have a responsibility to their 
employer to provide care in line with policy and guidance but this conflicts with their 
own sense of personal and professional responsibility to provide evidence based 
options of care for pregnant women.  
Organisational factors also influence the midwives interaction with other health care 
professionals. The care of a woman during pregnancy will often be shared between 
clinical areas at different stages of the pregnancy and birth, particularly if the woman 
requires additional care or intervention due to complications of pregnancy. It was 
interesting to note that although the midwives felt clear responsibility for the direct 
care that they provided, they did not regard it as important to know or understand 
procedures and practice in those other clinical areas. This has potential to impact on 
care that they themselves provide and is especially challenging in situations where 
there are not robust systems for handing over care, potentially leading to failures in 
care. The midwives reported situations where there was a degree of confusion 
concerning who was responsible for particular aspects of care and also described a 
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lack of clear procedures for handing over or communicating changes in 
responsibility. The way that care was organised appeared to impact on this, and they 
described procedures for handing over care, such as writing a name on a board or 
ticking a box, that did not require the healthcare professional to whom that care was 
being delegated to acknowledge receipt.  While midwives may have a responsibility 
to their employing organisation to follow procedures, the organisation equally has a 
responsibility to ensure that policies and procedures are robust and enable safe and 
effective clinical practice.  
The organisation of maternity care can have a very direct impact on midwives 
practice, and the focus group research uncovered examples of differences in 
organisation of maternity care and of policy at the two maternity units where the 
participants practiced. For example in one maternity unit the midwives prescribed 
and gave all routine antenatal and postnatal anti-D Ig, but in the other prescription of 
all anti-D Ig was the responsibility of medical staff, although the midwives offered 
and administered it. The midwives in the two maternity units clearly had very 
different roles and responsibilities in relation to administration of anti-D Ig, dictated 
by the organisation of care and the specific policies in place at their respective 
employing organisations. In another example one of the maternity units held an 
RAADP clinic, with all RhD negative women asked to attend the hospital clinic in 
order to receive their RAADP. As maternity care becomes increasingly complex and 
specialised there may be a tendency to organise it in a way that sees some aspects 
delegated to specific professionals. A midwife who worked in this RAADP clinic 
was a participant in the focus group and during the session it was very clear that she 
was considered an ‘expert’ and that the other midwives knew very little about 
procedures relating to anti-D Ig their maternity unit. Although these midwives felt 
that they did not require this knowledge because all RhD negative pregnant women 
would attend the RAADP clinic, it also emerged that anti-D Ig remained a significant 
aspect of their clinical practice.  They had responsibility for informing the woman of 
her blood type, providing initial information concerning the significance of being 
RhD negative during pregnancy, they would be a first point of contact if she 
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experienced a potentially sensitising event during pregnancy, and were also 
responsible for administering anti-D Ig after a homebirth. The way that the system 
was organised in this hospital appeared to foster a culture among the midwives that it 
was acceptable to delegate all things anti-D Ig to the hospital midwives. However 
this failed to take into account other factors, aside from actual administration of anti-
D Ig, that require midwives to understand the issues involved. The way that care was 
organised in this maternity unit made it difficult for midwives outside of the clinic 
area to remain up to date and aware of policy and procedures even although those 
policies and procedures impacted on the care that they provided.  
7.6.3.1.5 Recognising and reporting anti-D Ig errors 
The focus groups also explored reporting of anti-D Ig errors, and although this was 
done to a very limited extent, it remains useful to attempt to understand the findings 
in relation to the core concepts. Midwives in both groups described robust systems 
for reporting anti-D Ig errors and stated that they fully understood those systems. 
Their professional, and contractual, responsibility in this respect was also well 
understood with the midwives expressing that they would always report an incident. 
This could be said to reflect the culture of encouraging openness and accountability 
when errors happen, however clearly this research was not designed to explore this 
issue and it is not at all clear how the midwives might have behaved had they 
actually made an error.  
The error reporting systems that the midwives described would lead to onward 
reporting to the Serious Hazards of Transfusion (SHOT) reporting scheme. However 
this was largely done through a process that was remote from the clinical midwives. 
Clinical staff reported any error via their local system, DATIX, and then another 
person was responsible for investigation and onward reporting to SHOT. It was clear 
from the focus groups here that the midwives did not understand the function of 
SHOT in relation to anti-D Ig. Although some of them had heard of the scheme this 
was in relation to blood transfusion, and they did not associate it with anti-D Ig. The 
purpose of the SHOT scheme is to allow clinical groups to learn from errors, with 
lessons learned being used to prevent recurrence. However this research found that 
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the findings and recommendations from the SHOT report were not disseminated to 
the key clinical recipients: midwives providing clinical care. The midwives did not 
associate SHOT with anti-D Ig errors, and clearly in this case the organisation had 
failed in its aim to inform the staff groups who directly impact care. This would 
appear to be a lost opportunity for clinical staff to learn from a report that is directly 
relevant to their clinical practice.  
7.6.3.1.6 Routine Antenatal Anti-D Prophylaxis 
A very significant finding of this research was that the midwives described RAADP 
and anti-D Ig given following a PSE or delivery, as having different clinical 
significance: RAADP being considered less important than anti-D Ig given for other 
reasons. Again it was possible to better understand this finding by relating it to the 
three core concepts.  
The midwives here did not give any rationale to justify their attitude to RAADP, 
simply referring to the fact that for years they had not given it. The number of 
women who need to receive RAADP in order for one to benefit is very small and any 
benefit would impact a subsequent pregnancy rather than the current one. This means 
that the midwives are unlikely to encounter a woman who has benefited from 
RAADP, or to see any change in outcomes during their daily practice. This inability 
to link RAADP to any perceived change in outcomes could be a factor in the lack of 
benefit they associated with it. This again highlights the implications of learning 
around anti-D Ig being concerned with policy and procedure rather than 
understanding the evidence and wider issues involved.  
The midwives also expressed that when administering anti-D Ig following a 
potentially sensitising event (PSE), or delivery, they perceived a clear link between 
their responsibility to provide care in line with policy and the consequences for the 
woman of getting it wrong. With RAADP, although they described ambivalent 
feelings about the clinical significance of the policy, they still reported a strong sense 
of responsibility to ensure that women were offered the intervention. In this case 
however, the midwives’ commitment to offer RAADP was linked to understanding 
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that they would be held accountable for failure to provide care in line with procedure. 
This again reflects the midwives’ strong sense of contractual accountability to their 
employer.  
The focus groups included only a small number of midwives and, importantly, they 
were all very experienced, and had all practised as midwives before RAADP was 
introduced. It might be that had a group of midwives who had qualified after 
introduction of RAADP been interviewed, the findings would have been different. 
That said the strong sentiments voiced by the Royal College of Midwives (RCM, 
1999) around the time that RAADP was recommended together with the findings of 
this research suggest that this is an area of practice that could be explored further. 
Midwives’ attitudes and subsequent actions in relation to women who receive 
RAADP has potential to impact on clinical practice,  compliance with guidelines, 
and informed decision making. 
7.6.3.2 Summary of descriptive account and core concepts 
The focus group research suggests that the midwives have a strong sense of 
responsibility and of being held accountable, but raises questions about whether they 
fully understand the scope of their responsibility. Their sense of responsibility was 
closely linked to their accountability to their employing organisation and the 
complexity of professional responsibility and of responsibility to the women in their 
care did not appear to be well understood. This drive to provide care in line with the 
policy and procedures of their employing organisation impacted their ability to 
provide care that was flexible and woman centred. The midwives’ knowledge and 
understanding also impacted on the care they provided, and in turn was influenced by 
the organisation within which they worked. The education that midwives received 
again centred on knowing policy and procedure. The lack of information provided to 
them about the evidence base underpinning policy meant that they could not support 
women in a process of informed decision making and their lack of understanding 
impacted the clinical care that they provided. Organisational factors were found to 
directly influence the midwives practice through the way that care was organised and 
through specific policies and procedures. However the findings also suggest a less 
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immediately obvious influence through fostering a culture of following policy and 
procedure rather than providing woman centred care.  
The findings illustrate that the core concepts of responsibility, knowledge and 
understanding, and organisation factors underpin and influence almost every aspect 
of midwifery practice in relation to provision of care for pregnant women with an 
RhD negative blood type. 
 
7.7 Strengths and limitations of this research 
The strengths and limitations of this research are discussed in Chapter eight, section 
8.4, Pg 226.  
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Chapter 8: Discussion 
8.1 Introduction 
This research was conducted using three different methods, over a period of five 
years, with the aim of describing practice and policy surrounding the care of women 
with an RhD negative blood type from a midwifery perspective. The research found 
that by 2005 the NICE (2002) recommendation for routine antenatal anti-D 
prophylaxis (RAADP) had been widely implemented throughout the UK, but that 
there were significant variations within local policies and the information that was 
provided to pregnant women and healthcare professionals. The secondary analysis of 
the SHOT anti-D Ig error reports from 2007/2008 highlights aspects of practice and 
organisation of care that may result in errors occurring. Identification of proximal 
errors, trigger events and fallible practices provide valuable information for 
clinicians about how errors involving anti-D Ig occur. The final research, focus 
groups to gain a midwifery perspective, found that the midwives and the 
organisations within which they worked were driven to provide care in line with 
policy and procedure at the apparent expense of a woman centred approach. This 
appeared to be linked to the midwives’ understanding of their responsibility and 
accountability and the education and information that underpinned the care they 
provided. The other important finding from the focus group research was that the 
midwives regarded RAADP as a less important intervention than they did anti-D Ig 
given following a potentially sensitising event (PSE) during pregnancy or given 
following delivery.  
The strengths and limitations of the individual research projects were discussed 
alongside the findings within their specific chapters: Chapters five, six and seven. 
They are discussed again here within the context of the wider application and validity 
of specific findings and conclusions drawn. When considered together the research 
findings give unique and valuable insight to the care of pregnant women with an 
RhD negative blood type in the UK, from a midwifery perspective. The following 
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discussion aims to place the findings into context of the research as a whole, of the 
wider meaning and application of the findings for midwifery practice. 
8.2 Building the thesis from three pieces of research  
The thesis consists of three distinct, but related pieces of research. It is important to 
consider how they relate to one another and what each piece contributes to the thesis 
overall. 
The aim of the RAADP survey was to determine actual implementation of what was 
a new and, at the time, controversial recommendation. The survey formed the 
foundation on which to build the thesis by providing evidence that RAADP had 
become an integral aspect of maternity care within the UK. The findings describe 
policy across the UK but were not able to explain why aspects of implementation 
varied between maternity units, or what impact those variations might have on 
clinical practice. This raised important questions that informed the two subsequent 
pieces of research and also aided explanation of the findings of those research 
studies. 
The RAADP survey raised a number of questions about clinical practice in relation 
to the recommendation to offer RAADP. The second piece of research was a 
secondary analysis of anti-D Ig errors reported to the SHOT scheme. This work has 
arguably the most potential to be directly useful in clinical practice as it highlights 
aspects of organisation of care, local procedures and clinical practice which create 
situations or events that allow errors to happen. The findings highlight both 
individual and organisational impact on errors, and are unique and important as this 
is the first time that the SHOT anti-D Ig error data has been examined from a 
midwifery perspective. The research uncovered proximal errors, trigger events and 
fallible practices which provide a framework within which the common pathways to 
error involving anti-D Ig can be better understood, allowing midwives to understand 
and improve the care they provide. This piece of research also raised further 
questions about midwifery practice and those questions were used to inform the 
focus group research. 
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The aim of the focus group research was to consolidate the findings of previous 
research, presented in Chapters five and six, by gaining direct input from midwives. 
It met this aim to a large extent, and although the findings are limited by the factors 
discussed in Chapter seven, this research adds substance to the findings of Chapters 
five and six, to the wider evidence base and provides foundations for future research. 
This aspect of the research allowed midwives an opportunity to clarify and explore 
the issues that had been raised, giving a midwifery perspective, something that had 
never been sought before.  It answered the questions raised through the previous 
research and allowed exploration of other aspects of care relating to women with an 
RhD negative blood type. 
This research represents the first time that a midwifery perspective on care provided 
for women with an RhD negative blood type has been explored. When considered 
alongside each other, the findings of the three pieces of research provide original and 
important insight to midwifery practice in relation to the care of pregnant and 
parturient women with an RhD negative blood type. 
8.3 Discussion of findings 
The findings of all three pieces of research are discussed here, in relation to each 
other and the available evidence. In order to impose some structure to the discussion 
sub-headings are used within the discussion of findings. However, the findings are 
interrelated and it was frequently necessary to revisit particular issues when those 
were raised in context of further findings or pieces of research, necessitating 
discussion across subject headings 
8.3.1 Anti-D Ig in practice 
The research findings shed light on a number of important aspects of midwifery 
practice in relation to the care of RhD negative pregnant women and the 
administration of anti-D Ig in particular. 
The RAADP survey was conducted in 2005, soon after the NICE (2002) 
recommendation for RAADP was published and at a time when it was unclear how 
Policy and Practice Concerning Women with an RhD Negative Blood Type:              
A midwifery perspective 
Chapter Eight: Discussion 209 
many maternity units had actually implemented the recommendation. Previous audit 
found just 12% of maternity units offered RAADP (Chilcott et al, 2004), but this 
survey found widespread adoption of the policy with 75% of maternity units offering 
RAADP. At the time this was a very important finding which demonstrated the 
impact that the NICE guidance had and the contemporaneous significance of the 
findings were demonstrated through mention of the survey in the review of the NICE 
guidance  (NICE, 2008, Pg 7 (Appendix 2)) and publication of an article in 
Transfusion Medicine Journal (Harkness et al, 2008 (Appendix 1)). Implementation 
is now assumed to be even more widespread.  It is known all of Scotland’s maternity 
units now offer RAADP although it is not clear what the implementation rate is in 
the other UK countries. 
The research also found that although a policy for offering RAADP had been broadly 
implemented, there were significant variations in the local policies put in place by 
maternity units. These included whether one or two dose regimen for RAADP was 
used and whether routine paternal testing was offered. The variations in clinical 
practice are discussed in Chapter five.  It is of note here that just 12% of maternity 
units offered routine paternal blood type testing. By testing a paternal blood sample it 
is possible to determine those fathers who are also RhD negative, if both mother and 
father are RhD negative the baby must also be RhD negative and so there is no risk 
of maternal sensitisation. As such anti-D Ig is not necessary for those women who 
are certain that the father of their baby is RhD negative, making the test a useful tool 
when offering informed choice within an individualised and woman centred 
approach. However, this research found that the test was not offered to the vast 
majority of women. The reasons most often cited for not offering the test is potential 
misidentification of the father by the pregnant RhD negative woman (Urbaniak, 
1998). This attitude appears paternalistic, in that it dismisses involvement of the 
woman in her own care. It is important to acknowledge that this policy perspective is 
grounded in the scientific and medical professions and that the midwives interviewed 
for the focus group research, Chapter seven, saw value in determining the father’s 
blood type in order to avoid unnecessary anti-D Ig. Discussion of this sensitive 
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subject may be considered difficult, however midwives regularly engage with 
women to discuss sensitive issues. It is also routine practice in many maternity units 
for midwives to seek time with women when their partners are not present in order to 
discuss issues such as domestic violence. This could also provide an opportunity for 
confidential discussion with women about whether a paternal blood test would be 
appropriate. Although the medical and scientific policy makers may consider this a 
difficult issue to broach it would appear that midwives would not share those 
concerns to the same extent.  Offering routine paternal blood type testing could be a 
simple, and potentially cost effective, intervention that supports the NHS policy 
agenda to provide individualised care, and yet none of the policy documents that 
recommend RAADP have seriously considered it. There is no formal evidence to 
inform the use of routine paternal blood type testing for partners of pregnant women 
with an RhD negative blood type and it appears to have been dismissed as an option 
by the majority of maternity units.   
It is of note that although the midwives in the focus groups supported paternal 
testing, they felt powerless to offer it, instead suggesting that fathers donate blood to 
determine their blood type. This situation demonstrates the lack of input that 
midwives and RhD negative women themselves have had in policy in this area and 
how the dominance of a medical and scientific approach to addressing the problem of 
maternal sensitisation and subsequent haemolytic disease of the fetus and newborn 
(HDFN) may result in failure to consider areas of practice that have potential to 
improve the quality of care that is offered.  
This research also considered clinical practice by examining the mistakes that 
midwives make when administering anti-D Ig, the first time that such research had 
been undertaken. There is increasing evidence that clinical error is common within 
the National Health Service (NHS) (National Audit Office, 2005) and a number of 
patient safety initiatives have been introduced at National policy level. In relation to 
the care of RhD negative pregnant women there is little published evidence about 
how errors occur or what might be done to prevent them. The annual SHOT reports 
identify trends in type of errors, such as omission of anti-D Ig or inappropriate 
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administration. They also report on ‘stand out’ errors from which lessons may be 
learned. However the primary purpose of the SHOT organisation is haemovigilance 
and its focus is primarily on blood transfusion, with members including 
haematologists, biomedical scientists and transfusion specialist nurses.  There is no 
midwifery involvement in collating and analysing the data, or in making 
recommendations for practice based on the report findings.  Nemeth and Wessell 
(2010) suggest that around 50% of medication errors reported within the NHS could 
be prevented if lessons had been learned from previous experience. The research 
presented in Chapter six examines only anti-D Ig errors that involved midwives, 
from the perspective of midwives, for the first time and in doing so provides practical 
understanding of the factors that contribute to errors in this area of practice. It is 
anticipated that the findings will allow midwives and maternity units to identify 
situations within their workplaces and organisations that could be scrutinised in order 
to prevent error from occurring.  
The analysis of the SHOT anti-D Ig error reports involving midwives identified just 
four proximal errors: the final opportunity to prevent an error within that situation. 
The four proximal errors were: failure to complete checks, failure to follow up care, 
misinterpretation of results and failure to follow guidance. The proximal errors 
reflect what Reason (2000) describes as a ‘person approach’ and may result from 
forgetfulness, carelessness, poor motivation or even recklessness. These are 
important for midwives to consider within the context of their professional 
responsibility, however they are factors which all of us may experience at some time, 
and as a result they may be very difficult to control or influence even at an individual 
level. The findings of this research can also be interpreted within the framework of 
Reason’s ‘system approach’ (Reason, 2000) which takes as a premise the fact that 
human beings are fallible and will always make errors. Within this context the 
proximal errors are important in aiding understanding of an individual’s role in 
making an error, however it is the trigger events and the fallible practices which 
really allow scope for intervention that may reduce future errors. The research 
identified a number of relatively simple and easily rectified factors that could prevent 
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errors from recurring. These included factors influenced by culture and organisation 
and included numerous examples of poor communication and flawed procedures and 
ways of working. This is particularly significant as the focus group research found 
that midwives felt compelled to practice in line with the policy and procedures set 
out by the organisations within which they worked. Their sense of responsibility and 
accountability was strongly linked to their obligation to their employer and they 
described situations where they followed policy and procedure even when they had 
misgivings about the impact on women. This emphasises the potential for error when 
procedures and policies are flawed, and reinforces the understanding that those 
factors require effort beyond the influence of individual midwives in order prevent 
recurrence. 
Although the RAADP survey, Chapter five, found that the majority of maternity 
units had met their obligation to implement the NICE recommendation to offer 
RAADP, the subsequent pieces of research suggest that there are often factors within 
subsequent practice that could be improved. Organisations have a responsibility not 
only to implement National guidance but to do so in a way that establishes ways of 
working that enable staff to provide safe and effective care. This may be through 
ensuring that procedures and documentation minimise the risk of error, but also in 
supporting staff through provision of education and information. The midwives who 
participated in the focus group interviews were clear in understanding that they 
would be held accountable should care not be provided in line with policy, but failed 
to acknowledge a wider professional responsibility to provide evidence based, 
woman centred care that facilitated choice. This aspect of their practice is discussed 
further in the following section 8.3.2: Anti-D Ig and woman centred care. 
The number of anti-D Ig errors reported to SHOT has risen steadily since reporting 
began and it is thought that one of the reasons for the increase is the widespread 
introduction of RAADP with resultant increase in amount of anti-D Ig that is offered. 
This research found that the majority of errors reported to SHOT did not involve 
RAADP, suggesting that it is unlikely that implementation of RAADP policy has 
contributed significantly to the increased number of errors reported to SHOT. 
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Evidence reviewed in Chapter three suggests that when care provided for RhD 
negative women is routine and established, such as following delivery of an RhD 
positive baby, compliance with guidelines is high (Vause, Wray and Bailie, 2000, 
Howard et al ,1997). The RAADP survey, Chapter five, found that by 2005 RAADP 
was widely implemented across the UK, making it an established aspect of routine 
antenatal care in the majority of maternity units for a number of years now. There is 
also emerging evidence that compliance with RAADP is generally good (McKenzie 
et al, 2006, Chaffe et al, 2007). This adds weight to the finding that errors involving 
RAADP may be less common than errors concerning postnatal prophylaxis and anti-
D Ig given following a PSE. However, it is also important to consider that omission 
of RAADP may be under reported. Anti-D Ig used for RAADP is often held as stock 
in clinical areas, making it out with the normal controls levied by the laboratories, 
and omission subsequently susceptible to going unrecognised.  
It is interesting that the midwives who participated in the focus group interviews 
described anti-D Ig given as RAADP as less important than anti-D Ig following a 
PSE. This is not something that has been reported in the published literature 
previously, but may have important implications for midwifery practice. It was 
discussed in detail in Chapter seven, but is significant here as it raises the question of 
whether midwives are as rigorous in offering and administering RAADP as they 
might be for anti-D Ig given for other reasons. Although the midwives did not appear 
to see clear benefit in RAADP, they did describe a very strong commitment to 
ensuring women were offered, and received, it. This appeared to be linked to their 
strong sense of the importance of offering care in line with policy and, as such, their 
feelings about RAADP did not appear to influence this aspect of the care that they 
provided in relation to it. This adds further weight to previous research that suggest 
that compliance with guidelines for offering and administering RAADP is good 
(McKenzie et al, 2006, Chaffe et al, 2007). 
The finding that midwives regard RAADP as less clinically important than other 
anti-D Ig is potentially very significant. However it is important to acknowledge the 
limitations of this research and to consider whether this finding reflects how 
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midwives in general feel about RAADP, or if it simply reflects the views of those 
midwives who participated in this research. It is of particular note that all of the 
midwives who participated in the focus groups had practised as midwives prior to 
RAADP being offered and that this may have influenced their view of the 
intervention. Further research is required to establish whether this is a more general 
view held by midwives, and to establish the true incidence of error related to anti-D 
Ig given as RAADP. 
A more plausible explanation for the increase in anti-D Ig error reports is increased 
awareness of the need to report errors and improved systems for doing so.  This 
reflects a wider NHS policy focus on the patient safety agenda, with accompanying 
widespread implementation of local level formal incident and error reporting 
systems, such as DATIX, which enable onward reporting to appropriate 
organisations such as SHOT (National Audit Office, 2005). The focus group research 
findings support evidence that staff understand how to report errors and that the 
mechanisms are in place to facilitate onward reporting to SHOT. 
It is important to note that although the numbers of anti-D Ig errors reported to 
SHOT continue to rise, from just 5 in 1998/9 to 249 in 2011 (Bolton-Mags and 
Cohen, 2012). They represent a very small proportion of the total injections of anti-D 
Ig that are administered. There are no statistics available to tell us how much anti-D 
Ig is administered each year, however it is possible to estimate numbers.  
Based on a UK birth rate of around 800,000 births per year, approximately 128,000 
(16%) women will be RhD negative: 
• All 128,000 will be offered RAADP (at least one, possibly two doses)  
• 76,800 (60%) will also be offered postnatal anti-D Ig (those who deliver an 
RhD positive baby) 
• Therefore at least 204,800 doses of anti-D Ig will be offered.  
This does not take into account anti-D Ig given during pregnancy for a potentially 
sensitising event or additional anti-D Ig given at maternity units where a two dose 
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regimen is in place. Nor does it take into account those women who decline anti-D 
Ig, thought to be a small number. Given this it can be assumed that in excess of 
205,000 doses of anti-D Ig are administered in the UK each year, giving an error rate 
(based on the most recent, 2011, SHOT annual report) that is almost certainly less 
than 1 in every 823 doses, or 0.1%. 
It is difficult to know what error rate should be expected. Nemeth and Wessell (2010) 
report a prescription error rate of between 0.3% and 39% depending on their audit 
inclusion criteria. The SHOT annual report acknowledges that not all errors are 
reported (Taylor et al, 2009), and the research presented in Chapter six, analysis of 
anti-D Ig errors, suggests that some anti-D Ig errors may be underreported. In 
particular omission of anti-D Ig, where stock is held in clinical areas out with 
laboratory control, may be susceptible to going unrecognised. The SHOT annual 
reports find that the most common type of anti-D Ig errors are inappropriate and late 
administration of anti-D Ig (Bolton-Mags and Cohen, 2012). McSweeney et al 
(1998), following retrospective case note review, suggest that the most common 
failures are omission of anti-D Ig and failure to perform Kleihauer test. The SHOT 
analysis research, Chapter six, also suggests that omission of anti-D Ig may be 
underreported and highlighted situations where there is shared care and it is not 
always clear who is responsible for offering and administering anti-D Ig. Although 
the midwives in the focus groups felt very strongly that they and their colleagues 
would always report any error that they recognised, and the mechanisms appear to be 
in place to allow this, if there is no awareness that an error has been made it is 
impossible to report it.  
Failure to recognise erroneous omission of anti-D Ig would appear to be the most 
likely category of underreporting. This is of particular concern as this is the error that 
is most likely to lead to maternal sensitisation and subsequently morbidity and 
mortality as a consequence of haemolytic disease of the fetus and newborn (HDFN). 
The potential for failure to recognise errors that may have important health 
consequences raises the question of whether maternity units should perform regular 
audit of care to determine whether anti-D Ig has been given appropriately.  The 
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NICE (2008) RAADP guidance recommends that maternity units should perform 
regular audit to determine compliance with policy, although it is not clear how many 
maternity units do this. Regular and routine audit of RAADP policy is to be 
welcomed however this does not address errors that involve anti-D Ig given 
following potentially sensitising event or after delivery of an RhD positive baby. 
This research adds evidence to support the theory that omission of anti-D Ig is under 
reported and that organisations could do more to uncover this type of error. This 
holds particular clinical significance given the potential for omission of anti-D Ig to 
lead to morbidity and mortality due to HDFN.  
8.3.2 Anti-D Ig and woman centered care 
The most significant finding from the focus group research was that the midwives 
felt compelled to closely follow local policy and procedures. This was at the heart of 
their practice when providing care for women with an RhD negative blood type, and 
appeared at times to be at the expense of provision of woman centered, 
individualised care.  
The concept of woman centered care, taking into consideration a woman’s particular 
situation and needs and providing them with choice and control, has been central to 
maternity care policy in the UK since the publication in 1993 of the ‘Changing 
Childbirth’ report (Department of Health, 1993). The concept of patient centered care 
is now an established aspect of wider UK healthcare policy with Lord Darzi 
reporting that “care should be safe, effective and person centred” (Darzi, 2008, 
Pg8/9). Current Scottish policy such as the Refreshed Framework for Maternity Care 
(Maternity Services Action Group, 2011) reiterates its continued importance at 
government level NHS policy. Individualised, person centred, care is regarded as key 
to provision of quality care and, in maternity services in particular, as key to 
addressing lifelong health inequalities. 
The establishment of clinical governance as a statutory duty for UK health 
organisations in 1998 was accompanied by the creation of organisations such as the 
National Institute for Clinical Excellence (NICE). This had the aim of supporting the 
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principles of evidence based practice and reducing variations in care across the UK. 
It has been noted that the concept of evidence-based care, which determines the best 
option from a population perspective, fundamentally conflicts with provision of 
person centred care (Karwalish, Fox and Pearlman, 2002).   
The emphasis on policy and procedure rather than provision of individualised care 
pervaded through a number of themes within the focus group findings. These 
included the direct delivery of care, with an unwillingness to deviate from procedure 
for fear of being held accountable, to failure to engage with women due to lack of 
knowledge and understanding of the issues affecting their care. Willis (2001), cited 
by Watson (2004, Pg41), considers that within the context of professional 
accountability evidence based medicine can go wrong when “it stops being a tool and 
starts to become a master”.  That would appear to be the case here and the findings 
reflect failures at individual level to recognise and understand the scope of 
professional responsibility and the importance of person centred care in this aspect of 
practice. The findings also demonstrate the impact that organisation of care and 
organisational decision making with regard to policy and procedure have on 
midwives’ ability to provide person centred care. The organisations within which 
midwives worked appeared to convey a strong sense of obligation to provide care 
within the framework of clinical governance. This was reflected by the midwives’ 
equally strong sense that they would be held accountable should care deviate from 
local policy or were procedures not followed. In relation to the care of women with 
an RhD negative blood type, this resulted in failure to consider other aspects of 
quality care that could be achieved by using a person centred focus. 
Again it is important to note that the focus groups represent only a very small 
number of midwives, however it is also of note that the findings from separate 
maternity units reported broadly similar views. The observation that the midwives’ 
were intent on policy and procedure is an important finding and it highlights their 
failure to engage with women to provide individual care. An important aspect of 
provision of individual care is facilitation of informed decision making. This 
research has some important findings concerning the facilitation of informed 
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decision making in relation to anti-D Ig. It is of note that both the NICE (2002) and 
RCOG (1998) recommendations for RAADP contained a strong statements 
reiterating the importance of informed decision making and of encouraging women 
to make a choice about whether RAADP was right for them. The NICE (2002) 
guidance also included a list of the situations where a woman might decline RAADP 
such as when she was certain that the father of her baby was also RhD negative. 
However this research as a whole found that factors that might have supported 
midwives in delivery of that aspect of the guidance, such as education and written 
information, were of variable quality. The focus group interviews in particular found 
that the midwives who participated did not engage in in-depth discussion with 
women in order to facilitate choice about anti- D Ig. 
The findings of the RAADP survey shed light on two aspects of implementation that 
influence informed decision making in practice: provision of education or training 
for staff, and provision of written information for women. The survey found that the 
majority of maternity units did provide education for staff at the time of 
implementation of RAADP, but within the limitations of the brief questionnaire used 
it was not possible to explore what form that took. The focus group research 
supported the survey finding that maternity units provided education around the time 
that policy was changed, however the midwives reported that this had been a policy 
update, with limited or no information or discussion about the background and 
evidence base behind the new guidance. The midwives also reported that not all of 
them had been able to attend face to face sessions, instead receiving written 
information about the changes. These findings suggest that although the maternity 
units met their obligation to disseminate policy changes reflecting the new guidance, 
they did not go as far as to provide education that would enable midwives to engage 
with women in order to meet the recommendations concerning informed decision 
making.  
Watson (2004) suggests that instead of providing constraining frameworks for 
practice, we should educate practitioners properly to enable them to make decisions 
about care. The midwives who participated in the focus groups demonstrated a lack 
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of fundamental knowledge and understanding that would allow them to make 
decisions about care. A number of authors have suggested that healthcare 
professional’s knowledge about anti-D Ig is poor, and that this may contribute to 
failures in care (Wray, 2000, Wickham, 1999b, Van Dijk, 1997). However this 
represents informed speculation and no formal evidence exists concerning healthcare 
professional’s knowledge and understanding about anti-D Ig or the other issues that 
impact care offered to pregnant and parturient women with an RhD negative blood 
type. The focus group research undertaken here did find that the midwives who 
participated appeared to have good knowledge of the local policies and procedures 
that directly related to their practice, but that they had poor knowledge and 
understanding of other factors that impacted care. In particular they demonstrated 
poor knowledge of the risks and benefits of anti-D Ig and of the wider evidence that 
informed the recommendation to offer RAADP.  
Midwives have a professional responsibility to understand the care that they provide 
(NMC, 2008). In order to provide safe and effective care they need to know policy 
and protocols, but they should also understand the rationale for their actions and be 
able to explain the care that they offer to women. However, it is of note that the 
midwives themselves did not see the need to receive education beyond dissemination 
of policy changes. They saw their accountability as being directly linked to providing 
care in line with the policies and procedures laid out by their employing organisation, 
rather than understanding wider accountability in relation to the women in their care. 
It is also important to consider that in this situation it may be that the midwives did 
not appreciate the need for further education because they did not have the 
knowledge to allow them to understand why that might be relevant to their practice. 
The focus group research was unable to explore this further, however it would appear 
that there was failure at managerial, organisational and individual midwife level to 
appreciate the scope and implications that implementation of the NICE guidance for 
RAADP held.  
Perhaps unsurprisingly, given their apparent lack of understanding, the research also 
highlighted midwives dependence on written information. The focus group 
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interviews found that the midwives were very dependent on written information, 
both to support their own knowledge and to provide information to pregnant women. 
The midwives reported having limited discussion with women outside of presenting 
the information within the leaflets. The information they provided for women was 
that available within the organisations that they worked for. There is evidence that 
women like written information but that they also want an opportunity for face to 
face discussion. (O’Connor et al, 2007), and O’Cathain et al (2004) concludes that 
although patient information leaflets may help facilitate informed choice, they cannot 
deliver it when used alone. 
The RAADP survey, Chapter five, found widespread provision of written 
information for pregnant women (at 97% of maternity units). However it also found 
a wide variety of leaflets, many of which had been produced by the maternity units 
themselves. The research did not include formal evaluation of factors that might 
impact on quality, such as readability, but content analysis showed significant 
variation, with several missing key information.  This reflects the small study of 
information leaflets, aimed at RhD negative women, reported by Wickham (2007). 
Wickham (2007) questioned the quality and impartiality of the leaflets, finding that 
the majority did not mention side effects of anti-D Ig or present it as a choice. The 
RAADP survey, Chapter five, found that many maternity units produced their own 
leaflets about anti-D Ig. Although it is unclear why they should do so when NICE 
produced one to support implementation of the RAADP guidance, it has been 
suggested that some healthcare professionals choose to omit information that they 
think may cause anxiety (Oliver et al, 1999). Others suggest that when a choice being 
offered is policy, that it may be presented in such a way that they are not presented as 
choices at all (Davis, 2003).  The midwives’ dependence on written information and 
failure to engage in detailed discussion with the women, leads to concern about how 
women are able to make decisions about anti-D Ig. Although there is very little 
published evidence about this, several authors have questioned whether anti-D Ig is 
presented as a choice, and what exactly women understand about it (Wray, 2000, 
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Stewart, 1999, Wickham, 1999a, Wickham, 1999b), and others even question 
whether women know it is a blood product (Saha, 1998, Wickham, 2001).  
The analysis of leaflets during the RAADP survey supports previous evidence in that 
the written information was most likely to omit details that might influence a 
woman’s decision not to have anti-D Ig. The midwives within the focus group 
research also reported that they avoided discussing risks. During the focus group 
interviews, Chapter seven, the midwives described a process of documenting 
consent, rather than facilitating choice through discussion with the women. 
Midwives’ failure to engage with the women was also evident in the SHOT analysis 
research, Chapter six. The SHOT research highlighted a number of situations where 
including the woman in the process of offering and administrating anti-D Ig might 
have prevented an error. For example a significant proportion of the errors involved 
inappropriate administration of anti-D Ig, most often to an RhD positive woman. 
Situations such as this raise the question of what these women were told about why 
they needed anti-D Ig and what they understood about their care. Interestingly during 
the focus group interviews the midwives described a consenting process for RAADP, 
but did not appear to see a need for further discussion with women when they 
required anti-D Ig later in their pregnancy or following delivery.  
Some authors have questioned the appropriateness and achievability of informed 
decision making in today’s healthcare system (Davies 2005) but there is a wealth of 
midwifery research to support the use of informed decision making to empower 
women and improve the quality of the care they receive. Evidence suggests that 
midwives regard informed decision making as an important aspect of their job (Levy, 
2006) however this research found that the midwives here appeared instead to follow 
a consenting process that focussed on documenting the woman’s decision. This 
happened in place of, rather than alongside, engaging women in discussion and 
encouraging them to consider choice in relation to individual circumstances.  
Much of the research about informed decision making in maternity care concerns 
choice about issues such as place of birth and pain relief during labour. These issues 
Policy and Practice Concerning Women with an RhD Negative Blood Type:              
A midwifery perspective 
Chapter Eight: Discussion 222 
are entrenched in midwifery practice and are the type of choices that are considered 
integral to being a midwife. Although it is now a routine aspect of midwifery care, 
administration of anti-D Ig is in effect a medical intervention to prevent a 
complication of pregnancy. It may be that this has influenced midwives attitudes 
towards provision of choice around it and may help explain why they have not 
pursued acquisition of knowledge that might enable them to challenge aspects of 
policy such as provision of routine paternal testing, or to provide informed choice for 
women. Kirkham (2004) suggests that when a policy is routine there is risk of 
‘informed compliance’ rather than informed choice. This may be particularly true if 
that policy originates within medical rather than midwifery practice. 
8.3.3 Anti-D Ig and the midwifery profession 
When a policy of RAADP was first called for in the UK (RCOG, 1998), it was met 
with strong resistance from midwives who challenged blanket intervention and called 
for a focus on improving existing care (RCM, 1999). This was based on substantial 
evidence that compliance with the then current guidelines was suboptimal and 
contributed significantly to on-going maternal sensitisation (Vause, Wray and Bailie, 
2000, Howard et al, 1997, Ghosh and Murphy, 1994).   
Rooks (1999) sums up the difference in approaches of the medical and midwifery 
professions, stating that: 
“Medical management often calls for applying treatments as preventative measures. 
The midwifery model recommends waiting until there is evidence that the 
intervention is needed”. 
Rooks (1999, Pg 373) 
 
The stance by the midwifery profession demonstrated this difference in approach to 
care, with midwives concerned about introduction of a routine intervention based on 
a population perspective rather than on individual need. The RCM called for the 
policy of RAADP to be reviewed by the National Institute for Clinical Excellence 
(NICE), stating that they would support it should NICE subsequently recommend 
this (RCM, 1999). However, the NICE review was a technology appraisal and as 
Policy and Practice Concerning Women with an RhD Negative Blood Type:              
A midwifery perspective 
Chapter Eight: Discussion 223 
such considered the intervention from a clinical effectiveness and cost effectiveness 
perspective and there was no new scientific evidence available for inclusion than that 
previously presented in the consensus statement (RCOG, 1998). It is of note that of 
the 26 members of the Appraisal Committee who conducted the guidance review in 
2008 none were midwives (NICE, 2008). 
The findings of this research highlight the potential for reduced quality of care that 
stems from lack of engagement with and by the midwifery profession during the 
development and implementation of policy. As the staff group who administer the 
majority of anti-D Ig, midwives were in a position to understand how scrutiny of 
midwifery practice could contribute to improving compliance with current 
guidelines. Similarly facilitating woman centred care that would enhance decisions 
based on an individual’s situation, such as supporting paternal blood type testing, is 
an area of midwifery rather than medical expertise. Midwives could have made 
valuable contribution to formation of RAADP guidance and policy however, 
although the RCM called for exploration of such approaches, evidence in a form that 
would have been considered by NICE was not available for inclusion in the review.  
Midwifery remains a developing profession, in 1986 the United Kingdom Central 
Council for nursing, midwifery and health visiting (UKCC) launched ‘Project 2000’ 
(UKCC, 1986) transferring all nursing and midwifery professional education to the 
university setting. This coupled with the more recent establishment of Professors of 
midwifery and Consultant midwife posts further enhance the status of the profession 
(Yuill, 2012). Midwifery research is also a developing field, and formal midwifery 
evidence on care provided for pregnant women with an RhD negative blood type 
remains extremely limited. Although this area of practice may be considered medical 
in origin midwives are the key care givers, and this thesis highlights the potential for 
improved care were the midwifery profession to engage on an equal standing with 
policy makers and contribute formal evidence to inform practice.  
It is important to note however, that NICE chose to consider RAADP in isolation 
from other aspects of care that impact on pregnant and parturient women with an 
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RhD negative blood type, including when anti-D Ig is offered for other indications. 
In doing so the appraisal did not consider alternative approaches that had been 
suggested by midwives, such as the potential for reducing maternal sensitisation 
through improving current care. Although the midwifery profession failed to engage 
with policy makers at a level where they could effectively contribute to the NICE 
review  the decision by NICE to conduct a Technology Appraisal,  rather than 
produce more wide ranging clinical guidance, limited the contribution that midwives 
could make. 
This research also uncovered failure at organisational level to implement the 
recommendations in a way that would meet the expectations of the midwifery 
profession to provide informed choice and woman focused care in relation to 
RAADP (RCM, 1999). The focus group research found that midwives’ sense of 
responsibility to deliver care was closely linked their accountability to provide care 
in line with employer’s policies and procedures.  The organisations within which 
they worked fostered this culture through the way that care was organised and 
support, through provision of education and information, provided for the midwives. 
With both individual midwives and the wider organisations within which they work 
having written policy and procedure as a primary driver for provision of care, the 
wider objective of enhancing knowledge and understanding to support quality care 
and enabling staff to make decisions and to provide information to women was lost. 
This again reflects the opinion of Watson (2004) who suggests that clinical 
governance has seen an erosion of professionalism through the reduction of ability to 
exercise professional or personal accountability. It also echoes Kirkham (1999) who 
describes a culture of maternity services within the NHS in England which makes it 
difficult for midwives to practice within a woman centred approach to care. Kirkham 
(1999) states that 
“Midwives who are expected to facilitate choice and control for clients often lack 
professional experience of such facilitation, exercise little choice and control in their 
work and mistrust management”. 
Kirkham (1999, Pg 737) 
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Watson (2004) argues that the only way that individualised care can be provided is 
through professional and personal accountability, but to do this midwives must have 
knowledge and understanding that gives them confidence to offer and facilitate 
choices that do not reflect policy.  The midwives who participated in the focus group 
research neither had, nor recognised a need for, knowledge and understanding of the 
issues that influenced policy and failed to appreciate the scope of informed decision 
making for women with an RhD negative blood type. When describing clinical 
governance, Scally and Donaldson (1998) state that  
“NHS organisations are accountable for continuously improving the quality of their 
services… by creating an environment in which excellence in clinical care will 
flourish” 
Scally and Donaldson (1998, Pg 62).  
While clinical governance has as its intention the provision of quality care, Watson 
(2004) argues that it is in fact a threat to professionalism through making clinicians 
accountable to a pre-determined framework rather than their own practice.  
Although culture and practice at organisational level may be regarded as influencing 
individual midwives ability to provide quality care, it is important to acknowledge 
that organisations, in this case NHS Scotland and individual maternity units, employ 
members of the midwifery profession in senior positions from which they are able to 
influence policy and practice. Although midwives may have embraced the provision 
of choice for those issues that are deemed ‘midwifery practice’ such as place of birth 
and pain relief during labour,  the changing face of maternity care in the UK means 
that most midwives are now regularly required to provide care that has its roots in the 
medical profession. Mason (2000) states that  
“Earlier aspirations of midwifery led maternity services in the UK have been 
shattered by the increasing incidence of medical interventions as routine procedures 
in normal birth, and by managerial policies designed to turn midwives into 
functionally competent ‘service agents.’’ 
Mason (2000, web page) 
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However, it can be argued that it is within the power of the midwifery profession to 
regain control and influence over many of the ‘medical interventions’ that midwives 
now provide within the scope of routine maternity care. If midwives accept these 
interventions as part of their practice, they should also accept the challenge of 
providing them within the context of an evidence-based and woman focussed 
approach. It is vital that the midwifery profession engages with the development and 
implementation of such policies and that midwives at an individual level understand 
what they are offering and why.  
This research demonstrates that even when an intervention originates in medical 
practice midwifery input is valuable, relevant and has great potential to positively 
influence care.  
8.4 Limitations of research 
Each of the individual research studies had limitations. These were described in 
Chapters five, six and seven and have been mentioned again in context of discussion 
of specific findings. However, it is important to restate here the major limitations of 
each of the separate pieces of research.  
The RAADP survey questionnaire was intentionally short and simple. This approach 
was considered to be a significant factor in achieving the very high response rate, 
however it did limit the scope of the questions asked and meant that it could not 
explore issues in a way that might have added meaning to the results. The intention 
of this survey was to gain straight forward information about specific aspects of 
current policy and practice. The findings of the RAADP survey provided this and the 
additional questions it raised were addressed during the subsequent research 
presented in Chapters six and seven.  
A significant limitation of the research presented in Chapter six, analysis of anti-D Ig 
errors reported to SHOT, was the lack of control over the data collection. The error 
reports came from across the UK, each being made by a different person. As such 
they are accounts by unknown people with unknown biases, unknown involvement 
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in the error, and using unknown methodology for investigation and reaching 
conclusions about what happened. Despite this significant limitation it was 
considered that the data was unique, important and meaningful. A major strength 
being that the error reports that were available for analysis represent all recognised 
errors involving anti-D Ig in the UK that were reported to SHOT over a twelve 
month period. The incidents reflect real situations and events, and despite the 
limitations of the work they provide a unique insight to actual clinical practice in this 
area. 
A number of factors limit the scope of the focus group research. Conducting research 
that involves clinical staff in the NHS is always a challenge, and never more so than 
at a time where political and financial factors were imposing significant resource 
implications for maternity services in Scotland. Those constraints directly influenced 
the methods used here and, coupled with the resource limitations of this project, 
required the researcher to adopt a flexible and pragmatic approach to data collection. 
In practice this meant working with the midwifery managers and potential 
participants to find a way of holding the focus group interviews that would allow 
meaningful data collection within the serious constraints on time, availability and 
resources. Each session was allocated just one hour, and this meant that the 
moderator had to stick fairly rigidly to the topic guide and was not always able to 
explore ideas and areas of discussion that arose during the sessions in as much detail 
as she would have liked to. By adapting the methodology to a more structured 
approach than a traditional focus group, this was mitigated to an extent, however the 
data was limited both by lack of control over exactly who participated in the sessions 
and the need to cover a number of topics within the limited amount of time allocated.  
A significant limitation of the focus group research was the small number of 
midwives who participated.  Just eleven midwives in total, working at two of 
Scotland’s seventeen maternity units. It is of note that the midwives who participated 
in the group interviews were very experienced, all having trained prior to 2002 when 
RAADP was first recommended. This gave them a particular perspective on the care 
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they offered and may have influenced their knowledge and attitudes, most 
specifically in relation to the lack of perceived benefit associated with RAADP.  
Kitzinger (1995) describes the potential for the focus group setting to inhibit some 
participants from contributing fully. This did not appear to happen here and the 
midwives were at times quite open about not knowing or understanding issues. 
However, it is acknowledged that the group dynamic did influence the findings of 
this research. This was particularly true of the second group, group B. In group B the 
participants comprised one midwife who worked in an RAADP clinic and three 
community midwives who did not usually administer anti-D Ig. During the session 
the community midwives deferred to the specialist midwife’s knowledge of some of 
the issues discussed and as a result a disproportionate amount of the data collected 
from this session came from this midwife. The community midwives did make a 
significant contribution on a number of the issues covered, but clearly the structure 
of this group impacted on the findings and further limited their application to a wider 
population. 
However, the purpose of this research was not to generate findings that could be 
applied to a wider population, but rather it was to collect information to support and 
expand on the findings of the previous two pieces of research. The data collected was 
limited by the participants and by the time available for exploration of topics 
however the information and findings do reflect themes identified in published 
evidence and in SHOT reports and add an important and interesting perspective to 
the data collected through the other methods employed within this thesis. The 
limitations of the research are taken into account in interpretation of the findings.  
When considered as whole piece of work the thesis has further limitations. The work 
was conducted over a number of years and practice and attitudes may have changed 
over that period of time, impacting on how the individual pieces of research relate 
and are relevant to each other. In addition although the SHOT research, Chapter six, 
and RAADP survey, Chapter five, are UK wide, the focus groups took place in two 
Scottish maternity units. Although organisation of care differed in those units the 
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midwives were practising within the context of NHS Scotland and the policy and 
practices of that organisation, educational system and culture. This may differ from 
that in the rest of the UK and could have impacted how the focus group findings 
relate to the other two pieces of research. 
The limitations of the study are important and should be taken into consideration 
when applying the findings however the work remains valuable and is relevant to 
midwives, maternity units and the wider NHS when considering the organisation and 
provision of care for pregnant women with an RhD negative blood type in the UK.  
8.5 Questions for future research 
The thesis raises a host of questions for future research, reflecting the lack of 
midwifery research in this area of practice. Some of the questions have already been 
discussed in the earlier Chapters relating to the individual pieces of research that 
make up this thesis, and elsewhere within this discussion. Further pertinent questions 
are outlined here. 
A number of research questions arise from the fact that the RAADP survey was 
conducted a number of years ago, these include: What is the current state of RAADP 
policy implementation? Do the demonstrated variations in practice continue? Are 
maternity units still producing their own leaflets? Inevitable changes in policy, 
guidance updates and the significant change in financial climate with resultant 
impact on the NHS in the UK, mean that it is highly likely that practice will have 
changed. The RAADP survey provided important contemporaneous information and 
could be repeated to answer these questions. The question of what the perceived 
barriers and enablers to implementing RAADP policy was important at the time the 
original survey was conducted, however if all UK maternity units do now offer 
RAADP the question may have become irrelevant. It might be more useful to 
conduct research to determine organisation of care in relation to provision of 
RAADP, with a focus on describing the factors that support effective provision of 
care. The influence of initiatives such as RAADP clinics and systems to hold stock of 
anti-D Ig in clinical areas could also be explored further. Any such research should 
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consider the impact that organisation of care has on compliance with guidelines and 
the provision of woman centred care. 
Further research concerning the use of paternal blood type testing is also warranted. 
There is currently no evidence to tell us about the experience of women, their 
partners or midwives who use routine paternal testing. Conducting research that 
gains opinions on how such a policy might impact on current practice and whether it 
is a practical and effective option would be an important addition to the body of 
evidence to support provision of woman centred care for RhD negative women and 
their partners.  
The research raised a number of questions about midwives knowledge and 
understanding of the issues around anti-D Ig. In particular the focus group research 
found that the midwives lacked knowledge about the issues that underpin policy and 
that this impacted on their ability and willingness to facilitate informed decision 
making. Clearly this was a very limited sample of midwives and wider ranging 
research is required to determine what midwives know about anti-D Ig and care of 
RhD negative women and the implications this has for midwifery practice and 
provision of informed choice. This aspect of research might also consider midwives 
understanding of the scope of their responsibility and accountability in this area of 
practice. Potentially this research would have implications beyond care provided for 
RhD negative women, informing other aspects of practice where medical 
intervention has become routine midwifery practice.  
8.6 Conclusion 
This research produced original and important findings that provide valuable insight 
to the care that midwives provide for women with an RhD negative blood type.   
The midwifery approach to care acknowledges the significance of women’s 
individual differences and offers care based on specific needs and choices of a 
particular woman. Midwives recognise that involving women in their own care can 
have far reaching positive consequences for them and their families (Leap, 2009). 
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This contrasts significantly with the biomedical approach to care taken by scientists 
and medical staff in which care is often based on a population perspective. Policy 
and practice recommendation surrounding care for women with an RhD negative 
blood type is developed from a biomedical approach. As such it places great value on 
evidence gathered through large quantitative studies that informs biomedical 
outcomes, and little consideration is given to evidence of other types that may 
contribute to a wider view of quality care. This approach means that midwives have 
so far made very little contribution to the evidence base or policy formation in this 
area of practice. Importantly, although midwives provide the majority of direct 
clinical care in relation to anti-D Ig and the care of women with an RhD negative 
blood type, medical staff and scientists produce policy and most often dictate 
practice. This creates a conflict where midwives may be delivering care based on 
policy and practice that is contrary to their philosophy of care. 
The research presented in this thesis represents the first time that this aspect of care 
has been considered from a midwifery perspective. The research findings are broad 
and provide a unique and valuable insight that encompasses National implementation 
of policy, provision of direct clinical care and individual midwives knowledge, 
understanding and views on key issues identified as impacting the quality of care.  
Specifically, the findings of this research describe policy implementation at National 
level, highlighting widespread implementation but with significant local level 
variations. Those local level variations tend to be factors that impact on delivery of 
woman centred care by midwives, such as offering paternal blood group testing and 
provision of information about anti-D Ig. The findings also give insight to the errors 
involving anti-D Ig that are made by midwives, and for the first time provide a 
framework for examining procedures, documentation and organisation of care. This 
will allow midwives to examine and influence practice from their own perspective: 
providing a means for midwives themselves to scrutinise the care that they deliver, 
and to put in place measures to improve the quality of care provided for women with 
an RhD negative blood type.  
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The focus group research allowed consolidation of the previous findings and led to 
the development of unique and important insight to midwifery practice in this area. 
In particular the significant finding that midwives lacked knowledge and 
understanding of issues impacting provision of care beyond straight forward policy 
and procedure was found to influence the care they provided. The research also 
highlighted that midwives and the wider organisations that employed them were 
driven to provide care in line with policy and procedure, and that this had a negative 
impact on provision of woman centred care and informed decision making.  
The research findings demonstrate the potential impact that greater midwifery 
engagement and involvement could have on policy and practice development, and on 
the quality of clinical care provided to women with an RhD negative blood type. 
They highlight specific measures that midwives can take to regain a midwifery 
perspective on this aspect of care, and are significant for individual midwives, the 
NHS organisations who employ them, professional bodies that represent midwives 
and for women with an RhD negative blood type.  
The research as a whole raises important questions about how government objectives 
for individualised, woman centred care can be achieved within the framework of 
clinical governance and evidence based care that is also set out in National policy. It 
highlights the challenges that stem from midwives’ roles and responsibilities within 
the current maternity care setting, which increasingly see them accept responsibility 
for care that originated within the medical profession. This raises questions about 
how the midwifery profession engages with medical colleagues and policy makers to 
establish a midwifery context and maintain quality care. 
This research was focussed on provision of care for RhD negative pregnant women, 
however many of the issues raised are pertinent to other aspects of midwifery 
practice and the findings raise important questions about the organisation and culture 
of maternity services, and the midwifery profession, in relation to the role of medical 
and midwifery staff. Although this research has significant limitations, the thesis 
provides important, substantial and previously absent insight to the policy, practice, 
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and professional and organisational issues that impact the care provided for women 
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Purpose and format of the session –PhD research, to find out more about what 
midwives think and how they practice.  
 
Success depends on good discussion with each other  -hope they can feel open and 
honest, and that individual opinions and experiences will be respected now and in 
workplace going forward. 
 
Will tape record the session so that I can analyse the data –can’t take notes quickly 
enough. 
 
Completely anonymous, no-one will be named or identified in any way.  
 




Scenario 1, Mary.  
 
“You are working as a community midwife.  
 
Mary, a 23year old p2+0, has complex social problems and a history of poor 
attendance at antenatal appointments.  
 
At 28 weeks Mary attends your antenatal clinic without an appointment. You go 
ahead with her check, during which she tells you that she has a negative blood type. 
 
Mary does not have her hand held notes with her, there is no GP in the surgery and 
you are unable to contact BTS to confirm her blood type. You know that Mary is 
unlikely to attend the clinic again in the next few weeks.” 
 
 
Open a general discussion about what they would do. 
 
In particular:  
What are the risks of giving her anti-D if she is in fact RhD positive? 
What are the risks of her not receiving RAADP? 
Can you justify, in terms of professional accountability, giving anti-D without knowing 
her blood group? 
Do any other factors influence the decision you make? 












What is anti-D? 
Midwives attitudes towards it -Is it safe, are they OK with giving it? Do some 




“You are working as a midwife on a busy postnatal ward.  
 
The duty FY2 tells you that Diane, a p1 who had a caesarean section last night, 
requires anti-D. The doctor writes a prescription and asks you to give the anti-D from 
ward stock. 
 
Write your actions on post-it notes, step by step, up to the point you give anti-D”. 
 
 
Steps:  Who would you speak to, if anyone? 
What would you check if anything? 
What/where do you document, if anything? 
 
Who is responsible for the error? 
 





Have they heard of SHOT? 
Who reports errors and to where? 
Do they think it’s important to report errors? 
Do people always report errors? If not, why not? 
 
 
Scenario 2, Kim 
 
“Kim, who has blood type A negative, has an SVD at 7pm and is discharged home 
the following morning. 
  
That afternoon, anti-D for Kim arrives on the ward and is placed in the fridge.   
 
When the community midwife discharges Kim on Day 10, she notices that she 
should have received anti-d but did not. The ward check and find the anti-D still in 
the fridge.” 
 
Who is responsible? 
What could have been done differently? 
How does documentation influence whether anti-D is given when it should be? 





Is there a formal way of checking whether anti-D has been omitted? – how is this 
audited? 
Is communication between community and hospital good? 
How is need for anti-D highlighted? Documentation antenatally? Discharge 
checklists, is there something pre 72hours postnatal to remind midwives? 
 
 





What formal teaching have you had, in relation to anti-D, since qualifying as a 
midwife? 
 
Is poor understanding a problem?  
 
Who do you ask if you don’t know what to do, or what a result means? 
 
 
 
 
 
 
 
 
 
 
 
 
